<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">70779</article-id><article-id pub-id-type="doi">10.7554/eLife.70779</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>A conditional gene-based association framework integrating isoform-level eQTL data reveals new susceptibility genes for schizophrenia</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-241255"><name><surname>Li</surname><given-names>Xiangyi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9408-3016</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-241256"><name><surname>Jiang</surname><given-names>Lin</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-241257"><name><surname>Xue</surname><given-names>Chao</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-241258"><name><surname>Li</surname><given-names>Mulin Jun</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-228042"><name><surname>Li</surname><given-names>Miaoxin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4733-0109</contrib-id><email>limiaoxin@mail.sysu.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0064kty71</institution-id><institution>Program in Bioinformatics, Zhongshan School of Medicine and The Fifth Affiliated Hospital, Sun Yat-sen University</institution></institution-wrap><addr-line><named-content content-type="city">Guangzhou</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution>Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education</institution><addr-line><named-content content-type="city">Guangzhou</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0064kty71</institution-id><institution>Center for Precision Medicine, Sun Yat-sen University</institution></institution-wrap><addr-line><named-content content-type="city">Guangzhou</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/045kpgw45</institution-id><institution>Research Center of Medical Sciences, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences</institution></institution-wrap><addr-line><named-content content-type="city">Guangzhou</named-content></addr-line><country>China</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02mh8wx89</institution-id><institution>The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Tianjin</named-content></addr-line><country>China</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/023te5r95</institution-id><institution>Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University</institution></institution-wrap><addr-line><named-content content-type="city">Zhuhai</named-content></addr-line><country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Konopka</surname><given-names>Genevieve</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t9vx427</institution-id><institution>University of Texas Southwestern Medical Center</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Przeworski</surname><given-names>Molly</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00hj8s172</institution-id><institution>Columbia University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>12</day><month>04</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e70779</elocation-id><history><date date-type="received" iso-8601-date="2021-05-28"><day>28</day><month>05</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-11-11"><day>11</day><month>11</month><year>2021</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-06-09"><day>09</day><month>06</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.06.08.447608"/></event></pub-history><permissions><copyright-statement>© 2022, Li et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Li et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-70779-v1.pdf"/><abstract><p>Linkage disequilibrium and disease-associated variants in the non-coding regions make it difficult to distinguish the truly associated genes from the redundantly associated genes for complex diseases. In this study, we proposed a new conditional gene-based framework called eDESE that leveraged an improved effective chi-squared statistic to control the type I error rates and remove the redundant associations. eDESE initially performed the association analysis by mapping variants to genes according to their physical distance. We further demonstrated that the isoform-level eQTLs could be more powerful than the gene-level eQTLs in the association analysis using a simulation study. Then the eQTL-guided strategies, that is, mapping variants to genes according to their gene/isoform-level variant-gene <italic>cis</italic>-eQTLs associations, were also integrated with eDESE. We then applied eDESE to predict the potential susceptibility genes of schizophrenia and found that the potential susceptibility genes were enriched with many neuronal or synaptic signaling-related terms in the Gene Ontology knowledgebase and antipsychotics-gene interaction terms in the drug-gene interaction database (DGIdb). More importantly, seven potential susceptibility genes identified by eDESE were the target genes of multiple antipsychotics in DrugBank. Comparing the potential susceptibility genes identified by eDESE and other benchmark approaches (i.e., MAGMA and S-PrediXcan) implied that strategy based on the isoform-level eQTLs could be an important supplement for the other two strategies (physical distance and gene-level eQTLs). We have implemented eDESE in our integrative platform KGGSEE (<ext-link ext-link-type="uri" xlink:href="http://pmglab.top/kggsee/">http://pmglab.top/kggsee/</ext-link>#/) and hope that eDESE can facilitate the prediction of candidate susceptibility genes and isoforms for complex diseases in a multi-tissue context.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>conditional gene-based association</kwd><kwd>chi-squared statistic</kwd><kwd>eQTLs</kwd><kwd>isoform-level expression</kwd><kwd>druggable genes</kwd><kwd>schizophrenia</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31771401</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Miaoxin</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100012166</institution-id><institution>National Key Research and Development Program of China</institution></institution-wrap></funding-source><award-id>2018YFC0910500 and 2016YFC0904300</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Miaoxin</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>Science and Technology Program of Guangzhou</institution></institution-wrap></funding-source><award-id>201803010116</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Miaoxin</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>Guangdong project</institution></institution-wrap></funding-source><award-id>2017GC010644</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Miaoxin</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31970650</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Miaoxin</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>32170637</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Miaoxin</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution>Department of Science and Technology of Guangdong Province</institution></institution-wrap></funding-source><award-id>2018B030322006</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Miaoxin</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>An improved conditional gene-based association analysis framework guided by multiple variant-gene mapping strategies was built and evaluated based on its performance in predicting the potential susceptibility isoforms, genes, and tissues of schizophrenia.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Genome-wide association studies (GWASs) have been used to identify genotype-phenotype associations for over a decade, and thousands of single-nucleotide polymorphisms (SNPs) have been revealed for their associations with hundreds or thousands of complex human diseases (<xref ref-type="bibr" rid="bib46">Visscher et al., 2017</xref>; <xref ref-type="bibr" rid="bib10">Gallagher and Chen-Plotkin, 2018</xref>). Nevertheless, conventional GWASs analyses have limited power to produce a complete set of susceptibility variants for complex diseases (<xref ref-type="bibr" rid="bib43">Tam et al., 2019</xref>). Because most susceptibility SNPs only have small effects on a complex phenotype, conventional SNP-based association tests are generally underpowered to reveal susceptibility variants after multiple-testing corrections. Moreover, the susceptibility variants scattering randomly throughout the genome are often in strong linkage disequilibrium (LD) with numerous neutral SNPs, which makes the discrimination of truly causal variants from GWAS hits quite difficult (<xref ref-type="bibr" rid="bib43">Tam et al., 2019</xref>). Finally, more than 90% of the disease-associated variants are in non-coding regions of the genome, and many of them are far from the nearest known gene, and it remains a challenge to link genes and a complex phenotype through the non-coding variants (<xref ref-type="bibr" rid="bib41">Schaub et al., 2012</xref>; <xref ref-type="bibr" rid="bib34">Maurano et al., 2012</xref>). Accordingly, corresponding methodological strategies have been proposed to make up, at least partly, for the issues mentioned above.</p><p>First, gene-based approaches can reduce the multiple-testing burdens by considering the association between a phenotype and all variants within a gene (<xref ref-type="bibr" rid="bib36">Neale and Sham, 2004</xref>). Assigning a variant to a gene according to the physical distance of the variant from gene boundary is one of the most popular strategies for gene-based approaches. For example, MAGMA (Multi-marker Analysis of GenoMic Annotation), one of the most popular gene-based approaches, uses a multiple regression approach to incorporate LD between markers and detect multi-markers effects to perform gene-based analysis (<xref ref-type="bibr" rid="bib6">de Leeuw et al., 2015</xref>). VEGAS, a versatile gene-based test for GWAS, incorporates information from a full set of markers (or a defined subset) within a gene and accounts for LD between markers by simulations from the multivariate normal distribution (<xref ref-type="bibr" rid="bib33">Liu et al., 2010</xref>). GATES, a rapid gene-based association test that uses an extended Simes procedure to assess the statistical significance of gene-level associations (<xref ref-type="bibr" rid="bib30">Li et al., 2011</xref>). SuSiE (sum of single effects), a novel and popular approach to variable selection in linear regression, can use summary statistics and LD to produce gene-level evidence of association in terms of Bayes Factor (<xref ref-type="bibr" rid="bib47">Wang et al., 2020</xref>).</p><p>Second, evaluating the gene-phenotype associations at one gene conditioning on other genes can isolate true susceptibility genes from the redundant non-susceptibility genes (<xref ref-type="bibr" rid="bib31">Li et al., 2019</xref>). <xref ref-type="bibr" rid="bib49">Yang et al., 2012</xref> proposed an approximate conditional and joint association analysis method based on linear regression analysis to estimate the individual causal variant with GWAS summary statistics. Our previously proposed conditional gene-based association approach based on effective chi-squared statistics (ECS) could remove redundantly associated genes based on the GWAS p-values of variants. Comparing the conditional gene-based association approach with ECS, MAGMA, and VEGAS suggested that the former might be more powerful to predict biologically sensible susceptibility genes (<xref ref-type="bibr" rid="bib31">Li et al., 2019</xref>).</p><p>Third, the observation that variants in the non-coding regions were enriched in the transcriptional regulatory regions implied that these variants might affect the disease risk by altering the genetic regulation of target genes (<xref ref-type="bibr" rid="bib10">Gallagher and Chen-Plotkin, 2018</xref>). Integration of expression quantitative trait loci (eQTL) studies and GWAS has been used to investigate the genetic regulatory effects on complex diseases. As many complex diseases manifested themselves in certain tissues, using the eQTLs of potentially phenotype-associated tissues might help identify the true susceptibility genes in the tissue context (<xref ref-type="bibr" rid="bib19">Hekselman and Yeger-Lotem, 2020</xref>). Based on the framework of MAGMA, a method called eMAGMA integrated genetic and transcriptomic information (e.g. eQTLs) in a tissue-specific analysis to identify risk genes and was applied to identify novel genes underlying the major depression disorder (<xref ref-type="bibr" rid="bib16">Gerring et al., 2021</xref>; <xref ref-type="bibr" rid="bib15">Gerring et al., 2019</xref>). S-PrediXcan was developed for imputing the genetically regulated gene expression component based on GWAS summary statistics and transcriptome prediction models built from the eQTL/splicing QTL dataset of the Genotype Tissue Expression (GTEx) project (<xref ref-type="bibr" rid="bib2">Barbeira et al., 2018</xref>). Researchers have applied S-PrediXcan to study genetic mechanisms of multiple complex traits (<xref ref-type="bibr" rid="bib13">Gamazon et al., 2019</xref>; <xref ref-type="bibr" rid="bib12">Gamazon et al., 2018</xref>; <xref ref-type="bibr" rid="bib23">Huckins et al., 2019</xref>). In contrast to the considerable research focusing on integrating gene-level eQTLs with GWAS summary statistics, little attention has been paid to integrating isoform-level eQTLs with GWAS summary statistics. Michael Gandal et al. estimated the candidate risk genes of three psychiatric disorders based on GWAS summary statistics and isoform-level expression profiles. They emphasized the importance of isoform-level gene regulatory mechanisms in defining cell type and disease specificity (<xref ref-type="bibr" rid="bib14">Gandal et al., 2018</xref>), and similar analyses and conclusions were generated for Alzheimer’s disease (<xref ref-type="bibr" rid="bib7">Fan et al., 2021</xref>).</p><p>Although much achievement has been attained, identifying independently phenotype-associated genes with high reliability remains challenging, especially for complex diseases. Conventional gene-based approaches mainly focus on variants close (say ±5 kilo base pairs) to genes boundary and omit the distal but important variant-gene associations. Gene-based association approaches using eQTLs to identify candidate susceptibility genes and isoforms might raise the utilization rate of the distal but important variant-gene associations. The present study aimed to build a more powerful conditional gene-based framework based on a new ECS and mainly guided by eQTLs. We also investigated whether isoform-level eQTLs in the phenotype-associated tissues can help predict more significant susceptibility genes than gene-level eQTLs. The main assumption is that isoform-level eQTLs may reflect the more real regulatory relationship than gene-level eQTLs. Thus, using isoform-level eQTLs can help predict novel susceptibility genes and isoforms that the conventional gene-based approaches and gene-level eQTLs strategy cannot find. The following is the formation procedure of the assumption: Gene-level and isoform-level eQTLs are predicted based on the gene-level and isoform-level (or transcript-level) expression profiles, and the gene-level expression profiles are computed by averaging the expression of multiple isoforms produced by the gene. Thus, gene-level expression profiles may omit the expression heterogeneity among these isoforms, neutralize the opposite effects, and lower the power of gene-level eQTLs.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Overview of the present study</title><p>We previously proposed an <italic><underline>e</underline></italic>ffective <italic><underline>c</underline></italic>hi-squared <italic><underline>s</underline></italic>tatistic called ECS for the unconditional and conditional gene-based association analysis (<xref ref-type="bibr" rid="bib31">Li et al., 2019</xref>). Then we built a unified framework called DESE to estimate the potentially phenotype-associated tissues based on the conditional gene-based association analysis with ECS and gene selective expression analysis (<xref ref-type="bibr" rid="bib24">Jiang et al., 2019</xref>). However, we found that the previous ECS was hindered by a potential type I error inflation issue and further undermined the accuracy of DESE. Here we proposed a new conditional gene-based association framework, eDESE (<italic><underline>e</underline></italic>QTL-guided <italic><underline>DESE</underline></italic>), which could also perform conditional gene-based association analysis and geneselective expression analysis, to systematically explore the susceptibility genes and tissues associated with complex diseases by using the GWAS summary statistics and multiple gene-variant mapping strategies. eDESE inherited the framework of DESE but had two important advantages over DESE. First, eDESE is built based on a new ECS, with which the type I error could be controlled within a proper level. Second, eDESE expands the conditional gene-based association analysis of DESE by not only using physically nearby SNPs but also using the gene-level and isoform-level <italic>cis</italic>-eQTLs associations (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>The advantages of eDESE over ECS and DESE.</title><p>First, we proposed a new ECS and chose the best exponent <italic>c</italic> between 1 and 2 to properly control the type I error. Second, we first adopted three strategies to map SNP to genes to perform the unconditional gene-based association analysis with the improved ECS. Then the unconditional gene-based association analysis results were put into the conditional gene-based association analysis and the following iterative procedure. 5 kb: 5000 base pairs. 1 Mb: 10<sup>6</sup> base pairs.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70779-fig1-v1.tif"/></fig><p>To evaluate the performance of the new ECS and eDESE, we performed extensive simulations and a real data application to schizophrenia. Specifically, we organized the present study in several sequential parts that cover the optimizing the exponent of chi-squared statistics to control the type I error rates, applying the new ECS to perform conditional gene-based association analysis in simulation data and real-world schizophrenia GWAS summary statistics data. For simplicity and clarity, the model integrating different mapping strategies, that is, physically nearby SNPs (<italic><underline>dist</underline></italic>ance),<underline> g</underline><italic><underline>ene</underline></italic>-level and <italic><underline>isoform</underline></italic>-level variant-gene <italic>cis</italic>-eQTLs associations, were named eDESE:dist, eDESE:gene and eDESE:isoform, respectively.</p></sec><sec id="s2-2"><title>Choose the favorable exponent <italic>c</italic> for the correlation matrix of chi-squared statistics to control the type I error rates</title><p>We found that the exponent <italic>c</italic> in the correlation matrix of chi-squared statistics could determine the deviation of the p-values produced by the ECS tests against the uniform distribution. As shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>, the <italic>c</italic> = 1.0 led to deflated p-values while the <italic>c</italic> = 2.0 led to inflated p-values in the upper tail of the Q-Q plot against the uniform distribution. This pattern was independent of sample sizes, variant number and phenotype distribution (for binary or continuous traits) (<xref ref-type="fig" rid="fig2">Figure 2</xref>). The stable trend determined by the <italic>c</italic> value also implied that the favorable <italic>c</italic>, which could properly control the type I error rate, measured by the minimal mean log fold change (MLFC), must be within range 1 and 2. Besides, our theoretical derivation also demonstrated that the <italic>c</italic> value should be within range 1 and 2. Moreover, it seemed that given the <italic>c</italic> value, the distributions of p-values were similar at different sample sizes and phenotype distributions. <xref ref-type="fig" rid="fig3">Figure 3</xref> shows the favorable <italic>c</italic> obtained by the grid search algorithm at 84 different scenarios. As shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>, most majority p-values at the sample size 10,000 and 40,000 of binary or continuous phenotypes are overlapped. Again, the favorable <italic>c</italic> values were approximately independent of trait types, sample sizes and variant number. For the sake of simplicity, we proposed to use the averaged favorable <italic>c</italic> value, 1.432, and integrated it into the improved ECS.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Q-Q plots of the p-value of the ECS test under null hypothesis based on the two extreme exponents (i.e. 1 and 2).</title><p>(<bold>a</bold>), (<bold>b</bold>), and (<bold>c</bold>) represent the variant number of 50, 100, and 500, respectively.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70779-fig2-v1.tif"/></fig><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>The boxplots of the favorable <italic>c</italic> values at different simulation scenarios.</title><p>(<bold>a</bold>) Binary and continuous phenotypes; (<bold>b</bold>) Different sample sizes; (<bold>c</bold>) Different variant number.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70779-fig3-v1.tif"/></fig></sec><sec id="s2-3"><title>The type I error and power of the conditional gene-based association analysis based on the new effective chi-squared statistics (ECS)</title><p>We then investigated the type I error and power of the conditional gene-based association analysis based on the improved ECS with the favorable exponent <italic>c</italic> value. As shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>, in six different scenarios, the conditional p-values of the genes without truly casual loci approximately follow the uniform distribution <italic>U</italic>[0,1], regardless of the variance explained by its nearby genes. Moreover, the distribution of conditional p-value was similar to that produced by the conventional likelihood ratio test for the nested linear regression models. These results suggested that the conditional gene-based association analysis based on the improved ECS could produce valid p-values for statistical inference. In contrast, the unconditional association test based on the improved ECS produced an inflated p-value due to the indirect associations produced by the nearby causal genes in the LD block. Concerning the statistical power, we found that conditional gene-based association analysis based on the improved ECS produced smaller p-values than the likelihood ratio test (<xref ref-type="fig" rid="fig5">Figure 5</xref>), suggesting a higher statistical power of the former. Another advantage of conditional gene-based association analysis based on the improved ECS over the likelihood ratio test was that the former did not require individual genotypes. The reason might be that the degree of freedom in the latter was inflated by the LD among variants.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Q-Q plots of the conditional, unconditional gene-based association test and likelihood-ratio test under the null hypothesis.</title><p>(<bold>a</bold>) and (<bold>d</bold>) two gene-variant pairs with the similar variant number (SIPA1L2 with 29 variants and LOC729336 with 30 variants). (<bold>b</bold>) and (<bold>e</bold>) two gene-variant pairs with the different variant number, and the first is larger than the second (CACHD1 with 41 variants and RAVER2 with eight variants). (<bold>c</bold>) and (<bold>f</bold>) Two gene-variant pairs with the different variant number, and the second is larger than the first (LOC647132 with five variants and FAM5C with 48 variants). (<bold>a</bold>), (<bold>b</bold>) and (<bold>c</bold>) The former gene has no QTL, and QTL explained 0.5 % of heritability in the latter gene. (<bold>d</bold>), (<bold>e</bold>) and (<bold>f</bold>) The former gene has no QTL, and QTL explained 1 % of heritability in the latter gene. Ten thousand phenotype datasets were simulated for each scenario. Unconditional Eff. Chi. (the red) represents unconditional association analysis at the former gene by the improved ECS. Conditional Eff. Chi (the blue) represents conditional association analysis at the former gene conditioning on the latter gene by the improved ECS. The likelihood ratio test (the yellow) was conducted based on the nested linear regression models.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70779-fig4-v1.tif"/></fig><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Q-Q plots of the conditional gene-based association test and likelihood-ratio test at different representative gene-variant pairs.</title><p>The variant number of the two gene-variant pairs involved in (<bold>a</bold>)<bold>-</bold>(<bold>f</bold>) are the same as that in <xref ref-type="fig" rid="fig4">Figure 4</xref> legend. The difference is: in (<bold>a</bold>)-(<bold>c</bold>), the QTL in either gene (former and latter) explained 0.25% of heritability. In (<bold>d</bold>)-(<bold>f</bold>), the QTL in either gene explained 0.5% of heritability. One thousand phenotype datasets were simulated for each scenario.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70779-fig5-v1.tif"/></fig></sec><sec id="s2-4"><title>Apply eDESE:dist to predict the potential susceptibility genes of schizophrenia</title><p>We had demonstrated that the conditional gene-based analysis based on the improved ECS was more powerful than the likelihood ratio test in each simulation scenario. To evaluate the performance of the ECS and eDESE in the real-world data, we used a recent large-scale GWAS summary statistics dataset (<xref ref-type="bibr" rid="bib45">Trubetskoy et al., 2022</xref>) and gene expression profiles (GTEx v8) of multiple human tissues (<xref ref-type="bibr" rid="bib5">Consortium, 2020</xref>) to identify the susceptibility genes of schizophrenia. We found that the improved ECS identified 739 significant genes without conditioning on gene-expression profiles. Furthermore, we also found 205 significant genes out of the above 739 genes identified by eDESE:dist based on the improved ECS by conditioning on the gene-level expression profiles (see details in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>).</p><p>We then compared the significant susceptibility genes identified by eDESE:dist with that of MAGMA. We identified 619 significant susceptibility genes based on MAGMA. The significant gene count of MAGMA was about three times larger than that of eDESE:dist, which might partly result from the conditional gene-based analysis’s advantage of removing the redundantly associated genes. Besides, more than half of the significant susceptibility genes identified by eDESE:dist were also identified by MAGMA (<xref ref-type="fig" rid="fig6">Figure 6a</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>The comparison of the potential susceptibility genes for schizophrenia identified by MAGMA and eDESE:dist.</title><p>(<bold>a</bold>) The Venn diagram shows the overlapped and unique genes identified by MAGMA and eDESE:dist. (<bold>b</bold>) The bar plot shows the top GO enrichment terms of the overlapped genes. MF: Molecular Function of GO. BP: Biological Process terms of GO. CC: Cellular Component terms of GO. The <italic>x</italic>-axis label represents the top ( ≤ 10) significant GO enrichment terms (MF, BP, and CC). The <italic>y</italic>-axis label represents the negative log10 of the adjusted p-value of each term. See also <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>, <xref ref-type="supplementary-material" rid="fig6sdata2">Figure 6—source data 2</xref> and <xref ref-type="supplementary-material" rid="fig6sdata3">Figure 6—source data 3</xref>.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Significant genes identified by MAGMA.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70779-fig6-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Significant genes identified by eDESE:dist.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70779-fig6-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata3"><label>Figure 6—source data 3.</label><caption><title>Enrichment results of the common 105 genes identified by MAGMA and eDESE:dist.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70779-fig6-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70779-fig6-v1.tif"/></fig><p>Further, we performed Gene Ontology (GO) enrichment analysis to study the functional annotations of these significant genes. Interestingly, we found that most GO:BP and GO:CC enrichment terms of the overlapped genes were neuronal-, dendrite- or synaptic signaling-related terms. The GO:MF enrichment terms of the overlapped genes were all about signaling transduction (see examples in <xref ref-type="fig" rid="fig6">Figure 6b</xref> and details in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). We then found that the unique genes identified by eDESE:dist were enriched with three GO:CC terms, that is, dendrite, dendritic tree and distal axon, which were all dendrite-related terms. However, although the unique genes identified by MAGMA were enriched with thirty-one GO terms, none of these terms were neuronal-, dendrite-, or synaptic signaling-related terms. Moreover, systematic text-mining results in PubMed showed that 67 of the 205 (~32.7%) and 170 of the 619 (~27.5%) potential susceptibility genes had at least two search hits for eDESE:dist and MAGMA, respectively (see details in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c</xref>). The GO enrichment results and the text-mining results both implied the utility of eDESE:dist.</p></sec><sec id="s2-5"><title>Evaluate the type I error and power of gene-level eQTLs and isoform-level eQTLs in association analysis based on ECS</title><p>Next, we mapped variants to genes (or isoforms) according to their variant-gene/isoform eQTLs associations. Since the isoform-level and corresponding gene-level expression profiles were quantified based on the same RNA-sequencing data, we then investigated the type I error and power of the association analysis by ECS based on the gene-level and isoform-level eQTLs.</p><p>We considered the multiple different scenarios that variants affected phenotype through regulating the gene expression. We simulated genotype data, gene-level and isoform-level expression data and corresponding phenotype data. In <xref ref-type="table" rid="table1">Table 1</xref>, AllVar means that all variants are used in the gene-based association analysis based on ECS. IsoeQTL denotes that the eQTL is associated with a susceptibility isoform. GeneQTL denotes that the eQTL is associated with a gene whose expression is averaged from three susceptibility isoforms (homogeneity). Gen3eQTL and Gen6eQTL denote that the eQTL is associated with a gene whose expression is averaged by three and six isoforms, one of which is the susceptibility isoform (heterogeneity), respectively.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Type I error and power of different simulation scenarios in association analysis.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Scenarios</th><th align="left" colspan="3" valign="top">Important parameters</th><th align="left" colspan="5" valign="top">Binary trait</th><th align="left" colspan="5" valign="top">Continuous trait</th></tr></thead><tbody><tr><td align="left" valign="top"/><td align="char" char="." valign="top"><bold>Eg</bold></td><td align="left" valign="top"><bold>Vgp</bold></td><td align="left" valign="top"><bold>Vge</bold></td><td align="left" valign="top"><bold>AllVar</bold></td><td align="left" valign="top"><bold>IsoeQTL</bold></td><td align="left" valign="top"><bold>GeneQTL</bold></td><td align="left" valign="top"><bold>Gen3eQTL</bold></td><td align="left" valign="top"><bold>Gen6eQTL</bold></td><td align="left" valign="top"><bold>AllVar</bold></td><td align="left" valign="top"><bold>IsoeQTL</bold></td><td align="left" valign="top"><bold>GeneQTL</bold></td><td align="left" valign="top"><bold>Gen3eQTL</bold></td><td align="left" valign="top"><bold>Gen6eQTL</bold></td></tr><tr><td align="left" valign="top"/><td align="left" colspan="3" valign="top"/><td align="left" colspan="10" valign="top"><bold>Type I error</bold></td></tr><tr><td align="char" char="." valign="top">1</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0.05</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0.002</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0.001</td><td align="char" char="." valign="top">0.002</td><td align="char" char="." valign="top">0.003</td></tr><tr><td align="char" char="." valign="top">2</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0.15</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0.002</td><td align="char" char="." valign="top">0.001</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0.001</td><td align="char" char="." valign="top">0</td></tr><tr><td align="char" char="." valign="top">3</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0.3</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0.002</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0.001</td><td align="char" char="." valign="top">0.001</td><td align="char" char="." valign="top">0.002</td><td align="char" char="." valign="top">0.002</td></tr><tr><td align="left" valign="top"/><td align="left" colspan="3" valign="top"/><td align="left" colspan="10" valign="top"><bold>Power</bold></td></tr><tr><td align="char" char="." valign="top">4</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0.005</td><td align="char" char="." valign="top">0.05</td><td align="char" char="." valign="top">0.251</td><td align="char" char="." valign="top">0.036</td><td align="char" char="." valign="top">0.022</td><td align="char" char="." valign="top">0.034</td><td align="char" char="." valign="top">0.031</td><td align="char" char="." valign="top">0.246</td><td align="char" char="." valign="top">0.032</td><td align="char" char="." valign="top">0.019</td><td align="char" char="." valign="top">0.032</td><td align="char" char="." valign="top">0.038</td></tr><tr><td align="char" char="." valign="top">5</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0.005</td><td align="char" char="." valign="top">0.15</td><td align="char" char="." valign="top">0.219</td><td align="char" char="." valign="top">0.021</td><td align="char" char="." valign="top">0.013</td><td align="char" char="." valign="top">0.023</td><td align="char" char="." valign="top">0.032</td><td align="char" char="." valign="top">0.301</td><td align="char" char="." valign="top">0.025</td><td align="char" char="." valign="top">0.017</td><td align="char" char="." valign="top">0.037</td><td align="char" char="." valign="top">0.043</td></tr><tr><td align="char" char="." valign="top">6</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0.005</td><td align="char" char="." valign="top">0.3</td><td align="char" char="." valign="top">0.229</td><td align="char" char="." valign="top">0.028</td><td align="char" char="." valign="top">0.017</td><td align="char" char="." valign="top">0.021</td><td align="char" char="." valign="top">0.034</td><td align="char" char="." valign="top">0.282</td><td align="char" char="." valign="top">0.024</td><td align="char" char="." valign="top">0.017</td><td align="char" char="." valign="top">0.025</td><td align="char" char="." valign="top">0.039</td></tr><tr><td align="char" char="." valign="top">7</td><td align="char" char="." valign="top">0.1</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0.05</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top"><bold>0.017</bold></td><td align="char" char="." valign="top"><bold>0.019</bold></td><td align="char" char="." valign="top">0.006</td><td align="char" char="." valign="top">0.001</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top"><bold>0.017</bold></td><td align="char" char="." valign="top"><bold>0.027</bold></td><td align="char" char="." valign="top">0.009</td><td align="char" char="." valign="top">0.001</td></tr><tr><td align="char" char="." valign="top">8</td><td align="char" char="." valign="top">0.1</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0.15</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top"><bold>0.213</bold></td><td align="char" char="." valign="top"><bold>0.221</bold></td><td align="char" char="." valign="top">0.113</td><td align="char" char="." valign="top">0.054</td><td align="char" char="." valign="top">0.002</td><td align="char" char="." valign="top"><bold>0.245</bold></td><td align="char" char="." valign="top"><bold>0.245</bold></td><td align="char" char="." valign="top">0.132</td><td align="char" char="." valign="top">0.068</td></tr><tr><td align="char" char="." valign="top">9</td><td align="char" char="." valign="top">0.1</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0.3</td><td align="char" char="." valign="top">0.018</td><td align="char" char="." valign="top"><bold>0.704</bold></td><td align="char" char="." valign="top"><bold>0.659</bold></td><td align="char" char="." valign="top">0.581</td><td align="char" char="." valign="top">0.388</td><td align="char" char="." valign="top">0.027</td><td align="char" char="." valign="top"><bold>0.72</bold></td><td align="char" char="." valign="top"><bold>0.686</bold></td><td align="char" char="." valign="top">0.607</td><td align="char" char="." valign="top">0.446</td></tr><tr><td align="char" char="." valign="top">10</td><td align="char" char="." valign="top">0.1</td><td align="char" char="." valign="top">0.005</td><td align="char" char="." valign="top">0.05</td><td align="char" char="." valign="top">0.288</td><td align="char" char="." valign="top"><bold>0.052</bold></td><td align="char" char="." valign="top"><bold>0.076</bold></td><td align="char" char="." valign="top">0.043</td><td align="char" char="." valign="top">0.043</td><td align="char" char="." valign="top">0.313</td><td align="char" char="." valign="top"><bold>0.063</bold></td><td align="char" char="." valign="top"><bold>0.091</bold></td><td align="char" char="." valign="top">0.05</td><td align="char" char="." valign="top">0.041</td></tr><tr><td align="char" char="." valign="top">11</td><td align="char" char="." valign="top">0.1</td><td align="char" char="." valign="top">0.005</td><td align="char" char="." valign="top">0.15</td><td align="char" char="." valign="top">0.403</td><td align="char" char="." valign="top"><bold>0.33</bold></td><td align="char" char="." valign="top"><bold>0.302</bold></td><td align="char" char="." valign="top">0.199</td><td align="char" char="." valign="top">0.134</td><td align="char" char="." valign="top">0.46</td><td align="char" char="." valign="top"><bold>0.357</bold></td><td align="char" char="." valign="top"><bold>0.334</bold></td><td align="char" char="." valign="top">0.229</td><td align="char" char="." valign="top">0.136</td></tr><tr><td align="char" char="." valign="top">12</td><td align="char" char="." valign="top">0.1</td><td align="char" char="." valign="top">0.005</td><td align="char" char="." valign="top">0.3</td><td align="char" char="." valign="top">0.569</td><td align="char" char="." valign="top"><bold>0.778</bold></td><td align="char" char="." valign="top"><bold>0.738</bold></td><td align="char" char="." valign="top">0.677</td><td align="char" char="." valign="top">0.485</td><td align="char" char="." valign="top">0.62</td><td align="char" char="." valign="top"><bold>0.805</bold></td><td align="char" char="." valign="top"><bold>0.774</bold></td><td align="char" char="." valign="top">0.712</td><td align="char" char="." valign="top">0.512</td></tr></tbody></table><table-wrap-foot><fn><p>Eg denotes the effect size of gene expression on phenotype. Vgp denotes phenotype variance explained by all variants. Vge denotes gene expression variance explained by all variants.</p></fn></table-wrap-foot></table-wrap><p>As shown in <xref ref-type="table" rid="table1">Table 1</xref>, our simulations' type I error rates are controlled within 0% ~ 0.3% (on average &lt;0.1%) according to the p-value threshold 0.001 (scenarios 1–3). As expected, in scenarios 4–6, where gene expression cannot affect the phenotype (Eg = 0 in <xref ref-type="table" rid="table1">Table 1</xref>), AllVar is much more powerful than eQTLs. Further, in scenarios 7–12, where gene expression can affect the phenotype, our results suggest that the powers of eQTLs roughly increase with the phenotype variance explained by all variants (Vgp in <xref ref-type="table" rid="table1">Table 1</xref>) and gene expression variance explained by all variants (Vge in <xref ref-type="table" rid="table1">Table 1</xref>). Moreover, in scenarios 7–12, associations test totally based on the susceptibility isoforms (IsoeQTL and GeneQTL in <xref ref-type="table" rid="table1">Table 1</xref>) are more powerful than those based on the gene-level eQTLs. While IsoeQTL is computed based on fewer (i.e. one) susceptibility isoforms than GeneQTL (i.e. three), the power of IsoeQTL is the equal of GeneQTL. Thus, our simulation results revealed that isoform-level eQTLs were more powerful than gene-level eQTLs in association analysis in the scenarios that gene expression could affect the phenotype.</p></sec><sec id="s2-6"><title>Estimate the potentially phenotype-associated tissues for schizophrenia</title><p>Like DESE, eDESE can produce phenotype-associated genes and tissues. Therefore, we firstly adopted eDESE:dist to predict the phenotype-associated tissues of schizophrenia and found that all thirteen brain regions were significantly associated with schizophrenia and ranked the top based on the gene-level and isoform-level expression profiles, respectively (see details in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1d</xref>).</p><p>Since all thirteen brain regions were predicted as the potentially phenotype-associated tissues of schizophrenia by eDESE:dist, removing the possible false positives would be necessary. Then we resorted to the eQTLs and assumed that if a tissue (say <italic>T<sub>1</sub></italic>) is a phenotype-associated tissue, potential susceptibility genes identified based on the eQTLs of <italic>T<sub>1</sub></italic> will be more likely to be phenotype-associated genes and selectively express in <italic>T<sub>1</sub></italic> or similar tissues. We then computed the gene-level and isoform-level eQTLs of all thirteen brain regions and predicted the potentially phenotype-associated tissues using eDESE:gene and eDESE:isoform, respectively. Our results showed that the brain (all thirteen brain regions as a whole) was predicted as the schizophrenia-associated tissue based on the gene-level eQTLs of twelve brain regions, respectively (<xref ref-type="table" rid="table2">Table 2</xref>). However, on the more precise resolution, we found brain was predicted as schizophrenia-associated tissue only based on the isoform-level eQTLs of five brain regions, respectively (<xref ref-type="table" rid="table2">Table 2</xref>). Thus, the five brain regions were collectively optimized as the potentially phenotype-associated tissues of schizophrenia by eDESE:dist, eDESE:gene, and eDESE:isoform.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>The result about whether the brain was optimized as the schizophrenia-associated tissue based on each brain region’s gene/isoform-level eQTLs.</title><p><supplementary-material id="table2sdata1"><label>Table 2—source data 1.</label><caption><title>Tissue significance estimated by eDESE:dist based on the gene-level expression profiles.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70779-table2-data1-v1.xlsx"/></supplementary-material><supplementary-material id="table2sdata2"><label>Table 2—source data 2.</label><caption><title>Tissue significance estimated by eDESE:dist based on the isoform-level expression profiles.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70779-table2-data2-v1.xlsx"/></supplementary-material><supplementary-material id="table2sdata3"><label>Table 2—source data 3.</label><caption><title>Tissue significance estimated by eDESE:gene based on the gene-level eQTLs of each brain region.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70779-table2-data3-v1.xlsx"/></supplementary-material><supplementary-material id="table2sdata4"><label>Table 2—source data 4.</label><caption><title>Tissue significance estimated by eDESE:isoform based on the isoform-level eQTLs of each brain region.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70779-table2-data4-v1.xlsx"/></supplementary-material></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Brain regions</th><th align="left" valign="top">Gene-level eQTL</th><th align="left" valign="top">Isoform-level eQTL</th></tr></thead><tbody><tr><td align="left" valign="top"><bold>Brain-Anterior cingulate cortex (BA24</bold>)</td><td align="left" valign="top">Yes</td><td align="left" valign="top">Yes</td></tr><tr><td align="left" valign="top"><bold>Brain-Cerebellum</bold></td><td align="left" valign="top">Yes</td><td align="left" valign="top">Yes</td></tr><tr><td align="left" valign="top"><bold>Brain-Frontal Cortex (BA9</bold>)</td><td align="left" valign="top">Yes</td><td align="left" valign="top">Yes</td></tr><tr><td align="left" valign="top"><bold>Brain-Hippocampus</bold></td><td align="left" valign="top">Yes</td><td align="left" valign="top">Yes</td></tr><tr><td align="left" valign="top"><bold>Brain-Spinal cord (cervical c-1</bold>)</td><td align="left" valign="top">Yes</td><td align="left" valign="top">Yes</td></tr><tr><td align="left" valign="top">Brain-Amygdala</td><td align="left" valign="top">Yes</td><td align="left" valign="top">No</td></tr><tr><td align="left" valign="top">Brain-Caudate (basal ganglia)</td><td align="left" valign="top">Yes</td><td align="left" valign="top">No</td></tr><tr><td align="left" valign="top">Brain-Cerebellar Hemisphere</td><td align="left" valign="top">Yes</td><td align="left" valign="top">No</td></tr><tr><td align="left" valign="top">Brain-Cortex</td><td align="left" valign="top">Yes</td><td align="left" valign="top">No</td></tr><tr><td align="left" valign="top">Brain-Hypothalamus</td><td align="left" valign="top">Yes</td><td align="left" valign="top">No</td></tr><tr><td align="left" valign="top">Brain-Nucleus accumbens (basal ganglia)</td><td align="left" valign="top">Yes</td><td align="left" valign="top">No</td></tr><tr><td align="left" valign="top">Brain-Putamen (basal ganglia)</td><td align="left" valign="top">No</td><td align="left" valign="top">No</td></tr><tr><td align="left" valign="top">Brain-Substantia nigra</td><td align="left" valign="top">Yes</td><td align="left" valign="top">No</td></tr></tbody></table><table-wrap-foot><fn><p>“Yes” denotes that brain (i.e., all thirteen brain tissues) was estimated as the significantly schizophrenia-associated tissue based on the gene/isoform-level eQTLs of the tissue. “No” denotes the contrary. The font names of the optimized brain regions are bold. See also <xref ref-type="supplementary-material" rid="table2sdata1">Table 2—source data 1</xref>, <xref ref-type="supplementary-material" rid="table2sdata2">Table 2—source data 2</xref>, <xref ref-type="supplementary-material" rid="table2sdata3">Table 2—source data 3</xref> and <xref ref-type="supplementary-material" rid="table2sdata4">Table 2—source data 4</xref>.</p></fn></table-wrap-foot></table-wrap><p>In contrast, we predicted schizophrenia-associated tissues based on the gene-level and isoform-level eQTLs of Muscle Skeletal and Skin Sun Exposed Lower Leg, whose sample sizes were bigger than all the other tissues in GTEx(v8). The prediction results of Muscle Skeletal and Skin Sun Exposed Lower Leg showed that neither of them was predicted to be significant tissues of schizophrenia by using their gene-level and isoform-level eQTLs (see details in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1e</xref>), which demonstrated, at least partly, our assumption. Thus, our results showed the utility of integrating the three models of eDESE for optimizing the phenotype-associated tissues.</p></sec><sec id="s2-7"><title>The comparison of eDESE:isoform versus eDESE:gene and S-PrediXcan</title><sec id="s2-7-1"><title>eDESE:isoform can identify more potential susceptibility genes</title><p>Our simulation study demonstrated that association analysis based on the improved ECS with the isoform-level eQTLs was more powerful than with the gene-level eQTLs. We further tested this finding in the real data and identified the potential susceptibility genes for schizophrenia using the eDESE:isoform and eDESE:gene, respectively. We found the number of potential susceptibility genes identified by eDESE:isoform was larger than that of eDESE:gene and S-PrediXcan under the same adjustment filter cutoff (<xref ref-type="fig" rid="fig7">Figure 7a</xref>, see details in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1fg and h</xref>). We further combined the potential susceptibility genes of the five optimized brain regions identified by S-PrediXcan, eDESE:gene and eDESE:isoform, respectively. Still, we found that the susceptibility genes exclusively identified by eDESE:isoform were the most among the three models (<xref ref-type="fig" rid="fig7">Figure 7b</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Comparison of the potential susceptibility genes identified by S-PrediXcan, eDESE:gene, and eDESE:isoform.</title><p>(<bold>a</bold>) The bar plot shows the count of potential susceptibility genes in each of the five optimized brain regions. (<bold>b</bold>) The Venn diagram shows the count of the overlapped and unique genes identified by S-PrediXcan, eDESE:gene and eDESE:isoform in the five optimized brain regions. See also <xref ref-type="supplementary-material" rid="fig7sdata1">Figure 7—source data 1</xref> and <xref ref-type="supplementary-material" rid="fig7sdata2">Figure 7—source data 2</xref>.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>The count of potential susceptibility genes in each of the five optimized brain regions.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70779-fig7-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig7sdata2"><label>Figure 7—source data 2.</label><caption><title>The potential susceptibility genes identified by S-PrediXcan, eDESE:gene and eDESE:isoform in the five optimized brain regions.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70779-fig7-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70779-fig7-v1.tif"/></fig></sec><sec id="s2-7-2"><title>Potential susceptibility genes identified by eDESE:isoform were supported by more published studies</title><p>Then we searched the PubMed database with the combined susceptibility gene set (i.e. 391 genes for S-PrediXcan, 633 genes for eDESE:gene, and 854 genes for eDESE:isoform, <xref ref-type="fig" rid="fig7">Figure 7b</xref>) of all five optimized brain regions. We found that 135 genes for S-PrediXcan, 170 genes for eDESE:gene and 247 genes for eDESE:isoform had at least one search hit which reported the associations of these genes with schizophrenia in PubMed database, respectively (see details in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1ij and k</xref>).</p><p>We also found 138 of the 524 (26.3%) potential susceptibility genes exclusively predicted by eDESE:isoform each had a least one search hit. Moreover, we found that 19 of the 524 (3.6%) potential susceptibility genes each had at least 10 supported papers in PubMed (<xref ref-type="table" rid="table3">Table 3</xref>, see details in ). Interestingly, <italic>TCF4</italic> (transcription factor 4), <italic>RGS4</italic> (regulator of G protein signaling 4) and <italic>RANGAP1</italic> (Ran GTPase activating protein 1) were reported by more than 100 papers. <italic>RGS4</italic> is reported to be biased expressed in brain (<xref ref-type="bibr" rid="bib38">O’Leary et al., 2016</xref>). <italic>TCF4</italic> and <italic>RANGAP1</italic> are broadly expressed in the brain, and <italic>TCF4</italic> may play an important role in nervous system development (<xref ref-type="bibr" rid="bib38">O’Leary et al., 2016</xref>).</p><table-wrap id="table3" position="float"><label>Table 3.</label><caption><title>The important examples of potential susceptibility genes exclusively predicted by eDESE:isoform.</title><p><supplementary-material id="table3sdata1"><label>Table 3—source data 1.</label><caption><title>The PubMed search hits of the unique potential susceptibility genes of schizophrenia identified by eDESE:isoform (compared with S-PrediXcan and eDESE:gene).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70779-table3-data1-v1.xlsx"/></supplementary-material></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Gene name</th><th align="left" valign="top"># of hits in PubMed</th></tr></thead><tbody><tr><td align="left" valign="top">RGS4</td><td align="char" char="." valign="top">&gt; 100</td></tr><tr><td align="left" valign="top">TCF4</td><td align="char" char="." valign="top">&gt; 100</td></tr><tr><td align="left" valign="top">RANGAP1</td><td align="char" char="." valign="top">&gt; 100</td></tr><tr><td align="left" valign="top">GRIA1</td><td align="char" char="." valign="top">80</td></tr><tr><td align="left" valign="top">GRM3</td><td align="char" char="." valign="top">76</td></tr><tr><td align="left" valign="top">TSPO</td><td align="char" char="." valign="top">39</td></tr><tr><td align="left" valign="top">TPH2</td><td align="char" char="." valign="top">35</td></tr><tr><td align="left" valign="top">FEZ1</td><td align="char" char="." valign="top">31</td></tr><tr><td align="left" valign="top">ZDHHC8</td><td align="char" char="." valign="top">24</td></tr><tr><td align="left" valign="top">VRK2</td><td align="char" char="." valign="top">23</td></tr><tr><td align="left" valign="top">KCNN3</td><td align="char" char="." valign="top">20</td></tr><tr><td align="left" valign="top">NCAM1</td><td align="char" char="." valign="top">20</td></tr><tr><td align="left" valign="top">MIP</td><td align="char" char="." valign="top">15</td></tr><tr><td align="left" valign="top">SLC39A8</td><td align="char" char="." valign="top">14</td></tr><tr><td align="left" valign="top">DLG1</td><td align="char" char="." valign="top">14</td></tr><tr><td align="left" valign="top">BDNF-AS</td><td align="char" char="." valign="top">13</td></tr><tr><td align="left" valign="top">FGA</td><td align="char" char="." valign="top">13</td></tr><tr><td align="left" valign="top">ADRA1A</td><td align="char" char="." valign="top">12</td></tr><tr><td align="left" valign="top">MAPT</td><td align="char" char="." valign="top">10</td></tr></tbody></table></table-wrap><p>Furthermore, we applied the Hetionet (v1.0) (<xref ref-type="bibr" rid="bib21">Himmelstein et al., 2017</xref>), which encodes knowledge from millions of biomedical studies to connect diseases, genes, anatomies and more, to investigate the above top associations. We set the source node as the susceptibility gene and the target node as schizophrenia using the ‘Connectivity search’ function. We found that <italic>RGS4</italic> and <italic>RANGAP1</italic> both had multiple significant meta path types indicating their potential associations and mechanisms associated with schizophrenia.</p></sec><sec id="s2-7-3"><title>Potential susceptibility genes identified by eDESE:isoform were enriched with more biologically sensible GO terms</title><p>Next, we performed the GO enrichment analysis and found that the potential susceptibility genes identified by eDESE guided by the eQTLs (eDESE:gene and eDESE:isoform) had more biologically sensible GO enrichment terms than S-PrediXcan (<xref ref-type="table" rid="table4">Table 4</xref>). In addition, the GO enrichment results also showed that the potential susceptibility genes identified by eDESE:isoform were enriched with more neuronal, dendritic or synaptic signaling-related biological process GO terms than S-PrediXcan and eDESE:gene.</p><table-wrap id="table4" position="float"><label>Table 4.</label><caption><title>The GO enrichment terms of the potential susceptibility genes in each optimized brain region identified by S-PrediXcan, eDESE:gene and eDESE:isoform.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Tissue name</th><th align="left" valign="top"><xref ref-type="table-fn" rid="table4fn1">*</xref>S-PrediXcan</th><th align="left" valign="top">eDESE:gene</th><th align="left" valign="top">eDESE:isoform</th></tr></thead><tbody><tr><td align="left" valign="top">Brain-Anterior cingulate cortex (BA24)</td><td align="left" valign="top">-</td><td align="left" valign="top">Regulation of gap junction assembly (BP)</td><td align="left" valign="top">Potassium ion transmembrane transporter activity (MF); potassium: chloride symporter activity (MF); <bold>nervous system development</bold> (BP); <bold>generation of neurons</bold> (BP); <bold>neurogenesis</bold> (BP)</td></tr><tr><td align="left" valign="top">Brain-Cerebellum</td><td align="left" valign="top">Ion binding (MF); cation binding (MF); metal ion binding (MF); intracellular organelle (CC)</td><td align="left" valign="top">Dendrite (CC); dendritic tree (CC); neuron projection (CC); postsynapse (CC); synapse (CC)</td><td align="left" valign="top">Voltage-gated calcium channel activity involved in cardiac muscle cell action potential (MF); <bold>nervous system development</bold> (BP)</td></tr><tr><td align="left" valign="top">Brain-Frontal Cortex (BA9)</td><td align="left" valign="top">Intracellular organelle (CC); intracellular membrane-bounded organelle (CC)</td><td align="left" valign="top">Somatodendritic compartment (CC); dendrite (CC); dendritic tree (CC); synaptic vesicle membrane (CC); exocytic vesicle membrane (CC)</td><td align="left" valign="top">-</td></tr><tr><td align="left" valign="top">Brain-Hippocampus</td><td align="left" valign="top">Ion binding (MF)</td><td align="left" valign="top">-</td><td align="left" valign="top">Postsynaptic density (CC); asymmetric synapse (CC)</td></tr><tr><td align="left" valign="top">Brain-Spinal cord (cervical c-1)</td><td align="left" valign="top">-</td><td align="left" valign="top">High voltage-gated calcium channel activity (MF); voltage-gated calcium channel activity involved in AV node cell action potential (MF); regulation of B cell tolerance induction (BP); positive regulation of B cell tolerance induction (BP); L-type voltage-gated calcium channel complex (CC)</td><td align="left" valign="top">Nitrogen compound transport (BP); organelle (CC)</td></tr></tbody></table><table-wrap-foot><fn id="table4fn1"><label>*</label><p>MF: Molecular Function terms of GO. BP: Biological Process terms of GO. CC: Cellular Component terms of GO.</p></fn></table-wrap-foot></table-wrap><p>We further performed the GO enrichment analysis based on the combined gene lists of all five optimized brain regions for S-PrediXcan, eDESE:gene and eDESE:isoform. However, we found that the 55 genes commonly identified by the three models were enriched with no GO term. Furthermore, the 240 unique genes identified by S-PrediXcan were also enriched with no GO term. On the other hand, the 319 unique genes identified by the eDESE:gene were enriched with ‘integral component of synaptic vesicle membrane’ (CC) and several general GO terms. In comparison, the 524 unique genes identified by eDESE:isoform were enriched with a considerable number of GO terms, in which a few neuronal, dendritic or synaptic signaling-related GO terms were found (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1l</xref>).</p></sec><sec id="s2-7-4"><title>Potential susceptibility genes identified by eDESE:isoform were significantly enriched in a biologically sensible consensus module in the brain weighted gene co-expression network</title><p>We then tested the enrichment of the potential susceptibility genes in the consensus modules of the brain weighted gene co-expression network. We found that the potential susceptibility genes identified by eDESE:gene and eDESE:isoform based on the gene-level and isoform-level eQTLs of Brain-Cerebellum were both enriched with a brain consensus module (colored ‘turquoise’) with statistical significance, that is, adjusted p-value = 0.0046 and 0.0061, respectively. Besides, the potential susceptibility genes identified by eDESE:gene based on the gene-level eQTLs of Brain-Frontal Cortex (BA9) were also enriched (adjusted p-value = 0.024) with the consensus module colored ‘turquoise’. However, no enriched consensus module was found for the potential susceptibility genes identified by S-PrediXcan. Moreover, we found that the ‘turquoise’ consensus module contained 7,726 genes and was enriched with plenty of neuronal and synaptic signaling-related GO terms (<xref ref-type="fig" rid="fig8">Figure 8</xref>, see details in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1m</xref>).</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>The GO enrichment terms of the genes in the consensus module (colored ‘turquoise’).</title><p>The <italic>x</italic>-axis label represents the top (≤10) significant GO enrichment terms (in MF, BP, and CC). The y-axis label represents the negative log10 of the adjusted p<italic>-</italic>value of each term. See also <xref ref-type="supplementary-material" rid="fig8sdata1">Figure 8—source data 1</xref> and <xref ref-type="supplementary-material" rid="fig8sdata2">Figure 8—source data 2</xref>.</p><p><supplementary-material id="fig8sdata1"><label>Figure 8—source data 1.</label><caption><title>Genes in the consensus module (colored &quot;turquoise&quot;).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70779-fig8-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8sdata2"><label>Figure 8—source data 2.</label><caption><title>Enrichment results of the genes in the consensus module (colored ‘turquoise’).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70779-fig8-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70779-fig8-v1.tif"/></fig></sec><sec id="s2-7-5"><title>eDESE:isoform can predict the potential susceptibility isoforms of corresponding phenotype-associated tissues</title><p>As shown in <xref ref-type="fig" rid="fig7">Figure 7b</xref>, 55 genes were collectively predicted to be susceptible to schizophrenia by S-PrediXcan, eDESE:gene, and eDESE:isoform. As eDESE:isoform could output susceptibility gene-isoform pairs for corresponding tissues, we further got the corresponding susceptibility isoforms of the 55 genes (see details in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1n</xref>). Interestingly, we found that the number or type of susceptibility isoforms for a gene varied greatly in the different optimized brain regions. For example, <italic>NAGA</italic> and <italic>CHRNA2</italic> were reported to be associated with schizophrenia by three and seven research papers in the PubMed database, respectively. <italic>ENST00000407991</italic> of <italic>CHRNA2</italic> was significantly associated with schizophrenia only in Brain-Cerebellum, while <italic>ENST00000396398</italic> of <italic>NAGA</italic> was significantly associated with schizophrenia in all the five optimized brain regions. We also found that different isoforms of the same gene were predicted to be significantly associated with schizophrenia in the different optimized brain regions. For example, <italic>SNX19</italic> was reported to be associated with schizophrenia by seven research papers. <italic>ENST00000527116</italic> of <italic>SNX19</italic> in Brain-Anterior cingulate cortex (BA24), <italic>ENST00000528555</italic> of <italic>SNX19</italic> in Brain-Cerebellum, <italic>ENST00000265909</italic> of <italic>SNX19</italic> in Brain-Frontal Cortex (BA9) and Brain-Hippocampus, and <italic>ENST00000526579</italic> of <italic>SNX19</italic> in Brain-Spinal cord (cervical c-1) were significantly associated with schizophrenia, respectively.</p><p>The above comparisons suggested that incorporating isoform-level eQTLs can help eDESE predict more potential susceptibility genes than gene-level eQTLs and S-PrediXcan in each optimized brain region. Our results further pointed that eDESE:isoform could help find some novel, biologically sensible susceptibility genes which S-PrediXcan and eDESE:gene cannot find. Moreover, we also found that the potential susceptibility genes identified by eDESE were enriched with a consensus module in the brain weighted gene co-expression network, which was significantly enriched with plenty of biologically sensible GO terms. Based on the isoform-level eQTLs of each phenotype-associated brain region, eDESE:isoform can also help gain insight into the potential susceptibility isoforms. Thus, our results revealed the potential advantages of eDESE:isoform, at least partly, over eDESE:gene and S-PrediXcan.</p></sec></sec><sec id="s2-8"><title>The druggability of the potential susceptibility genes</title><p>Since drug target genes with genetic support are twice or as likely to be approved than target genes with no known genetic associations (<xref ref-type="bibr" rid="bib25">King et al., 2019</xref>; <xref ref-type="bibr" rid="bib37">Nelson et al., 2015</xref>), we searched the DrugBank database (<xref ref-type="bibr" rid="bib48">Wishart et al., 2018</xref>) and found that seven potential susceptibility genes identified by eDESE in total (0.976% for eDESE:dist, 0.632% for eDESE:gene and 0.703% for eDESE:isoform) were the target genes of multiple antipsychotics (<xref ref-type="table" rid="table5">Table 5</xref>). Several popular target genes, such as <italic>DRD2</italic> and <italic>ADRA1A</italic>, were identified by different eDESE models. Besides, we found that three genes (0.485%) of the 619 potential susceptibility genes identified by MAGMA were also the target genes of multiple antipsychotics. One gene (0.256%) of the 391 potential susceptibility genes identified by S-PrediXcan was the target gene of an atypical antipsychotic (i.e. paliperidone). The results suggested that the three models of eDESE could complement each other to identify more susceptibility genes which could be the target genes of the therapeutic drugs.</p><table-wrap id="table5" position="float"><label>Table 5.</label><caption><title>The target genes of the antipsychotics predicted as the potential susceptibility genes by MAGMA, S-PrediXcan, and eDESE.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Target gene</th><th align="left" valign="top">Models</th></tr></thead><tbody><tr><td align="left" valign="top">DRD2</td><td align="left" valign="top">eDESE:dist &amp; eDESE:gene &amp; eDESE:isoform &amp; MAGMA</td></tr><tr><td align="left" valign="top">ADRA1A</td><td align="left" valign="top">eDESE:isoform</td></tr><tr><td align="left" valign="top">CHRM3</td><td align="left" valign="top">eDESE:gene &amp; eDESE:isoform</td></tr><tr><td align="left" valign="top">CHRM4</td><td align="left" valign="top">eDESE:gene &amp; eDESE:isoform&amp; MAGMA</td></tr><tr><td align="left" valign="top">OPRD1</td><td align="left" valign="top">eDESE:dist</td></tr><tr><td align="left" valign="top">GABRD</td><td align="left" valign="top">eDESE:isoform</td></tr><tr><td align="left" valign="top">CYP2D6</td><td align="left" valign="top">eDESE:gene &amp; eDESE:isoform&amp; MAGMA &amp; S-PrediXcan</td></tr></tbody></table></table-wrap><p>To further investigate the drug-gene interactions of the potential susceptibility genes, we searched the Drug Gene Interaction database (DGIdb v4.2.0) (<xref ref-type="bibr" rid="bib9">Freshour et al., 2021</xref>) and kept the drug-gene interaction terms with at least one supported PubMed paper. After the filtration, we kept 30,072 unique drug-gene interaction terms and found 679 unique drug-gene interaction terms for 34 antipsychotics (see details in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1o</xref>). Then we put the combined potential susceptibility gene list (identified by MAGMA, S-PrediXcan, eDESE:dist, eDESE:gene and eDESE:isoform, respectively) into DGIdb to investigate if the ‘antipsychotic’-‘potential susceptibility gene’ interaction terms were enriched in the known drug-gene interaction database, that is, DGIdb. As shown in <xref ref-type="table" rid="table6">Table 6</xref>, we found that ‘antipsychotic’ - ‘potential susceptibility gene’ interaction terms identified by MAGMA and the three models of eDESE were all significantly enriched in DGIdb. We also found 452 drug-gene interaction terms for the susceptibility gene identified by S-PrediXcan. However, only 12 ‘antipsychotic’- ‘potential susceptibility gene’ interaction terms were found (hypergeometric distribution test p-value = 0.33).</p><table-wrap id="table6" position="float"><label>Table 6.</label><caption><title>The enrichment of drug-gene interaction terms in DGIdb for the susceptibility genes identified by MAGMA, S-PrediXcan and eDESE.</title><p><supplementary-material id="table6sdata1"><label>Table 6—source data 1.</label><caption><title>The drug-gene interaction term results of the potential susceptibility genes of schizophrenia identified by MAGMA in DGIdb.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70779-table6-data1-v1.xlsx"/></supplementary-material><supplementary-material id="table6sdata2"><label>Table 6—source data 2.</label><caption><title>The drug-gene interaction term results of the potential susceptibility genes of schizophrenia identified by S-PrediXcan in DGIdb.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70779-table6-data2-v1.xlsx"/></supplementary-material><supplementary-material id="table6sdata3"><label>Table 6—source data 3.</label><caption><title>The drug-gene interaction term results of the potential susceptibility genes of schizophrenia identified by eDESE:dist in DGIdb.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70779-table6-data3-v1.xlsx"/></supplementary-material><supplementary-material id="table6sdata4"><label>Table 6—source data 4.</label><caption><title>The drug-gene interaction term results of the potential susceptibility genes of schizophrenia identified by eDESE:gene in DGIdb.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70779-table6-data4-v1.xlsx"/></supplementary-material><supplementary-material id="table6sdata5"><label>Table 6—source data 5.</label><caption><title>The drug-gene interaction term results of the potential susceptibility genes of schizophrenia identified by eDESE:isoform in DGIdb.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70779-table6-data5-v1.xlsx"/></supplementary-material></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Models</th><th align="left" valign="top"># of antipsychotics-gene interaction terms</th><th align="left" valign="top"># of total drug-gene interaction terms</th><th align="left" valign="top">Enrichment p<xref ref-type="table-fn" rid="table6fn1">*</xref></th></tr></thead><tbody><tr><td align="left" valign="top">MAGMA</td><td align="char" char="." valign="top">57</td><td align="char" char="." valign="top">937</td><td align="char" char="hyphen" valign="top">1.62e-11</td></tr><tr><td align="left" valign="top">S-PrediXcan</td><td align="char" char="." valign="top">12</td><td align="char" char="." valign="top">452</td><td align="char" char="." valign="top">0.33</td></tr><tr><td align="left" valign="top">eDESE:dist</td><td align="char" char="." valign="top">34</td><td align="char" char="." valign="top">279</td><td align="char" char="hyphen" valign="top">1.56e-15</td></tr><tr><td align="left" valign="top">eDESE:gene</td><td align="char" char="." valign="top">56</td><td align="char" char="." valign="top">968</td><td align="char" char="hyphen" valign="top">1.65e-10</td></tr><tr><td align="left" valign="top">eDESE:isoform</td><td align="char" char="." valign="top">70</td><td align="char" char="." valign="top">1,104</td><td align="char" char="hyphen" valign="top">8.74e-15</td></tr></tbody></table><table-wrap-foot><fn id="table6fn1"><label>*</label><p>Enrichment p denotes the p-value of the hypergeometric distribution test. See also <xref ref-type="supplementary-material" rid="table6sdata1">Table 6—source data 1</xref>, <xref ref-type="supplementary-material" rid="table6sdata2">Table 6—source data 2</xref>, <xref ref-type="supplementary-material" rid="table6sdata3">Table 6—source data 3</xref>, <xref ref-type="supplementary-material" rid="table6sdata4">Table 6—source data 4</xref>, and <xref ref-type="supplementary-material" rid="table6sdata5">Table 6—source data 5</xref>.</p></fn></table-wrap-foot></table-wrap><p>Moreover, we investigated the potential druggability of the potential susceptibility genes. Among the 42 potentially druggable gene categories in DGIdb, we found that the top potentially druggable category for the potential susceptibility genes identified by MAGMA, S-PrediXcan and eDESE all were the “DRUGGABLE GENOME”. The number of “DRUGGABLE GENOME” genes were 168 (27.1%) for MAGMA, 86 (22.0%) for S-PrediXcan, 62 (30.2%) for eDESE:dist, 136 (21.5%) for eDESE:gene and 207 (24.2%) for eDESE:isoform.</p><p>Taken together, compared with MAGMA and S-PrediXcan, our results showed that the potential susceptibility genes identified by eDESE were more likely to be the target genes of therapeutic drugs. Besides, the application of eQTLs (especially the isoform-level eQTLs) could aid eDESE in identifying more potentially druggable genes.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we proposed a multi-strategy conditional gene-based association framework, eDESE, based on a new effective chi-squared statistic (ECS) to identify the potential susceptibility tissues, genes, and isoforms for complex diseases. Compared with the unconditional association test based on the new ECS and likelihood ratio test, the conditional association test based on the new ECS showed a lower type I error rate and higher statistical power. Except the improved ECS, eDESE has another advantage of using three mapping strategies, that is, mapping based on physical position and the gene-level and isoform-level variant-gene eQTLs associations, to perform the gene-based association analysis. We implemented the three mapping strategies in corresponding three conditional gene-based association models, that is, eDESE:dist, eDESE:gene, and eDESE:isoform.</p><p>eDESE:dist and conventional MAGMA both map variants to genes based on their physical distance to perform gene-based association analysis. eDESE:dist differs from MAGMA mainly in that the former is a conditional gene-based association analysis based on the improved ECS. Although eDESE:dist predicted a smaller size of potential susceptibility genes than MAGMA, more than half of the genes identified by eDESE:dist were also identified by MAGMA. The overlapped potential susceptibility genes (accounting for 51.2% in eDESE:dist and 17.0% in MAGMA) were enriched with plenty of neuronal- or synaptic signaling-related GO terms. Similar results of a recent large-scale GWAS were obtained by gene-set analyses (<xref ref-type="bibr" rid="bib45">Trubetskoy et al., 2022</xref>; <xref ref-type="bibr" rid="bib29">Legge et al., 2021</xref>). The comparison of MAGMA and eDESE:dist revealed the advantage of conditional association analysis, that is, removing the redundantly associated genes. In addition, our results showed that the unique potential susceptibility genes identified by eDESE:dist were enriched with more biologically sensible GO terms than MAGMA. Moreover, the proportion of the susceptibility genes identified by eDESE:dist supported by research papers were more than that of MAGMA. Besides, eDESE:dist could produce a potential susceptibility tissue list for complex diseases because of the involvement of gene selective expression analysis.</p><p>Nevertheless, eDESE:dist might omit some distal but important variant-gene associations. We thus expanded eDESE by using eDESE:gene and eDESE:isoform. Using a simulation study, we firstly demonstrated that isoform-level eQTLs were more powerful than gene-level eQTLs in association analysis based on the improved ECS. Then taking schizophrenia as an example, we predicted the potential susceptibility tissues by integrating the results of eDESE:dist, eDESE:gene and eDESE:isoform based on the principle of ‘wisdom of the crowds’ and finally optimized five brain regions. Interestingly, four of the five optimized brain regions (i.e. Brain-Anterior cingulate cortex (BA24), Brain-Cerebellum, Brain-Frontal Cortex (BA9), and Brain-Hippocampus) were also reported by the Schizophrenia Working Group of the Psychiatric Genomics Consortium, in which the genes with high relative specificity for bulk expression were strongly enriched with schizophrenia associations (<xref ref-type="bibr" rid="bib45">Trubetskoy et al., 2022</xref>).</p><p>Furthermore, we compared the potential susceptibility genes identified by eDESE:isoform with eDESE:gene and S-PrediXcan, based on the eQTLs of the five optimized brain regions, to demonstrate its potential gains and insights in the biology of schizophrenia. We found that eDESE:isoform could identify more susceptibility genes supported by the published papers and enriched with biologically sensible GO biological process terms. Interestingly, we also found susceptibility genes identified by eDESE:isoform in Brain-Cerebellum and eDESE:gene in both Brain-Cerebellum and Brain-Frontal Cortex (BA9), to be enriched with the same consensus module, which was stunningly enriched with plenty of neuronal- or synaptic signaling-related GO terms. Moreover, to our best knowledge, eDESE:isoform is the first conditional gene-based association model to produce a list of phenotype-associated isoforms (or transcripts) for complex diseases. The comparisons among eDESE:isoform, eDESE:gene, and S-PrediXcan revealed that our model, especially the eDESE:isoform, can gain more potential insights for schizophrenia biology.</p><p>To further investigate if eDESE can help gain more insights into the gene druggability, we compared the drug-gene interaction terms and potentially druggable category of the susceptibility genes identified by MAGMA, S-PrediXcan and eDESE. Seven susceptibility genes identified by eDESE were found to be the target genes of multiple FDA-approved antipsychotics, and six (85.7%) of the seven target genes were found by eDESE:isoform. On the other hand, only one and three susceptibility genes identified by S-PrediXcan and MAGMA were found to be the target genes of several FDA-approved antipsychotics. In addition, the ‘antipsychotics’-‘susceptibility gene’ interactions terms for MAGMA and eDESE were both significantly enriched in the known drug-gene interaction database (DGIdb). Moreover, we found that the number of potential susceptibility genes identified by eDESE:isoform and denoted as ‘DRUGGABLE GENOME’ in DGIdb, were the most among MAGMA, S-PrediXcan, and eDESE. The comparison revealed that the druggablilty of the potential susceptibility genes identified by eDESE, especially the eDESE:isoform, provided more credible supports for the utility of eDESE.</p><p>Our framework might have three potential applications. First, eDESE can be used to predict the potential susceptibility genes and isoforms for other complex diseases. Second, eDESE can help optimize the more biologically sensible phenotype-associated tissues for other complex diseases. Third, the expression profiles used by eDESE can be replaced with other profiles, such as drug-induced gene expression profiles, to investigate the potential drug mechanism of action (MOA).</p><p>The present study was also limited by several factors. First, the moderate sample size in GTEx (v8) might lead the gene/isoform-level eQTLs to be underpowered. Future genetic studies based on the increased sample sizes might alleviate this problem. Second, the size of the susceptibility genes identified by the eDESE:gene and eDESE:isoform was a little larger than that of the conventional studies. The main reasons might lie in the gene-level and isoform-level eQTLs selected based on a lenient threshold (p-value &lt; 0.01) to involve more eQTLs in the association analysis, which was taken as the remedy against the underpowered eQTLs. As shown in the present study, conventional MAGMA also identified 619 significant genes. The comparison of MAGMA and eDESE showed the advantages of eDESE in GO enrichment analysis, text-mining analyses and druggability. Although these potential susceptibility genes identified by eDESE lacked systematically experimental validation, we shared these genes in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1ag and h</xref> and encouraged the follow-up studies to evaluate their functions and roles in the development of schizophrenia. Future studies based on increased sample sizes with a stricter threshold to select the eQTLs can reduce the potential susceptibility gene count, and this is also a topic for our future exploration. Third, the performance of conditional association analysis for fine-mapping can be greatly influenced by the gene orders of entering the analysis. Although the improved effective chi-squared test with eDESE can work well in the real data of schizophrenia, integrating some non-conditional fine-mapping methods, such as SuSiE, with eDESE is worth trying. Fourth, the optimal <italic>c</italic> value of the effective chi-squared test is still empirical although we derived its range and relevant factors. The optimal <italic>c</italic> value can be improved to be better suited for other specific application scenarios.</p><p>In conclusion, in this study, we proposed a new statistical framework to predict potential susceptibility genes for complex diseases based on the GWAS summary statistics and three different variant-gene mapping strategies. The application of our framework to schizophrenia revealed many novel susceptible and druggable candidate genes. Besides, our results suggested that the usage of isoform-level eQTLs can be an important supplement for the conventional gene-based approaches. The framework was packaged and implemented in our integrative platform KGGSEE. We hope our framework can facilitate researchers to gain more insights into the susceptibility genes, isoforms and tissues for complex diseases.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>The new effective chi-squared statistics (ECS) for conditional gene-based association analysis</title><p>The effective chi-squared statistics, ECS (<xref ref-type="bibr" rid="bib31">Li et al., 2019</xref>), was improved by using a new correlation matrix of chi-squared statistics, which had two methodological advances to address the potential inflation issue, that is, a type I error-controlled correlation matrix of the observed chi-squared statistics and a non-negative least square solution for the independent chi-squared statistics. Suppose that gene set <italic>A</italic> contains <italic>n</italic> loci, to calculate the association p-value of another physically nearby gene (containing <italic>m</italic> loci) by conditioning on <italic>A</italic>, the first step of the conditional analysis was to produce the effective chi-squared statistics for <italic>A</italic> (<italic>n</italic> loci) and all the genes (n + <italic>m</italic> loci in total). Each locus had a p-value for phenotype association in the GWAS. The p<italic>-</italic>values can be converted to corresponding chi-squared statistics with the degree of freedom 1. According to <xref ref-type="bibr" rid="bib31">Li et al., 2019</xref>, each locus could be assumed to have a virtually independent chi-squared statistic. An observed marginal chi-squared statistic of a locus was equal to the summation of its virtually independent chi-squared statistic and the weighted virtually independent chi-squared statistic of the nearby loci. The weight was related to the correlation of chi-squared statistics, a key parameter of the analysis. The correlation of chi-squared statistics between two loci was approximated by the absolute value of genotypic correlation to the power of <italic>c</italic>, that is, |<italic>r</italic>|<italic><sup>c</sup></italic>. We derived that exponent <italic>c</italic> ranged from 1 to 2, corresponding to different noncentrality parameters of a non-central chi-squared distribution (See the derivation in the third section of Materials and methods). The <italic>n</italic> virtually independent chi-squared statistics of the gene set <italic>A</italic> could be approximated by a linear transformation of the <italic>n</italic> observed chi-squared statistics by <bold>Formula (1)</bold>,<disp-formula id="equ1"><label>(1)</label><mml:math id="m1"><mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mtable columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:msubsup><mml:mrow><mml:mover><mml:mi>x</mml:mi><mml:mo>´</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mtd><mml:mtd><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo></mml:mtd><mml:mtd><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msubsup><mml:mrow><mml:mover><mml:mi>x</mml:mi><mml:mo>´</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mtd><mml:mtd><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mtd></mml:mtr></mml:mtable><mml:mo>]</mml:mo></mml:mrow><mml:mo>≈</mml:mo><mml:msup><mml:mrow><mml:mo>[</mml:mo><mml:mtable columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mn>1</mml:mn></mml:mtd><mml:mtd><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo></mml:mtd><mml:mtd><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msup></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo></mml:mtd><mml:mtd><mml:mn>1</mml:mn></mml:mtd><mml:mtd><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msup></mml:mtd><mml:mtd><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo></mml:mtd><mml:mtd><mml:mn>1</mml:mn></mml:mtd></mml:mtr></mml:mtable><mml:mo>]</mml:mo></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo>×</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mtable columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mtd><mml:mtd><mml:mn>1</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo></mml:mtd><mml:mtd><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mtd><mml:mtd><mml:mn>1</mml:mn></mml:mtd></mml:mtr></mml:mtable><mml:mo>]</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msubsup><mml:mrow><mml:mover><mml:mi>x</mml:mi><mml:mo>´</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo>≥</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> , <inline-formula><mml:math id="inf2"><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> ( &gt; 0), <inline-formula><mml:math id="inf3"><mml:msubsup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> and <inline-formula><mml:math id="inf4"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> denoted a virtually independent chi-squared statistic, degree of freedom of the virtually independent chi-squared statistic, an observed chi-squared statistic and the absolute value of the LD correlation coefficient (approximated by genotypic correlation), respectively. The effective chi-squared statistic <inline-formula><mml:math id="inf5"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mi>S</mml:mi><mml:mo>´</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> with the degree of freedom <inline-formula><mml:math id="inf6"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mi>d</mml:mi><mml:mo>´</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> of the <italic>n</italic> loci was then obtained by <bold>Formula (2)</bold>:<disp-formula id="equ2"><label>(2)</label><mml:math id="m2"><mml:mrow><mml:mrow><mml:mo>{</mml:mo><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mover><mml:mi>S</mml:mi><mml:mo>´</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msubsup><mml:mi mathvariant="normal">Σ</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msubsup><mml:msubsup><mml:mrow><mml:mover><mml:mi>x</mml:mi><mml:mo>´</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mover><mml:mi>d</mml:mi><mml:mo>´</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msubsup><mml:mi mathvariant="normal">Σ</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msubsup><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mtd></mml:mtr></mml:mtable><mml:mo fence="true" stretchy="true" symmetric="true"/></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>The effective chi-squared statistics (<inline-formula><mml:math id="inf7"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mi>S</mml:mi><mml:mo>´</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>) and degree of freedom (<inline-formula><mml:math id="inf8"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mi>d</mml:mi><mml:mo>´</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>) of the n + <italic>m</italic> loci were calculated in the same way. The effective chi-squared statistics of the <italic>m</italic> loci conditioning on the <italic>n</italic> loci were approximated by <bold>Formula (3)</bold>,<disp-formula id="equ3"><label>(3)</label><mml:math id="m3"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mi>S</mml:mi><mml:mo>´</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mover><mml:mi>S</mml:mi><mml:mo>´</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mover><mml:mi>S</mml:mi><mml:mo>´</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></disp-formula></p><p>with the degree of freedom <inline-formula><mml:math id="inf9"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mi>d</mml:mi><mml:mo>´</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mover><mml:mi>d</mml:mi><mml:mo>´</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mover><mml:mi>d</mml:mi><mml:mo>´</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> . Because <inline-formula><mml:math id="inf10"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mi>d</mml:mi><mml:mo>´</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> was no longer an integer, we used the Gamma distribution to calculate the p-values. Given the above statistics and degree of freedom, the p-value was equal to <inline-formula><mml:math id="inf11"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>F</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo>≥</mml:mo><mml:mfrac><mml:msub><mml:mrow><mml:mover><mml:mi>S</mml:mi><mml:mo>´</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mn>2</mml:mn></mml:mfrac><mml:mo>;</mml:mo><mml:mfrac><mml:msub><mml:mrow><mml:mover><mml:mi>d</mml:mi><mml:mo>´</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mn>2</mml:mn></mml:mfrac><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula> , where the <italic>F</italic>(<italic>x</italic>) function was the cumulative distribution function of a Gamma distribution.</p><p>Because the virtually independent chi-squared statistics and degree of freedom were expected to be larger than 0, we adopted a sequential coordinate-wise algorithm to approximate them (<xref ref-type="bibr" rid="bib8">Franc et al., 2005</xref>). This algorithm avoided unstable solutions in <bold>Formula (1)</bold> due to stochastic errors in the correlation matrix and observed chi-squared statistics.</p></sec><sec id="s4-2"><title>Choose the favorable <italic>c</italic> value for the correlation matrix of chi-squared statistics</title><p>After multiple approximations, the analytic solution for the exponent <italic>c</italic> in <bold>Formula (1)</bold> was still difficult to obtain. We proposed a grid search algorithm to find a favorable value of exponent <italic>c</italic> to control the type I error rates of ECS. The type I error rate was examined by the departure between the obtained and the theoretical (under the uniform distribution) top 1% p-values given a <italic>c</italic> value, measured as mean log fold change (MLFC) (<xref ref-type="bibr" rid="bib44">Tokheim et al., 2016</xref>). In the grid search process, we increased <italic>c</italic> from 1.00 to 2.00 by an interval of 0.01. The <italic>c</italic> value leading to the minimal MLFC was defined as the favorable <italic>c</italic> value. We considered in total 84 parameter settings, i.e., a combination of three different sample sizes (10,000, 20,000 and 40,000) and 14 different variant number (10, 30, 50, 80, 100, 125, 150, 200, 250, 300, 400, 500, 800, and 1000) for both binary and continuous traits, respectively. For a parameter setting, 40,000 datasets were simulated and used to produce p-values to determine the favorable <italic>c</italic> value. A region on chromosome 2 [chr2: 169,428,016–189,671,923] was randomly drawn for the simulation. The allele frequencies and LD structure of variants in the European panel of the 1000 Genomes Project were used as a reference to simulate genotype data by the HapSim algorithm (<xref ref-type="bibr" rid="bib35">Montana, 2005</xref>). Each subject was randomly assigned a phenotype value under the null hypothesis according to the Bernoulli or Gaussian distribution. The Wald test, which encoded the major and minor allele as 0 and 1 under either logistic regression or linear regression, was used to produce the association <italic>p</italic>-value at each variant. The <italic>p</italic>-values of the variants were then analyzed by the effective chi-squared test for the gene-based association analysis.</p></sec><sec id="s4-3"><title>Approximate the correlation of chi-square statistics under the alternative Hypothesis</title><p>Let two normal random variables <inline-formula><mml:math id="inf12"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>X</mml:mi><mml:mtext> </mml:mtext><mml:mo>∼</mml:mo><mml:mi>N</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula> and <inline-formula><mml:math id="inf13"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>Y</mml:mi><mml:mtext> </mml:mtext><mml:mo>∼</mml:mo><mml:mi>N</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula> have covariance <bold><italic>a</italic></bold>. Note that a squared normal random variable has non-central chi-square distribution, and the squared mean of the variable is called noncentrality parameter. The two variables can also be factorized as <inline-formula><mml:math id="inf14"><mml:mi>X</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mi>U</mml:mi></mml:math></inline-formula>, <inline-formula><mml:math id="inf15"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>Y</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>ρ</mml:mi><mml:mi>U</mml:mi><mml:mo>+</mml:mo><mml:msqrt><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msup><mml:mi>ρ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:msqrt><mml:mi>V</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula> where <inline-formula><mml:math id="inf16"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>U</mml:mi><mml:mo>,</mml:mo><mml:mi>V</mml:mi><mml:mover><mml:mo>∼</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:mover><mml:mi>N</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula> and <inline-formula><mml:math id="inf17"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>ρ</mml:mi><mml:mo>=</mml:mo><mml:mi>a</mml:mi><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula> .</p><p>Then we can calculate the correlation of the two non-central chi-square variables <bold><italic>X<sup>2</sup></italic></bold> and <bold><italic>Y<sup>2</sup></italic></bold> by the factorized variables, <inline-formula><mml:math id="inf18"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mi>X</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:msup><mml:mi>Y</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mi>a</mml:mi><mml:mo>+</mml:mo><mml:msup><mml:mi>a</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:msqrt><mml:mn>2</mml:mn><mml:msubsup><mml:mi>μ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:msubsup></mml:msqrt><mml:msqrt><mml:mn>2</mml:mn><mml:msubsup><mml:mi>μ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:msubsup></mml:msqrt></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:math></inline-formula> . Suppose <bold><italic>X</italic></bold> is the z-score of the true casual variant, and <bold><italic>Y</italic></bold> is the z-score of a non-functional variant in LD (coefficient <bold><italic>r</italic></bold>) with the causal variant. One can assume <inline-formula><mml:math id="inf19"><mml:msub><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>r</mml:mi><mml:msub><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> , <inline-formula><mml:math id="inf20"><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:math></inline-formula> , <inline-formula><mml:math id="inf21"><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:math></inline-formula> and <bold><italic>a</italic></bold> = <bold><italic>r</italic></bold>. Therefore, the correlation of <bold><italic>X<sup>2</sup></italic></bold> and <bold><italic>Y<sup>2</sup></italic></bold> can be simplified as, <inline-formula><mml:math id="inf22"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msup><mml:mi>c</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:msup><mml:mi>r</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:msubsup><mml:mi>μ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msup><mml:mi>r</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:msqrt><mml:mn>2</mml:mn><mml:msubsup><mml:mi>μ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:msqrt><mml:msqrt><mml:mn>2</mml:mn><mml:msubsup><mml:mi>μ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:msup><mml:mi>r</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:msqrt></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:math></inline-formula> .</p><p>Under the null hypothesis, <inline-formula><mml:math id="inf23"><mml:msub><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:math></inline-formula> then <inline-formula><mml:math id="inf24"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mi>X</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:msup><mml:mi>Y</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:msup><mml:mi>r</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mstyle></mml:math></inline-formula> . Under the alternative hypothesis, <inline-formula><mml:math id="inf25"><mml:msubsup><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> is the noncentrality parameter (<italic>λ</italic>). According to Sham and Purcel (<xref ref-type="bibr" rid="bib42">Sham and Purcell, 2014</xref>), the noncentrality parameter can be approximated by the following Formula for a quantitative phenotype, <inline-formula><mml:math id="inf26"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msubsup><mml:mi mathvariant="bold-italic">μ</mml:mi><mml:mrow><mml:mn mathvariant="bold">1</mml:mn></mml:mrow><mml:mrow><mml:mn mathvariant="bold">2</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mi>λ</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="bold-italic">N</mml:mi><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:msup><mml:mi>β</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>p</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>u</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mspace width="thinmathspace"/><mml:mspace width="thinmathspace"/><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mspace width="thinmathspace"/><mml:mspace width="thinmathspace"/><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mspace width="thinmathspace"/><mml:mspace width="thinmathspace"/><mml:mi>p</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>y</mml:mi><mml:mi>p</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:math></inline-formula><bold>,</bold> where <italic>N</italic>, <italic>p</italic> and <italic>β</italic> are the sample sizes, allele frequency and the regression coefficient (corresponding to effect size), respectively. This Formula can be extended for qualitative phenotype under a liability threshold model. <italic>N</italic> is very large for a large sample, and the noncentrality parameter will be large for common variants. Therefore, the correlation of <bold><italic>X<sup>2</sup></italic></bold> and <bold><italic>Y<sup>2</sup></italic></bold> converges to |<bold><italic>r|</italic></bold> as <inline-formula><mml:math id="inf27"><mml:mi>λ</mml:mi><mml:mo>→</mml:mo><mml:mi>∞</mml:mi></mml:math></inline-formula>,<inline-formula><mml:math id="inf28"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mi>X</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:msup><mml:mi>Y</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula> <inline-formula><mml:math id="inf29"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mi>r</mml:mi><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msqrt><mml:mn>2</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:msubsup><mml:mi>μ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mfrac></mml:msqrt><mml:msqrt><mml:mn>2</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msup><mml:mi>r</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:msubsup><mml:mi>μ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac></mml:msqrt></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:msup><mml:mi>r</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mrow><mml:msqrt><mml:mn>2</mml:mn><mml:msubsup><mml:mi>μ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:msqrt><mml:msqrt><mml:mn>2</mml:mn><mml:msup><mml:mi>r</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:msubsup><mml:mi>μ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:msqrt></mml:mrow></mml:mfrac><mml:mo>=</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula> <inline-formula><mml:math id="inf30"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mi>r</mml:mi><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msqrt><mml:mn>2</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>λ</mml:mi></mml:mfrac></mml:msqrt><mml:msqrt><mml:mn>2</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi>λ</mml:mi><mml:msup><mml:mi>r</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:msqrt></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:msup><mml:mi>r</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mrow><mml:msqrt><mml:mn>2</mml:mn><mml:mi>λ</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:msqrt><mml:msqrt><mml:mn>2</mml:mn><mml:mi>λ</mml:mi><mml:msup><mml:mi>r</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:msqrt></mml:mrow></mml:mfrac><mml:mo stretchy="false">→</mml:mo><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mi mathvariant="bold-italic">r</mml:mi><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula>.</p><p>Overall, the correlation between the two (non-central) chi-square ranges can be approximated as |<italic>r</italic>|<italic><sup>c'</sup></italic>, in which the <italic>c'</italic> ranges from 1 to 2. In simulation studies, we also showed that as the relative risk ratio increased to 1.5 in a moderate sample of 1000 cases and 1000 controls, the correlation of <bold><italic>X<sup>2</sup></italic></bold> and <bold><italic>Y<sup>2</sup></italic></bold> became close to |<bold><italic>r</italic></bold><italic>|</italic> (See <xref ref-type="fig" rid="fig9">Figure 9</xref>).</p><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>The effect sizes of variants to the correlation of chi-squares.</title><p>(<bold>a</bold>) Under the additive model; (<bold>b</bold>) Under the multiplicative model. The allele frequencies are assigned randomly.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70779-fig9-v1.tif"/></fig></sec><sec id="s4-4"><title>The conditional gene-based association analysis for genome-wide association study</title><p>In a GWAS, the <italic>p</italic>-values of all genes in the unconditional gene-based association analysis were firstly calculated using the above effective chi-squared statistics. Then, for a given <italic>p</italic>-value cutoff, the significant genes were extracted and subjected to the conditional gene-based association analysis. Multiple significant genes in an LD block were conditioned one by one in a pre-defined order. The order of the gene was defined according to the unconditional <italic>p</italic>-value of the gene. Here the genes within 5 Mb were assigned into the same LD block. The conditional <italic>p</italic>-value of the first gene was defined as its unconditional <italic>p</italic>-value. The conditional <italic>p</italic>-value of the second gene was obtained by conditioning on the first gene, and that of the third gene was obtained by conditioning on the first two genes. The conditional <italic>p</italic>-values of subsequent genes were calculated according to the same procedure.</p></sec><sec id="s4-5"><title>Investigate the type I error and power of the conditional gene-based association analysis</title><p>Independent computer simulations based on a different reference population (i.e., EAS) and genomic regions were performed to investigate type I error and the power of the conditional gene-based association analysis. To approach the association redundancy pattern in realistic scenarios, we used the real genotypes and simulated phenotypes. The high-quality genotypes of 2,507 Chinese subjects from a GWAS were used (<xref ref-type="bibr" rid="bib26">Kung et al., 2010</xref>), and phenotypes of subjects were simulated according to the genotypes under an additive model. Given total variance explained by <italic>n</italic> independent variants, V<sub>g</sub>, the effect of an allele at a bi-allelic variant was calculated by <inline-formula><mml:math id="inf31"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>a</mml:mi><mml:mo>=</mml:mo><mml:msqrt><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:munderover><mml:mn>2</mml:mn><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:msqrt></mml:mrow></mml:mstyle></mml:math></inline-formula> , where <inline-formula><mml:math id="inf32"><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></inline-formula> was the frequency of alternative alleles. The total expected effect <italic>A</italic> of a subject was equal to a*[the number of alternative alleles of all the n variants]. Each subject’s phenotype was simulated by <italic>P</italic> = A + e, where <italic>e</italic> was sampled from a normal distribution <italic>N</italic>(<italic>0</italic>, 1-V<sub>g</sub>). We randomly sampled three pairs of genes, i.e., <italic>SIPA1L2</italic> vs. <italic>LOC729336</italic>, <italic>CACHD1</italic> vs. <italic>RAVER2</italic>, and <italic>LOC647132</italic> vs. <italic>FAM5C</italic>, representing three scenarios where the nearby gene (i.e., the first gene) had similar (<italic>SIPA1L2</italic> vs. <italic>LOC729336</italic>), larger (<italic>CACHD1</italic> vs. <italic>RAVER2</italic>) and smaller (<italic>LOC647132</italic> vs. <italic>FAM5C</italic>) variant number than the target gene (i.e., the second gene) in terms of SNP number, respectively. The target gene had no QTLs in the type I error investigation, while the nearby gene had one or two QTLs. In the investigation of the statistical power, both the target and nearby genes had QTLs.</p><p>The likelihood ratio test based on the linear regression was adopted for power comparison to perform the conditional gene-based association analysis with raw genotypes. In the full model, genotypes of all SNPs encoded as 0, 1, or 2 according to the number of alternative variants entered the regression model as explanatory variables. In the subset model, the SNPs of the nearby genes entered the regression model. The calculation of the likelihood ratio test was performed according to the conventional procedure. The R packaged &quot;lmtest&quot; (version 0.9.37) was adopted to perform the likelihood ratio test.</p></sec><sec id="s4-6"><title>Investigate the power and type I error of gene-level eQTLs and isoform-level eQTLs in gene-based association analysis</title><p>The same region on chromosome 2 [chr2: 169,428,016–189,671,923] was considered for the simulation. In the EUR panel of 1000 Genomes Project (<xref ref-type="bibr" rid="bib1">Auton et al., 2015</xref>), this region contains 1,600 common variants (MAF &gt;0.05). Genotypes of the variants were simulated given allelic frequencies and LD correlation matrix according to the HapSim algorithm (<xref ref-type="bibr" rid="bib35">Montana, 2005</xref>). Phenotypes were simulated under a polygenic model of random effect (<xref ref-type="bibr" rid="bib4">Bulik-Sullivan et al., 2015</xref>). According to severe LD pruning (<italic>r</italic><sup>2</sup> &lt;0.01), eighty-two independent variants were extracted from the 1,600 variants. The SNPs' genotypes (<italic>s</italic>) contributing to the phenotypes were then standardized as, <inline-formula><mml:math id="inf33"><mml:mi>g</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mi>s</mml:mi><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:mi>q</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:msqrt><mml:mn>2</mml:mn><mml:mi>q</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>q</mml:mi></mml:mrow></mml:mfenced></mml:msqrt></mml:mrow></mml:mrow></mml:math></inline-formula> , where <italic>q</italic> was the allele frequency of the alterative allele. Phenotypes were simulated under a polygenic model of random effect (<xref ref-type="bibr" rid="bib4">Bulik-Sullivan et al., 2015</xref>). We assumed that 40% of the independent causal variants (<italic>m</italic><sub>X</sub>) regulated gene expression (total heritability <inline-formula><mml:math id="inf34"><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula>). The expression of a gene (X) was simulated according to <bold>Formula (4)</bold>:<disp-formula id="equ4"><label>(4)</label><mml:math id="m4"><mml:mrow><mml:mi>X</mml:mi><mml:mo>=</mml:mo><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mi>m</mml:mi><mml:mi>X</mml:mi></mml:msub></mml:mrow></mml:munderover><mml:msub><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mi>X</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>ϵ</mml:mi><mml:mi>X</mml:mi></mml:msub></mml:mrow></mml:math></disp-formula></p><p>Where <inline-formula><mml:math id="inf35"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mi>X</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>∼</mml:mo><mml:mi>N</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msubsup><mml:mi>h</mml:mi><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:msub><mml:mi>m</mml:mi><mml:mrow><mml:mi>X</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula> and <inline-formula><mml:math id="inf36"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>ϵ</mml:mi><mml:mrow><mml:mi>X</mml:mi></mml:mrow></mml:msub><mml:mo>∼</mml:mo><mml:mi>N</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msubsup><mml:mi>h</mml:mi><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula>.</p><p>The gene expression then contributed <inline-formula><mml:math id="inf37"><mml:mi>δ</mml:mi></mml:math></inline-formula> to a phenotype (Y). The phenotype value was simulated according to the <bold>Formula (5)</bold>:<disp-formula id="equ5"><label>(5)</label><mml:math id="m5"><mml:mi>Y</mml:mi><mml:mo>=</mml:mo><mml:mi>δ</mml:mi><mml:mi>X</mml:mi><mml:mo>+</mml:mo><mml:mrow><mml:msubsup><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>Y</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msubsup><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>Y</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>ϵ</mml:mi></mml:mrow><mml:mrow><mml:mi>Y</mml:mi></mml:mrow></mml:msub></mml:math></disp-formula></p><p>where Y was a continuous phenotype, <inline-formula><mml:math id="inf38"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mi>Y</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mtext> </mml:mtext><mml:mo>∼</mml:mo><mml:mi>N</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msubsup><mml:mi>h</mml:mi><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:msub><mml:mi>m</mml:mi><mml:mrow><mml:mi>Y</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula> and <inline-formula><mml:math id="inf39"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>ϵ</mml:mi><mml:mrow><mml:mi>Y</mml:mi></mml:mrow></mml:msub><mml:mtext> </mml:mtext><mml:mo>∼</mml:mo><mml:mi>N</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msubsup><mml:mi>h</mml:mi><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>−</mml:mo><mml:msup><mml:mi>δ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula> . For a binary phenotype, a cutoff <italic>t</italic> was set according to a given disease prevalence <italic>K</italic> under a standard normal distribution and the liability threshold model (<xref ref-type="bibr" rid="bib17">Gillett et al., 2018</xref>). Subjects with simulated Y values ≥ <italic>t</italic> were set as patients, and others were set as normal controls.</p><p>When a gene had multiple isoforms, we assumed that one of the isoforms was associated with phenotype, and we simulated the expression values of the isoform according to <bold>Formula (5)</bold>. The expression values of the remaining isoforms were simulated by the standard normal distribution <italic>N</italic>(0,1). The expression profile of a gene with multiple isoforms was averaged by all the isoforms belonging to the gene. The gene-level eQTLs and isoform-level eQTLs were examined by the Wald test under the linear regression model. The variant-phenotype association analysis was performed based on the conventional association analysis procedure, and the statistical significance cutoff was p-value &lt; 0.001. For each parameter setting, <italic>t</italic> (an integer) datasets were simulated, and the power and type I error were estimated by <italic>m</italic>/<italic>t</italic>, in which <italic>m</italic> was the number of datasets with significant <italic>p</italic>-values for testing δ.</p></sec><sec id="s4-7"><title>Genome-wide association study of schizophrenia</title><p>The schizophrenia GWAS included 53,386 cases and 77,258 controls of European ancestry samples (hg19 assembly). Genotypes in the CEU panel from the 1000 Genomes Project were used to correct for the relatedness of the summary statistics. The variants in the major histocompatibility complex (MHC) region, i.e., chr6:27,477,797–34,448,354, were excluded in the present study because of the high polymorphism. Detailed descriptions of population cohorts, quality control methods and association analysis methods can be found in reference (<xref ref-type="bibr" rid="bib45">Trubetskoy et al., 2022</xref>).</p></sec><sec id="s4-8"><title>The Genotype-Tissue Expression (GTEx) Project</title><p>The GTEx project (release v8, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_013042">SCR_013042</ext-link>) created a resource including whole-genome sequence data and RNA sequencing data from ~900 deceased adult donors (<xref ref-type="bibr" rid="bib5">Consortium, 2020</xref>). Four tissues or cell types (i.e., whole blood, stomach, pancreas and pituitary) were filtered out in the following analyses because of their small sample sizes or weak correlations with most other tissues.</p></sec><sec id="s4-9"><title>g:Profiler and Hetionet</title><p>All GO enrichment analyses were performed by g:Profiler (<xref ref-type="bibr" rid="bib40">Raudvere et al., 2019</xref>). g:Profiler (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_006809">SCR_006809</ext-link>) is based on Fisher’s one-tailed test. The statistical <italic>p</italic>-value is multiple testing-corrected. The GO enrichment analysis uses the set of all annotated protein-coding genes for <italic>Homo sapiens</italic> (Human) as background. Significant GO terms were filtered by the threshold of &quot;Padj&quot; &lt; 0.05. The bar plots of GO enrichment terms were drawn based on R-4.0.3.</p><p>Hetionet (<xref ref-type="bibr" rid="bib21">Himmelstein et al., 2017</xref>) integrates relationships among genes, compounds, diseases, and more from 29 different databases. It can help researchers refine their phenotype-gene associations by considering anatomies, biological processes, side-effects, symptoms and more.</p></sec><sec id="s4-10"><title>Construct the weighted gene co-expression network for brain and perform the consensus analysis</title><p>The thirteen brain regions' fully processed, filtered, and normalized gene-level expression profiles in GTEx (v8) were used. Consensus network analysis and module identification were performed based on the &quot;WGCNA&quot; (v1.69, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003302">SCR_003302</ext-link>) (<xref ref-type="bibr" rid="bib27">Langfelder and Horvath, 2008</xref>). For each dataset, WGCNA was performed to build a signed gene co-expression network following the standard procedure, and the soft-threshold was finally set as 12 after testing a series of soft-threshold powers (ranging from 2 to 20). As for constructing the block-wise consensus modules, the hierarchical cluster tree in the co-expression network was cut into gene modules using the dynamic tree cut algorithm with a minimum module size of 30 genes (<xref ref-type="bibr" rid="bib28">Langfelder et al., 2008</xref>). The parameter of &quot;networkCalibration&quot; was set as &quot;single quantile&quot;. The &quot;consensusQuantile&quot; and &quot;calibrationQuantile&quot; were both set as 0.95. The parameter of &quot;deepSplit&quot; was set as 3. Other parameters were used as recommended by WGCNA. The co-expression analysis and consensus clustering analysis produced eighteen consensus modules, in which the module sizes ranged from 41 to 7,726. The significant consensus modules were filtered by the threshold of &quot;Padj&quot; &lt; 0.05.</p></sec><sec id="s4-11"><title>Drug Gene Interaction Database (DGIdb)</title><p>DGIdb (v4.2.0, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_006608">SCR_006608</ext-link>) provides a resource of genes that have the potential to be druggable and contains two main classes of druggable genome information (<xref ref-type="bibr" rid="bib9">Freshour et al., 2021</xref>). The first class includes genes with known drug interactions, and the other includes genes that are potentially druggable according to their membership in gene categories associated with druggability.</p></sec><sec id="s4-12"><title>PubMed text-mining analysis</title><p>To find supports from the published research, we performed a text-mining analysis based on PubMed database on August 27th, 2021 using a java script. We put each gene symbol name or its synonyms into the PubMed database with the items of “((schizophrenia[tiab]+ OR + Schizophrenia[tiab]+ OR + SCZ[tiab])+ AND + (genename[tiab])+ AND + (gene[tiab]+ OR + genes[tiab]+ OR + mRNA[tiab]+ OR + protein[tiab]+ OR + proteins[tiab]+ OR + transcription[tiab]+ OR + transcript[tiab]+ OR + transcripts[tiab]+ OR + expressed[tiab]+ OR + expression[tiab]+ OR + expressions[tiab]+ OR + locus[tiab]+ OR + loci[tiab]+ OR + SNP[tiab]))&amp;datetype = edat&amp;retmax = 100”. The java script output a file with the first column representing gene name, the second column representing the synonym of the gene name and the last column representing the PubMed ids of hit papers.</p></sec><sec id="s4-13"><title>Identify the potentially phenotype-associated tissues of schizophrenia</title><p>To estimate the potentially phenotype-associated tissues, eDESE:dist, eDESE:gene and eDESE:isoform were used, respectively. The Genotypes in the EUR panel from the 1000 Genomes Project (phase 3) were downloaded from IGSR and used as reference genotype data. Three columns, that is., chromosome identifier, base-pair position and p-value in the GWAS summary statistics, were used. SNPs with minor allele frequency (MAF) less than 0.05 were excluded. Genes approved by HGNC (<xref ref-type="bibr" rid="bib20">HGNC Database, H.G.N.C.H, 2021</xref>) were included in the following analyses. The multiple testing adjustment method was Bonferroni correction, and the cutoff for the adjusted p-value was set as p-value &lt; 0.05. The threshold for filtering the significant phenotype-associated tissues was set as <italic>α</italic> = 0.05/50 = 1e-3. The detailed commands of eDESE to identify the potential phenotype-associated tissues are described on the KGGSEE website and the original paper (<xref ref-type="bibr" rid="bib24">Jiang et al., 2019</xref>).</p></sec><sec id="s4-14"><title>Identify gene-level and isoform-level eQTLs</title><p>The present study focused on the <italic>cis</italic>-eQTLs. Specifically, two files (expression profiles and corresponding genotype data file from the European ancestry subjects in GTEx v8) were put into KGGSEE to produce the gene/isoform-level eQTLs for each tissue. Two levels (gene-level and isoform-level) expression profiles of 50 tissues were downloaded from the GTEx v8 project and were normalized as GTEx did (<ext-link ext-link-type="uri" xlink:href="https://gtexportal.org/home/documentationPage">https://gtexportal.org/home/documentationPage</ext-link>). Genes/isoforms were selected based on TPM &gt;0.1 and read count ≥6 in at least 20% of all samples. Only variants with MAF ≥0.05 were included in the eQTLs identification. GTEx v8 is based on the human reference genome GRCh38/hg38. Thus, to be consistent with the GWAS results of schizophrenia (hg19 assembly), we converted the GRCh38/hg38 coordinates into hg19 by using the UCSC LiftOver (<xref ref-type="bibr" rid="bib22">Hinrichs et al., 2006</xref>). Variants with Hardy-Weinberg disequilibrium (HWD) test p<italic>-</italic>value &lt; 1.0e-3 were filtered out. The mapping window was defined as 1 Mb up- and downstream of the gene boundary. The covariates used in eQTLs identification include donor sex, age and death classification. The threshold for selecting the gene-level/isoform-level eQTLs was p-value &lt; 0.01.</p></sec><sec id="s4-15"><title>Estimate the potential susceptibility genes and isoforms</title><p>For eDESE:dist, if a variant was within ±5 kb around a gene boundary, the variant will be mapped to the gene according to a gene model, for example, RefSeqGene. For eDESE:gene and eDESE:isoform, a variant was mapped to a gene or isoform if the variant is a gene/isoform-level eQTL of the gene or isoform.</p><p>eDESE adopted the iterative procedure from DESE (<xref ref-type="bibr" rid="bib24">Jiang et al., 2019</xref>). In the first iterative step, genes with smaller p-values generated from the unconditional association analysis (based on the improved ECS) were given higher priority to enter the following conditional gene-based association analysis. We then dealt with the three models of eDESE in different ways. For eDESE:dist and eDESE:gene, the order of a gene entering the conditional gene-based association analysis was determined by its p-value generated from the unconditional association analysis. For eDESE:isoform, assume that gene <italic>A</italic> has <italic>m</italic> isoforms. Each isoform could get a p-value generated from the unconditional association analysis, representing the overall statistical significance of all isoform-level eQTLs (simultaneously variants) associated with this isoform. If the isoform with the smallest p-value was isoform <italic>a</italic> with p-value <italic>p<sub>a</sub></italic> among the <italic>m</italic> isoforms, we only kept the most significant isoform, that is, isoform <italic>a</italic> of gene <italic>A</italic> for the following analyses. The p-value for isoform <italic>a</italic> was adjusted to <italic>m* p<sub>a</sub></italic> before entering the following conditional gene-based association analysis.</p><p>The second step was to compute the robust-regression z-score of each gene/isoform (see details in reference <xref ref-type="bibr" rid="bib24">Jiang et al., 2019</xref>). The Wilcoxon rank-sum test was then performed by using the robust-regression z-score of the associated and not-associated gene/isoform set (generated by the first step) in each tissue.</p><p>In the third step, all genes/isoforms were ranked in descending order based on their tissue-selective expression score, which was computed based on the rank of this gene’s or isoform’s robust-regression z-score and the p-value of the Wilcoxon rank-sum test (generated by the second step).</p><p>In the following iteration, genes/isoforms with higher tissue-selective expression scores (generated in the third step) were given higher priority to enter the conditional gene-based association analysis (back to the first step). The above three iterative steps would not stop until the p-values of the Wilcoxon rank-sum test did not change almost. Then corresponding significant genes/isoforms and tissues were deemed to be potentially associated with the phenotype. More details about the iterative procedure can be found in the original papers (<xref ref-type="bibr" rid="bib24">Jiang et al., 2019</xref>).</p><p>The detailed commands, input and output datasets of eDESE can be seen on the KGGSEE website. The bar plot of the comparison of potential susceptibility genes was drawn based on R-4.0.3. The venn diagram was drawn based on a web app Venny 2.1.0.</p></sec><sec id="s4-16"><title>MAGMA</title><p>MAGMA (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_005757">SCR_005757</ext-link>) is a popular tool for gene and generalized gene-set analysis based on the GWAS summary statistics. Here the parameters and options were used as recommended by MAGMA (v 1.09). Annotation analysis was performed based on the SNP and gene location files (hg19, build 37). The SNP location information was extracted from the GWAS summary statistics file of schizophrenia. Both gene location and reference data were downloaded from the MAGMA website. An SNP was mapped to a gene if the SNP was in the window of ±5 kb around the gene boundary (same as eDESE:dist). Then the gene analysis was performed based on the annotation results and reference data file which was created from Phase 3 of 1000 Genomes of the European population in reference to the human genome (build 37). Multiple testing was corrected by using Bonferroni correction. Significant genes were filtered by &quot;Padj&quot; &lt; 0.05.</p></sec><sec id="s4-17"><title>S-PrediXcan</title><p>S-PrediXcan is command-line based and implemented with python environment and mainly uses summary statistics. To estimate the disease-associated genes of each tissue, we prepared three input files, that is, schizophrenia GWAS summary statistics file, a transcriptome prediction model database file and a file with the covariance matrices of the SNPs within each gene model (<xref ref-type="bibr" rid="bib2">Barbeira et al., 2018</xref>; <xref ref-type="bibr" rid="bib11">Gamazon et al., 2015</xref>; <xref ref-type="bibr" rid="bib3">Barbeira et al., 2021</xref>). Here, GTEx-based tissues and 1000 Genomes covariances precalculated data from the PredictDB repository were downloaded (<ext-link ext-link-type="uri" xlink:href="http://predictdb.org">http://predictdb.org</ext-link>), and the MASHR-based model based on the expression data of GTEx v8 release was used. Other options and parameters were used as recommended. Multiple testing was corrected by using Bonferroni correction. Significant genes in each tissue were filtered by &quot;Padj&quot; &lt; 0.05.</p></sec><sec id="s4-18"><title>Data availability statement</title><p>All the data used in this study are from public resources. The source data files for the main figures and tables in the manuscript have been provided and are specified in Source Data. The annotations of drug-gene interaction terms are publicly available in Drug Gene Interaction (DGIdb v4.2.0) database in <ext-link ext-link-type="uri" xlink:href="https://dgidb.org">https://dgidb.org</ext-link>. The information on FDA-approved antipsychotics was extracted from DrugBank 5.1.1, which can be freely downloaded from <ext-link ext-link-type="uri" xlink:href="https://go.drugbank.com/releases/5-1-1/downloads/all-full-database">https://go.drugbank.com/releases/5-1-1/downloads/all-full-database</ext-link> with a simple registration for academic users. The functional enrichment analyses were performed by g:Profiler in <ext-link ext-link-type="uri" xlink:href="https://biit.cs.ut.ee/gprofiler">https://biit.cs.ut.ee/gprofiler</ext-link>. Hetionet v1.0 can be freely accessed at <ext-link ext-link-type="uri" xlink:href="https://het.io/">https://het.io/</ext-link>. Venny is in <ext-link ext-link-type="uri" xlink:href="https://bioinfogp.cnb.csic.es/tools/venny/index.html">https://bioinfogp.cnb.csic.es/tools/venny/index.html</ext-link>. MAGMA and corresponding reference data were freely downloaded from <ext-link ext-link-type="uri" xlink:href="https://ctg.cncr.nl/software/magma">https://ctg.cncr.nl/software/magma</ext-link>. S-PrediXcan was freely downloaded from <ext-link ext-link-type="uri" xlink:href="https://github.com/hakyimlab/MetaXcan">https://github.com/hakyimlab/MetaXcan</ext-link> (<xref ref-type="bibr" rid="bib18">hakyimlab, 2021</xref>) copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:d751af806aed116450da5ddb3d3f3a7fe7674f2b;origin=https://github.com/hakyimlab/MetaXcan;visit=swh:1:snp:799a434225d880a1e06acde3cba4e6fda167496f;anchor=swh:1:rev:cfc9e369bbf5630e0c9488993cd877f231c5d02e">swh:1:rev:cfc9e369bbf5630e0c9488993cd877f231c5d02e</ext-link>. The source code of eDESE (including eDESE:dist, eDESE:gene and eDESE:isoform) is implemented in KGGSEE and can be publicly available in <ext-link ext-link-type="uri" xlink:href="http://pmglab.top/kggsee/">http://pmglab.top/kggsee/</ext-link>#/.The custom scripts used in this study can be freely accessed at <ext-link ext-link-type="uri" xlink:href="https://github.com/pmglab/eDESE">https://github.com/pmglab/eDESE</ext-link> (<xref ref-type="bibr" rid="bib39">pmglab, 2021</xref>) copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:e05743e5b3d0bf28d873512a6a86398881e1baf2;origin=https://github.com/pmglab/eDESE;visit=swh:1:snp:0458f672b46af7d6b96a332263eea3531578a963;anchor=swh:1:rev:68fbbe429f23011f544cdd34ce09c98a2540f68b">swh:1:rev:68fbbe429f23011f544cdd34ce09c98a2540f68b</ext-link> (<xref ref-type="bibr" rid="bib32">Li and Li, 2021</xref>).</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Investigation, Methodology, Validation, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, The gene/isoform-level eQTLs were calculated by Mulin Jun Li who has the permission to access the GTEx genotype data</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Data curation, Methodology, Software, Supervision, Writing – review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>For eDESE analyses.</title><p>(a) The schizophrenia potential susceptibility genes identified by eDESE:dist. (b) The GO enrichment results based on the overlapped susceptibility genes identified by MAGMA and eDESE:dist. (c) The PubMed search hits of the schizophrenia potential susceptibility genes identified by MAGMA and eDESE:dist. (d) Tissue significances generated by eDESE:dist based on the gene-level and isoform-level expression profiles. (e) Tissue significances generated by eDESE:gene/isoform using the gene-level and isoform-level eQTLs of Muscle Skeletal and Skin Sun Exposed Lower Leg. (f-h) The schizophrenia potential susceptibility genes identified by S-PrediXcan, eDESE:gene and eDESE:isoform, respectively. (i-k) The PubMed search hits of the combined susceptibility gene set of schizophrenia identified by S-PrediXcan, eDESE:gene and eDESE:isoform, respectively. (l) The GO enrichment results based on the susceptibility genes exclusively predicted by eDESE:isoform. (m) The genes in the consensus module (colored &quot;turquoise&quot;) of the brain weighted gene co-expression network. (n) The potential susceptibility isoforms of the 55 overlapped genes. (o) The FDA-approved antipsychotics included in the DGIdb (v4.2.0).</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70779-supp1-v1.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-70779-transrepform1-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All the data used in this study are from public resources. The source data files for the main figures and tables in the manuscript have been provided and are specified in source data. The annotations of drug-gene interaction terms are publicly available in Drug Gene Interaction database (DGIdb v4.2.0) in <ext-link ext-link-type="uri" xlink:href="https://dgidb.org/">https://dgidb.org/</ext-link>. The information on FDA-approved antipsychotics was extracted from DrugBank 5.1.1, which can be freely downloaded from <ext-link ext-link-type="uri" xlink:href="https://go.drugbank.com/releases/5-1-1/downloads/all-full-database">https://go.drugbank.com/releases/5-1-1/downloads/all-full-database</ext-link> with a simple registration for academic users. The functional enrichment analyses were performed by g:Profiler in <ext-link ext-link-type="uri" xlink:href="https://biit.cs.ut.ee/gprofiler">https://biit.cs.ut.ee/gprofiler</ext-link>. Hetionet v1.0 can be freely accessed at <ext-link ext-link-type="uri" xlink:href="https://het.io/">https://het.io/</ext-link>. Venny is in <ext-link ext-link-type="uri" xlink:href="https://bioinfogp.cnb.csic.es/tools/venny/index.html">https://bioinfogp.cnb.csic.es/tools/venny/index.html</ext-link>. MAGMA and corresponding reference data were freely downloaded from <ext-link ext-link-type="uri" xlink:href="https://ctg.cncr.nl/software/magma">https://ctg.cncr.nl/software/magma</ext-link>. S-PrediXcan was freely downloaded from <ext-link ext-link-type="uri" xlink:href="https://github.com/hakyimlab/MetaXcan">https://github.com/hakyimlab/MetaXcan</ext-link> (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:d751af806aed116450da5ddb3d3f3a7fe7674f2b;origin=https://github.com/hakyimlab/MetaXcan;visit=swh:1:snp:08335577fba5b869fec2b3c7422e0a18d3f40dee;anchor=swh:1:rev:cfc9e369bbf5630e0c9488993cd877f231c5d02e">swh:1:rev:cfc9e369bbf5630e0c9488993cd877f231c5d02e</ext-link>). The source code of eDESE (including eDESE:dist, eDESE:gene and eDESE:isoform) is implemented in KGGSEE and can be publicly available in <ext-link ext-link-type="uri" xlink:href="http://pmglab.top/kggsee/#/">http://pmglab.top/kggsee/#/</ext-link>.The custom scripts used in this study can be freely accessed at <ext-link ext-link-type="uri" xlink:href="https://github.com/pmglab/eDESE">https://github.com/pmglab/eDESE</ext-link> (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:e05743e5b3d0bf28d873512a6a86398881e1baf2;origin=https://github.com/pmglab/eDESE;visit=swh:1:snp:0458f672b46af7d6b96a332263eea3531578a963;anchor=swh:1:rev:68fbbe429f23011f544cdd34ce09c98a2540f68b">swh:1:rev:68fbbe429f23011f544cdd34ce09c98a2540f68b</ext-link>).</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Xue</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Mj</surname><given-names>Li</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Gene-level eQTLs (hg19) based on GTEx v8</data-title><source>figshare</source><pub-id pub-id-type="doi">10.6084/m9.figshare.16959604</pub-id></element-citation></p><p><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Xue</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Mj</surname><given-names>Li</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Isoform-level eQTLs (hg19) based on GTEx v8</data-title><source>figshare</source><pub-id pub-id-type="doi">10.6084/m9.figshare.16959616</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>The Schizophrenia Working Group of the Psychiatric Genomics Consortium</collab><name><surname>Ripke</surname><given-names>S</given-names></name><name><surname>Walters</surname><given-names>JTR</given-names></name><name><surname>O'Donovan</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>GWAS summary statistics of schizophrenia</data-title><source>PGC</source><pub-id pub-id-type="accession" xlink:href="https://www.med.unc.edu/pgc/download-results/">SCZ2022</pub-id></element-citation></p><p><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>GTEx Consortium</collab></person-group><year iso-8601-date="2020">2020</year><data-title>RNA-Seq Data</data-title><source>GTEx v8</source><pub-id pub-id-type="accession" xlink:href="https://gtexportal.org/home/datasets#filesetFilesDiv13">RNA-Seq-Data</pub-id></element-citation></p><p><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Barbeira</surname><given-names>AN</given-names></name><name><surname>Bonazzola</surname><given-names>R</given-names></name><name><surname>Gamazon</surname><given-names>ER</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>MASHR-based models for eQTLs</data-title><source>PredictDB</source><pub-id pub-id-type="accession" xlink:href="https://zenodo.org/record/3518299/files/mashr_eqtl.tar?download=1">mashr_eqtl.tar</pub-id></element-citation></p><p><element-citation id="dataset6" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Gerring</surname><given-names>ZF</given-names></name><name><surname>Mina-Vargas</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>NG</given-names></name><name><surname>Gamazon</surname><given-names>ER</given-names></name><name><surname>Derks</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>emagma_annot_1.tar.gz</data-title><source>Github</source><pub-id pub-id-type="accession" xlink:href="https://github.com/eskederks/eMAGMA-tutorial/blob/gtex_v8/emagma_annot_1.tar.gz">emagma_annot_1.tar.gz</pub-id></element-citation></p><p><element-citation id="dataset7" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>1000 Genomes Project Consortium</collab></person-group><year iso-8601-date="2015">2015</year><data-title>Genotype data from the 1000 Genomes Project (phase 3)</data-title><source>IGSR</source><pub-id pub-id-type="accession" xlink:href="http://ftp.1000genomes.ebi.ac.uk/vol1/ftp/">1000genomes</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank the GTEx Consortium and 1000 Genomes Projects for providing access to the data and thank the GTEx Consortium for the code to preprocess and normalize the expression profiles. We also appreciate the authors of the schizophrenia study and the Schizophrenia Working Group of the Psychiatric Genomics Consortium for sharing their GWAS summary statistics. Finally, we also thank the authors of E-MAGMA for providing their preprocessed tissue-specific eQTLs of GTEx (v8). This work was funded by the National Natural Science Foundation of China (31771401, 32170637 and 31970650), National Key R&amp;D Program of China (2018YFC0910500 and 2016YFC0904300), Science and Technology Program of Guangzhou (201803010116), Guangdong project (2017GC010644), Department of Science and Technology of Guangdong Province (2018B030322006).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auton</surname><given-names>A</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><collab>Steering committee</collab><name><surname>Altshuler</surname><given-names>DM</given-names></name><name><surname>Durbin</surname><given-names>RM</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Bentley</surname><given-names>DR</given-names></name><name><surname>Chakravarti</surname><given-names>A</given-names></name><name><surname>Clark</surname><given-names>AG</given-names></name><name><surname>Donnelly</surname><given-names>P</given-names></name><name><surname>Eichler</surname><given-names>EE</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name><name><surname>Gabriel</surname><given-names>SB</given-names></name><name><surname>Gibbs</surname><given-names>RA</given-names></name><name><surname>Green</surname><given-names>ED</given-names></name><name><surname>Hurles</surname><given-names>ME</given-names></name><name><surname>Knoppers</surname><given-names>BM</given-names></name><name><surname>Korbel</surname><given-names>JO</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Lehrach</surname><given-names>H</given-names></name><name><surname>Mardis</surname><given-names>ER</given-names></name><name><surname>Marth</surname><given-names>GT</given-names></name><name><surname>McVean</surname><given-names>GA</given-names></name><name><surname>Nickerson</surname><given-names>DA</given-names></name><name><surname>Schmidt</surname><given-names>JP</given-names></name><name><surname>Sherry</surname><given-names>ST</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wilson</surname><given-names>RK</given-names></name><collab>Production group</collab><collab>Baylor College of Medicine</collab><name><surname>Gibbs</surname><given-names>RA</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Doddapaneni</surname><given-names>H</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Korchina</surname><given-names>V</given-names></name><name><surname>Kovar</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Muzny</surname><given-names>D</given-names></name><name><surname>Reid</surname><given-names>JG</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><collab>BGI-Shenzhen</collab><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Chang</surname><given-names>Y</given-names></name><name><surname>Feng</surname><given-names>Q</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Jian</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Jin</surname><given-names>X</given-names></name><name><surname>Lan</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>R</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><collab>Broad Institute of MIT and Harvard</collab><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Altshuler</surname><given-names>DM</given-names></name><name><surname>Gabriel</surname><given-names>SB</given-names></name><name><surname>Gupta</surname><given-names>N</given-names></name><collab>Coriell Institute for Medical Research</collab><name><surname>Gharani</surname><given-names>N</given-names></name><name><surname>Toji</surname><given-names>LH</given-names></name><name><surname>Gerry</surname><given-names>NP</given-names></name><name><surname>Resch</surname><given-names>AM</given-names></name><collab>European Molecular Biology Laboratory, European Bioinformatics Institute</collab><name><surname>Flicek</surname><given-names>P</given-names></name><name><surname>Barker</surname><given-names>J</given-names></name><name><surname>Clarke</surname><given-names>L</given-names></name><name><surname>Gil</surname><given-names>L</given-names></name><name><surname>Hunt</surname><given-names>SE</given-names></name><name><surname>Kelman</surname><given-names>G</given-names></name><name><surname>Kulesha</surname><given-names>E</given-names></name><name><surname>Leinonen</surname><given-names>R</given-names></name><name><surname>McLaren</surname><given-names>WM</given-names></name><name><surname>Radhakrishnan</surname><given-names>R</given-names></name><name><surname>Roa</surname><given-names>A</given-names></name><name><surname>Smirnov</surname><given-names>D</given-names></name><name><surname>Smith</surname><given-names>RE</given-names></name><name><surname>Streeter</surname><given-names>I</given-names></name><name><surname>Thormann</surname><given-names>A</given-names></name><name><surname>Toneva</surname><given-names>I</given-names></name><name><surname>Vaughan</surname><given-names>B</given-names></name><name><surname>Zheng-Bradley</surname><given-names>X</given-names></name><collab>Illumina</collab><name><surname>Bentley</surname><given-names>DR</given-names></name><name><surname>Grocock</surname><given-names>R</given-names></name><name><surname>Humphray</surname><given-names>S</given-names></name><name><surname>James</surname><given-names>T</given-names></name><name><surname>Kingsbury</surname><given-names>Z</given-names></name><collab>Max Planck Institute for Molecular Genetics</collab><name><surname>Lehrach</surname><given-names>H</given-names></name><name><surname>Sudbrak</surname><given-names>R</given-names></name><name><surname>Albrecht</surname><given-names>MW</given-names></name><name><surname>Amstislavskiy</surname><given-names>VS</given-names></name><name><surname>Borodina</surname><given-names>TA</given-names></name><name><surname>Lienhard</surname><given-names>M</given-names></name><name><surname>Mertes</surname><given-names>F</given-names></name><name><surname>Sultan</surname><given-names>M</given-names></name><name><surname>Timmermann</surname><given-names>B</given-names></name><name><surname>Yaspo</surname><given-names>ML</given-names></name><collab>McDonnell Genome Institute at Washington University</collab><name><surname>Mardis</surname><given-names>ER</given-names></name><name><surname>Wilson</surname><given-names>RK</given-names></name><name><surname>Fulton</surname><given-names>L</given-names></name><name><surname>Fulton</surname><given-names>R</given-names></name><collab>US National Institutes of Health</collab><name><surname>Sherry</surname><given-names>ST</given-names></name><name><surname>Ananiev</surname><given-names>V</given-names></name><name><surname>Belaia</surname><given-names>Z</given-names></name><name><surname>Beloslyudtsev</surname><given-names>D</given-names></name><name><surname>Bouk</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Church</surname><given-names>D</given-names></name><name><surname>Cohen</surname><given-names>R</given-names></name><name><surname>Cook</surname><given-names>C</given-names></name><name><surname>Garner</surname><given-names>J</given-names></name><name><surname>Hefferon</surname><given-names>T</given-names></name><name><surname>Kimelman</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Lopez</surname><given-names>J</given-names></name><name><surname>Meric</surname><given-names>P</given-names></name><name><surname>O’Sullivan</surname><given-names>C</given-names></name><name><surname>Ostapchuk</surname><given-names>Y</given-names></name><name><surname>Phan</surname><given-names>L</given-names></name><name><surname>Ponomarov</surname><given-names>S</given-names></name><name><surname>Schneider</surname><given-names>V</given-names></name><name><surname>Shekhtman</surname><given-names>E</given-names></name><name><surname>Sirotkin</surname><given-names>K</given-names></name><name><surname>Slotta</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><collab>University of Oxford</collab><name><surname>McVean</surname><given-names>GA</given-names></name><collab>Wellcome Trust Sanger Institute</collab><name><surname>Durbin</surname><given-names>RM</given-names></name><name><surname>Balasubramaniam</surname><given-names>S</given-names></name><name><surname>Burton</surname><given-names>J</given-names></name><name><surname>Danecek</surname><given-names>P</given-names></name><name><surname>Keane</surname><given-names>TM</given-names></name><name><surname>Kolb-Kokocinski</surname><given-names>A</given-names></name><name><surname>McCarthy</surname><given-names>S</given-names></name><name><surname>Stalker</surname><given-names>J</given-names></name><name><surname>Quail</surname><given-names>M</given-names></name><collab>Analysis group</collab><collab>Affymetrix</collab><name><surname>Schmidt</surname><given-names>JP</given-names></name><name><surname>Davies</surname><given-names>CJ</given-names></name><name><surname>Gollub</surname><given-names>J</given-names></name><name><surname>Webster</surname><given-names>T</given-names></name><name><surname>Wong</surname><given-names>B</given-names></name><name><surname>Zhan</surname><given-names>Y</given-names></name><collab>Albert Einstein College of Medicine</collab><name><surname>Auton</surname><given-names>A</given-names></name><name><surname>Campbell</surname><given-names>CL</given-names></name><name><surname>Kong</surname><given-names>Y</given-names></name><name><surname>Marcketta</surname><given-names>A</given-names></name><name><surname>Gibbs</surname><given-names>RA</given-names></name><name><surname>Yu</surname><given-names>F</given-names></name><name><surname>Antunes</surname><given-names>L</given-names></name><name><surname>Bainbridge</surname><given-names>M</given-names></name><name><surname>Muzny</surname><given-names>D</given-names></name><name><surname>Sabo</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Coin</surname><given-names>LJM</given-names></name><name><surname>Fang</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Jin</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Luo</surname><given-names>R</given-names></name><name><surname>Shao</surname><given-names>H</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Ye</surname><given-names>C</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><collab>Bilkent University</collab><name><surname>Alkan</surname><given-names>C</given-names></name><name><surname>Dal</surname><given-names>E</given-names></name><name><surname>Kahveci</surname><given-names>F</given-names></name><collab>Boston College</collab><name><surname>Marth</surname><given-names>GT</given-names></name><name><surname>Garrison</surname><given-names>EP</given-names></name><name><surname>Kural</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>WP</given-names></name><name><surname>Fung Leong</surname><given-names>W</given-names></name><name><surname>Stromberg</surname><given-names>M</given-names></name><name><surname>Ward</surname><given-names>AN</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>DePristo</surname><given-names>MA</given-names></name><name><surname>Handsaker</surname><given-names>RE</given-names></name><name><surname>Altshuler</surname><given-names>DM</given-names></name><name><surname>Banks</surname><given-names>E</given-names></name><name><surname>Bhatia</surname><given-names>G</given-names></name><name><surname>del Angel</surname><given-names>G</given-names></name><name><surname>Gabriel</surname><given-names>SB</given-names></name><name><surname>Genovese</surname><given-names>G</given-names></name><name><surname>Gupta</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Kashin</surname><given-names>S</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>McCarroll</surname><given-names>SA</given-names></name><name><surname>Nemesh</surname><given-names>JC</given-names></name><name><surname>Poplin</surname><given-names>RE</given-names></name><collab>Cold Spring Harbor Laboratory</collab><name><surname>Yoon</surname><given-names>SC</given-names></name><name><surname>Lihm</surname><given-names>J</given-names></name><name><surname>Makarov</surname><given-names>V</given-names></name><collab>Cornell University</collab><name><surname>Clark</surname><given-names>AG</given-names></name><name><surname>Gottipati</surname><given-names>S</given-names></name><name><surname>Keinan</surname><given-names>A</given-names></name><name><surname>Rodriguez-Flores</surname><given-names>JL</given-names></name><name><surname>Korbel</surname><given-names>JO</given-names></name><name><surname>Rausch</surname><given-names>T</given-names></name><name><surname>Fritz</surname><given-names>MH</given-names></name><name><surname>Stütz</surname><given-names>AM</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name><name><surname>Beal</surname><given-names>K</given-names></name><name><surname>Clarke</surname><given-names>L</given-names></name><name><surname>Datta</surname><given-names>A</given-names></name><name><surname>Herrero</surname><given-names>J</given-names></name><name><surname>McLaren</surname><given-names>WM</given-names></name><name><surname>Ritchie</surname><given-names>GRS</given-names></name><name><surname>Smith</surname><given-names>RE</given-names></name><name><surname>Zerbino</surname><given-names>D</given-names></name><name><surname>Zheng-Bradley</surname><given-names>X</given-names></name><collab>Harvard University</collab><name><surname>Sabeti</surname><given-names>PC</given-names></name><name><surname>Shlyakhter</surname><given-names>I</given-names></name><name><surname>Schaffner</surname><given-names>SF</given-names></name><name><surname>Vitti</surname><given-names>J</given-names></name><collab>Human Gene Mutation Database</collab><name><surname>Cooper</surname><given-names>DN</given-names></name><name><surname>Ball</surname><given-names>EV</given-names></name><name><surname>Stenson</surname><given-names>PD</given-names></name><name><surname>Bentley</surname><given-names>DR</given-names></name><name><surname>Barnes</surname><given-names>B</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Keira Cheetham</surname><given-names>R</given-names></name><name><surname>Cox</surname><given-names>A</given-names></name><name><surname>Eberle</surname><given-names>M</given-names></name><name><surname>Humphray</surname><given-names>S</given-names></name><name><surname>Kahn</surname><given-names>S</given-names></name><name><surname>Murray</surname><given-names>L</given-names></name><name><surname>Peden</surname><given-names>J</given-names></name><name><surname>Shaw</surname><given-names>R</given-names></name><collab>Icahn School of Medicine at Mount Sinai</collab><name><surname>Kenny</surname><given-names>EE</given-names></name><collab>Louisiana State University</collab><name><surname>Batzer</surname><given-names>MA</given-names></name><name><surname>Konkel</surname><given-names>MK</given-names></name><name><surname>Walker</surname><given-names>JA</given-names></name><collab>Massachusetts General Hospital</collab><name><surname>MacArthur</surname><given-names>DG</given-names></name><name><surname>Lek</surname><given-names>M</given-names></name><name><surname>Sudbrak</surname><given-names>R</given-names></name><name><surname>Amstislavskiy</surname><given-names>VS</given-names></name><name><surname>Herwig</surname><given-names>R</given-names></name><name><surname>Mardis</surname><given-names>ER</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Koboldt</surname><given-names>DC</given-names></name><name><surname>Larson</surname><given-names>D</given-names></name><name><surname>Ye</surname><given-names>K</given-names></name><collab>McGill University</collab><name><surname>Gravel</surname><given-names>S</given-names></name><collab>National Eye Institute, NIH</collab><name><surname>Swaroop</surname><given-names>A</given-names></name><name><surname>Chew</surname><given-names>E</given-names></name><collab>New York Genome Center</collab><name><surname>Lappalainen</surname><given-names>T</given-names></name><name><surname>Erlich</surname><given-names>Y</given-names></name><name><surname>Gymrek</surname><given-names>M</given-names></name><name><surname>Frederick Willems</surname><given-names>T</given-names></name><collab>Ontario Institute for Cancer Research</collab><name><surname>Simpson</surname><given-names>JT</given-names></name><collab>Pennsylvania State University</collab><name><surname>Shriver</surname><given-names>MD</given-names></name><collab>Rutgers Cancer Institute of New Jersey</collab><name><surname>Rosenfeld</surname><given-names>JA</given-names></name><collab>Stanford University</collab><name><surname>Bustamante</surname><given-names>CD</given-names></name><name><surname>Montgomery</surname><given-names>SB</given-names></name><name><surname>De La Vega</surname><given-names>FM</given-names></name><name><surname>Byrnes</surname><given-names>JK</given-names></name><name><surname>Carroll</surname><given-names>AW</given-names></name><name><surname>DeGorter</surname><given-names>MK</given-names></name><name><surname>Lacroute</surname><given-names>P</given-names></name><name><surname>Maples</surname><given-names>BK</given-names></name><name><surname>Martin</surname><given-names>AR</given-names></name><name><surname>Moreno-Estrada</surname><given-names>A</given-names></name><name><surname>Shringarpure</surname><given-names>SS</given-names></name><name><surname>Zakharia</surname><given-names>F</given-names></name><collab>Tel-Aviv University</collab><name><surname>Halperin</surname><given-names>E</given-names></name><name><surname>Baran</surname><given-names>Y</given-names></name><collab>The Jackson Laboratory for Genomic Medicine</collab><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Cerveira</surname><given-names>E</given-names></name><name><surname>Hwang</surname><given-names>J</given-names></name><name><surname>Malhotra</surname><given-names>A</given-names></name><name><surname>Plewczynski</surname><given-names>D</given-names></name><name><surname>Radew</surname><given-names>K</given-names></name><name><surname>Romanovitch</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><collab>Thermo Fisher Scientific</collab><name><surname>Hyland</surname><given-names>FCL</given-names></name><collab>Translational Genomics Research Institute</collab><name><surname>Craig</surname><given-names>DW</given-names></name><name><surname>Christoforides</surname><given-names>A</given-names></name><name><surname>Homer</surname><given-names>N</given-names></name><name><surname>Izatt</surname><given-names>T</given-names></name><name><surname>Kurdoglu</surname><given-names>AA</given-names></name><name><surname>Sinari</surname><given-names>SA</given-names></name><name><surname>Squire</surname><given-names>K</given-names></name><name><surname>Sherry</surname><given-names>ST</given-names></name><name><surname>Xiao</surname><given-names>C</given-names></name><collab>University of California, San Diego</collab><name><surname>Sebat</surname><given-names>J</given-names></name><name><surname>Antaki</surname><given-names>D</given-names></name><name><surname>Gujral</surname><given-names>M</given-names></name><name><surname>Noor</surname><given-names>A</given-names></name><name><surname>Ye</surname><given-names>K</given-names></name><collab>University of California, San Francisco</collab><name><surname>Burchard</surname><given-names>EG</given-names></name><name><surname>Hernandez</surname><given-names>RD</given-names></name><name><surname>Gignoux</surname><given-names>CR</given-names></name><collab>University of California, Santa Cruz</collab><name><surname>Haussler</surname><given-names>D</given-names></name><name><surname>Katzman</surname><given-names>SJ</given-names></name><name><surname>James Kent</surname><given-names>W</given-names></name><collab>University of Chicago</collab><name><surname>Howie</surname><given-names>B</given-names></name><collab>University College London</collab><name><surname>Ruiz-Linares</surname><given-names>A</given-names></name><collab>University of Geneva</collab><name><surname>Dermitzakis</surname><given-names>ET</given-names></name><collab>University of Maryland School of Medicine</collab><name><surname>Devine</surname><given-names>SE</given-names></name><collab>University of Michigan</collab><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Min Kang</surname><given-names>H</given-names></name><name><surname>Kidd</surname><given-names>JM</given-names></name><name><surname>Blackwell</surname><given-names>T</given-names></name><name><surname>Caron</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Emery</surname><given-names>S</given-names></name><name><surname>Fritsche</surname><given-names>L</given-names></name><name><surname>Fuchsberger</surname><given-names>C</given-names></name><name><surname>Jun</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Lyons</surname><given-names>R</given-names></name><name><surname>Scheller</surname><given-names>C</given-names></name><name><surname>Sidore</surname><given-names>C</given-names></name><name><surname>Song</surname><given-names>S</given-names></name><name><surname>Sliwerska</surname><given-names>E</given-names></name><name><surname>Taliun</surname><given-names>D</given-names></name><name><surname>Tan</surname><given-names>A</given-names></name><name><surname>Welch</surname><given-names>R</given-names></name><name><surname>Kate Wing</surname><given-names>M</given-names></name><name><surname>Zhan</surname><given-names>X</given-names></name><collab>University of Montréal</collab><name><surname>Awadalla</surname><given-names>P</given-names></name><name><surname>Hodgkinson</surname><given-names>A</given-names></name><collab>University of North Carolina at Chapel Hill</collab><name><surname>Li</surname><given-names>Y</given-names></name><collab>University of North Carolina at Charlotte</collab><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Quitadamo</surname><given-names>A</given-names></name><name><surname>Lunter</surname><given-names>G</given-names></name><name><surname>McVean</surname><given-names>GA</given-names></name><name><surname>Marchini</surname><given-names>JL</given-names></name><name><surname>Myers</surname><given-names>S</given-names></name><name><surname>Churchhouse</surname><given-names>C</given-names></name><name><surname>Delaneau</surname><given-names>O</given-names></name><name><surname>Gupta-Hinch</surname><given-names>A</given-names></name><name><surname>Kretzschmar</surname><given-names>W</given-names></name><name><surname>Iqbal</surname><given-names>Z</given-names></name><name><surname>Mathieson</surname><given-names>I</given-names></name><name><surname>Menelaou</surname><given-names>A</given-names></name><name><surname>Rimmer</surname><given-names>A</given-names></name><name><surname>Xifara</surname><given-names>DK</given-names></name><collab>University of Puerto Rico</collab><name><surname>Oleksyk</surname><given-names>TK</given-names></name><collab>University of Texas Health Sciences Center at Houston</collab><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Xiong</surname><given-names>M</given-names></name><collab>University of Utah</collab><name><surname>Jorde</surname><given-names>L</given-names></name><name><surname>Witherspoon</surname><given-names>D</given-names></name><name><surname>Xing</surname><given-names>J</given-names></name><collab>University of Washington</collab><name><surname>Eichler</surname><given-names>EE</given-names></name><name><surname>Browning</surname><given-names>BL</given-names></name><name><surname>Browning</surname><given-names>SR</given-names></name><name><surname>Hormozdiari</surname><given-names>F</given-names></name><name><surname>Sudmant</surname><given-names>PH</given-names></name><collab>Weill Cornell Medical College</collab><name><surname>Khurana</surname><given-names>E</given-names></name><name><surname>Durbin</surname><given-names>RM</given-names></name><name><surname>Hurles</surname><given-names>ME</given-names></name><name><surname>Tyler-Smith</surname><given-names>C</given-names></name><name><surname>Albers</surname><given-names>CA</given-names></name><name><surname>Ayub</surname><given-names>Q</given-names></name><name><surname>Balasubramaniam</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Colonna</surname><given-names>V</given-names></name><name><surname>Danecek</surname><given-names>P</given-names></name><name><surname>Jostins</surname><given-names>L</given-names></name><name><surname>Keane</surname><given-names>TM</given-names></name><name><surname>McCarthy</surname><given-names>S</given-names></name><name><surname>Walter</surname><given-names>K</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><collab>Yale University</collab><name><surname>Gerstein</surname><given-names>MB</given-names></name><name><surname>Abyzov</surname><given-names>A</given-names></name><name><surname>Balasubramanian</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Clarke</surname><given-names>D</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Harmanci</surname><given-names>AO</given-names></name><name><surname>Jin</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Jasmine Mu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><collab>Structural variation group</collab><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>R</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Alkan</surname><given-names>C</given-names></name><name><surname>Dal</surname><given-names>E</given-names></name><name><surname>Kahveci</surname><given-names>F</given-names></name><name><surname>Marth</surname><given-names>GT</given-names></name><name><surname>Garrison</surname><given-names>EP</given-names></name><name><surname>Kural</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>WP</given-names></name><name><surname>Ward</surname><given-names>AN</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>McCarroll</surname><given-names>SA</given-names></name><name><surname>Handsaker</surname><given-names>RE</given-names></name><name><surname>Altshuler</surname><given-names>DM</given-names></name><name><surname>Banks</surname><given-names>E</given-names></name><name><surname>del Angel</surname><given-names>G</given-names></name><name><surname>Genovese</surname><given-names>G</given-names></name><name><surname>Hartl</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Kashin</surname><given-names>S</given-names></name><name><surname>Nemesh</surname><given-names>JC</given-names></name><name><surname>Shakir</surname><given-names>K</given-names></name><name><surname>Yoon</surname><given-names>SC</given-names></name><name><surname>Lihm</surname><given-names>J</given-names></name><name><surname>Makarov</surname><given-names>V</given-names></name><name><surname>Degenhardt</surname><given-names>J</given-names></name><name><surname>Korbel</surname><given-names>JO</given-names></name><name><surname>Fritz</surname><given-names>MH</given-names></name><name><surname>Meiers</surname><given-names>S</given-names></name><name><surname>Raeder</surname><given-names>B</given-names></name><name><surname>Rausch</surname><given-names>T</given-names></name><name><surname>Stütz</surname><given-names>AM</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name><name><surname>Paolo Casale</surname><given-names>F</given-names></name><name><surname>Clarke</surname><given-names>L</given-names></name><name><surname>Smith</surname><given-names>RE</given-names></name><name><surname>Stegle</surname><given-names>O</given-names></name><name><surname>Zheng-Bradley</surname><given-names>X</given-names></name><name><surname>Bentley</surname><given-names>DR</given-names></name><name><surname>Barnes</surname><given-names>B</given-names></name><name><surname>Keira Cheetham</surname><given-names>R</given-names></name><name><surname>Eberle</surname><given-names>M</given-names></name><name><surname>Humphray</surname><given-names>S</given-names></name><name><surname>Kahn</surname><given-names>S</given-names></name><name><surname>Murray</surname><given-names>L</given-names></name><name><surname>Shaw</surname><given-names>R</given-names></name><collab>Leiden University Medical Center</collab><name><surname>Lameijer</surname><given-names>EW</given-names></name><name><surname>Batzer</surname><given-names>MA</given-names></name><name><surname>Konkel</surname><given-names>MK</given-names></name><name><surname>Walker</surname><given-names>JA</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Hall</surname><given-names>I</given-names></name><name><surname>Ye</surname><given-names>K</given-names></name><name><surname>Lacroute</surname><given-names>P</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Cerveira</surname><given-names>E</given-names></name><name><surname>Malhotra</surname><given-names>A</given-names></name><name><surname>Hwang</surname><given-names>J</given-names></name><name><surname>Plewczynski</surname><given-names>D</given-names></name><name><surname>Radew</surname><given-names>K</given-names></name><name><surname>Romanovitch</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Craig</surname><given-names>DW</given-names></name><name><surname>Homer</surname><given-names>N</given-names></name><name><surname>Church</surname><given-names>D</given-names></name><name><surname>Xiao</surname><given-names>C</given-names></name><name><surname>Antaki</surname><given-names>D</given-names></name><name><surname>Bafna</surname><given-names>V</given-names></name><name><surname>Michaelson</surname><given-names>J</given-names></name><name><surname>Ye</surname><given-names>K</given-names></name><name><surname>Devine</surname><given-names>SE</given-names></name><name><surname>Gardner</surname><given-names>EJ</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Kidd</surname><given-names>JM</given-names></name><name><surname>Mills</surname><given-names>RE</given-names></name><name><surname>Dayama</surname><given-names>G</given-names></name><name><surname>Emery</surname><given-names>S</given-names></name><name><surname>Jun</surname><given-names>G</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Quitadamo</surname><given-names>A</given-names></name><name><surname>Lunter</surname><given-names>G</given-names></name><name><surname>McVean</surname><given-names>GA</given-names></name><collab>University of Texas MD Anderson Cancer Center</collab><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Chong</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Witherspoon</surname><given-names>D</given-names></name><name><surname>Xing</surname><given-names>J</given-names></name><name><surname>Eichler</surname><given-names>EE</given-names></name><name><surname>Chaisson</surname><given-names>MJ</given-names></name><name><surname>Hormozdiari</surname><given-names>F</given-names></name><name><surname>Huddleston</surname><given-names>J</given-names></name><name><surname>Malig</surname><given-names>M</given-names></name><name><surname>Nelson</surname><given-names>BJ</given-names></name><name><surname>Sudmant</surname><given-names>PH</given-names></name><collab>Vanderbilt University School of Medicine</collab><name><surname>Parrish</surname><given-names>NF</given-names></name><name><surname>Khurana</surname><given-names>E</given-names></name><name><surname>Hurles</surname><given-names>ME</given-names></name><name><surname>Blackburne</surname><given-names>B</given-names></name><name><surname>Lindsay</surname><given-names>SJ</given-names></name><name><surname>Ning</surname><given-names>Z</given-names></name><name><surname>Walter</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Gerstein</surname><given-names>MB</given-names></name><name><surname>Abyzov</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Clarke</surname><given-names>D</given-names></name><name><surname>Lam</surname><given-names>H</given-names></name><name><surname>Jasmine Mu</surname><given-names>X</given-names></name><name><surname>Sisu</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><collab>Exome group</collab><name><surname>Gibbs</surname><given-names>RA</given-names></name><name><surname>Yu</surname><given-names>F</given-names></name><name><surname>Bainbridge</surname><given-names>M</given-names></name><name><surname>Challis</surname><given-names>D</given-names></name><name><surname>Evani</surname><given-names>US</given-names></name><name><surname>Kovar</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Muzny</surname><given-names>D</given-names></name><name><surname>Nagaswamy</surname><given-names>U</given-names></name><name><surname>Reid</surname><given-names>JG</given-names></name><name><surname>Sabo</surname><given-names>A</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>R</given-names></name><name><surname>Marth</surname><given-names>GT</given-names></name><name><surname>Garrison</surname><given-names>EP</given-names></name><name><surname>Fung Leong</surname><given-names>W</given-names></name><name><surname>Ward</surname><given-names>AN</given-names></name><name><surname>del Angel</surname><given-names>G</given-names></name><name><surname>DePristo</surname><given-names>MA</given-names></name><name><surname>Gabriel</surname><given-names>SB</given-names></name><name><surname>Gupta</surname><given-names>N</given-names></name><name><surname>Hartl</surname><given-names>C</given-names></name><name><surname>Poplin</surname><given-names>RE</given-names></name><name><surname>Clark</surname><given-names>AG</given-names></name><name><surname>Rodriguez-Flores</surname><given-names>JL</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name><name><surname>Clarke</surname><given-names>L</given-names></name><name><surname>Smith</surname><given-names>RE</given-names></name><name><surname>Zheng-Bradley</surname><given-names>X</given-names></name><name><surname>MacArthur</surname><given-names>DG</given-names></name><name><surname>Mardis</surname><given-names>ER</given-names></name><name><surname>Fulton</surname><given-names>R</given-names></name><name><surname>Koboldt</surname><given-names>DC</given-names></name><name><surname>Gravel</surname><given-names>S</given-names></name><name><surname>Bustamante</surname><given-names>CD</given-names></name><name><surname>Craig</surname><given-names>DW</given-names></name><name><surname>Christoforides</surname><given-names>A</given-names></name><name><surname>Homer</surname><given-names>N</given-names></name><name><surname>Izatt</surname><given-names>T</given-names></name><name><surname>Sherry</surname><given-names>ST</given-names></name><name><surname>Xiao</surname><given-names>C</given-names></name><name><surname>Dermitzakis</surname><given-names>ET</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Min Kang</surname><given-names>H</given-names></name><name><surname>McVean</surname><given-names>GA</given-names></name><name><surname>Gerstein</surname><given-names>MB</given-names></name><name><surname>Balasubramanian</surname><given-names>S</given-names></name><name><surname>Habegger</surname><given-names>L</given-names></name><collab>Functional interpretation group</collab><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name><name><surname>Clarke</surname><given-names>L</given-names></name><name><surname>Cunningham</surname><given-names>F</given-names></name><name><surname>Dunham</surname><given-names>I</given-names></name><name><surname>Zerbino</surname><given-names>D</given-names></name><name><surname>Zheng-Bradley</surname><given-names>X</given-names></name><name><surname>Lage</surname><given-names>K</given-names></name><name><surname>Berg Jespersen</surname><given-names>J</given-names></name><name><surname>Horn</surname><given-names>H</given-names></name><name><surname>Montgomery</surname><given-names>SB</given-names></name><name><surname>DeGorter</surname><given-names>MK</given-names></name><name><surname>Khurana</surname><given-names>E</given-names></name><name><surname>Tyler-Smith</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Colonna</surname><given-names>V</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Gerstein</surname><given-names>MB</given-names></name><name><surname>Balasubramanian</surname><given-names>S</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><collab>Chromosome Y group</collab><name><surname>Auton</surname><given-names>A</given-names></name><name><surname>Marcketta</surname><given-names>A</given-names></name><collab>American Museum of Natural History</collab><name><surname>Desalle</surname><given-names>R</given-names></name><name><surname>Narechania</surname><given-names>A</given-names></name><collab>Arizona State University</collab><name><surname>Wilson Sayres</surname><given-names>MA</given-names></name><name><surname>Garrison</surname><given-names>EP</given-names></name><name><surname>Handsaker</surname><given-names>RE</given-names></name><name><surname>Kashin</surname><given-names>S</given-names></name><name><surname>McCarroll</surname><given-names>SA</given-names></name><name><surname>Rodriguez-Flores</surname><given-names>JL</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name><name><surname>Clarke</surname><given-names>L</given-names></name><name><surname>Zheng-Bradley</surname><given-names>X</given-names></name><name><surname>Erlich</surname><given-names>Y</given-names></name><name><surname>Gymrek</surname><given-names>M</given-names></name><name><surname>Frederick Willems</surname><given-names>T</given-names></name><name><surname>Bustamante</surname><given-names>CD</given-names></name><name><surname>Mendez</surname><given-names>FL</given-names></name><name><surname>David Poznik</surname><given-names>G</given-names></name><name><surname>Underhill</surname><given-names>PA</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Cerveira</surname><given-names>E</given-names></name><name><surname>Malhotra</surname><given-names>A</given-names></name><name><surname>Romanovitch</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><collab>University of Queensland</collab><name><surname>Coin</surname><given-names>L</given-names></name><name><surname>Shao</surname><given-names>H</given-names></name><collab>Virginia Bioinformatics Institute</collab><name><surname>Mittelman</surname><given-names>D</given-names></name><name><surname>Tyler-Smith</surname><given-names>C</given-names></name><name><surname>Ayub</surname><given-names>Q</given-names></name><name><surname>Banerjee</surname><given-names>R</given-names></name><name><surname>Cerezo</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Fitzgerald</surname><given-names>TW</given-names></name><name><surname>Louzada</surname><given-names>S</given-names></name><name><surname>Massaia</surname><given-names>A</given-names></name><name><surname>McCarthy</surname><given-names>S</given-names></name><name><surname>Ritchie</surname><given-names>GR</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><collab>Data coordination center group</collab><name><surname>Gibbs</surname><given-names>RA</given-names></name><name><surname>Kovar</surname><given-names>C</given-names></name><name><surname>Kalra</surname><given-names>D</given-names></name><name><surname>Hale</surname><given-names>W</given-names></name><name><surname>Muzny</surname><given-names>D</given-names></name><name><surname>Reid</surname><given-names>JG</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Dan</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Ye</surname><given-names>C</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Altshuler</surname><given-names>DM</given-names></name><name><surname>Clarke</surname><given-names>L</given-names></name><name><surname>Zheng-Bradley</surname><given-names>X</given-names></name><name><surname>Bentley</surname><given-names>DR</given-names></name><name><surname>Cox</surname><given-names>A</given-names></name><name><surname>Humphray</surname><given-names>S</given-names></name><name><surname>Kahn</surname><given-names>S</given-names></name><name><surname>Sudbrak</surname><given-names>R</given-names></name><name><surname>Albrecht</surname><given-names>MW</given-names></name><name><surname>Lienhard</surname><given-names>M</given-names></name><name><surname>Larson</surname><given-names>D</given-names></name><name><surname>Craig</surname><given-names>DW</given-names></name><name><surname>Izatt</surname><given-names>T</given-names></name><name><surname>Kurdoglu</surname><given-names>AA</given-names></name><name><surname>Sherry</surname><given-names>ST</given-names></name><name><surname>Xiao</surname><given-names>C</given-names></name><name><surname>Haussler</surname><given-names>D</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>McVean</surname><given-names>GA</given-names></name><name><surname>Durbin</surname><given-names>RM</given-names></name><name><surname>Balasubramaniam</surname><given-names>S</given-names></name><name><surname>Keane</surname><given-names>TM</given-names></name><name><surname>McCarthy</surname><given-names>S</given-names></name><name><surname>Stalker</surname><given-names>J</given-names></name><collab>Samples and ELSI group</collab><name><surname>Chakravarti</surname><given-names>A</given-names></name><name><surname>Knoppers</surname><given-names>BM</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Barnes</surname><given-names>KC</given-names></name><name><surname>Beiswanger</surname><given-names>C</given-names></name><name><surname>Burchard</surname><given-names>EG</given-names></name><name><surname>Bustamante</surname><given-names>CD</given-names></name><name><surname>Cai</surname><given-names>H</given-names></name><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Durbin</surname><given-names>RM</given-names></name><name><surname>Gerry</surname><given-names>NP</given-names></name><name><surname>Gharani</surname><given-names>N</given-names></name><name><surname>Gibbs</surname><given-names>RA</given-names></name><name><surname>Gignoux</surname><given-names>CR</given-names></name><name><surname>Gravel</surname><given-names>S</given-names></name><name><surname>Henn</surname><given-names>B</given-names></name><name><surname>Jones</surname><given-names>D</given-names></name><name><surname>Jorde</surname><given-names>L</given-names></name><name><surname>Kaye</surname><given-names>JS</given-names></name><name><surname>Keinan</surname><given-names>A</given-names></name><name><surname>Kent</surname><given-names>A</given-names></name><name><surname>Kerasidou</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Mathias</surname><given-names>R</given-names></name><name><surname>McVean</surname><given-names>GA</given-names></name><name><surname>Moreno-Estrada</surname><given-names>A</given-names></name><name><surname>Ossorio</surname><given-names>PN</given-names></name><name><surname>Parker</surname><given-names>M</given-names></name><name><surname>Resch</surname><given-names>AM</given-names></name><name><surname>Rotimi</surname><given-names>CN</given-names></name><name><surname>Royal</surname><given-names>CD</given-names></name><name><surname>Sandoval</surname><given-names>K</given-names></name><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Sudbrak</surname><given-names>R</given-names></name><name><surname>Tian</surname><given-names>Z</given-names></name><name><surname>Tishkoff</surname><given-names>S</given-names></name><name><surname>Toji</surname><given-names>LH</given-names></name><name><surname>Tyler-Smith</surname><given-names>C</given-names></name><name><surname>Via</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><collab>Sample collection</collab><collab>British from England and Scotland (GBR)</collab><name><surname>Bodmer</surname><given-names>W</given-names></name><collab>Colombians in Medellín, Colombia (CLM)</collab><name><surname>Bedoya</surname><given-names>G</given-names></name><name><surname>Ruiz-Linares</surname><given-names>A</given-names></name><collab>Han Chinese South (CHS)</collab><name><surname>Cai</surname><given-names>Z</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Chu</surname><given-names>J</given-names></name><collab>Finnish in Finland (FIN)</collab><name><surname>Peltonen</surname><given-names>L</given-names></name><collab>Iberian Populations in Spain (IBS)</collab><name><surname>Garcia-Montero</surname><given-names>A</given-names></name><name><surname>Orfao</surname><given-names>A</given-names></name><collab>Puerto Ricans in Puerto Rico (PUR)</collab><name><surname>Dutil</surname><given-names>J</given-names></name><name><surname>Martinez-Cruzado</surname><given-names>JC</given-names></name><name><surname>Oleksyk</surname><given-names>TK</given-names></name><collab>African Caribbean in Barbados (ACB)</collab><name><surname>Barnes</surname><given-names>KC</given-names></name><name><surname>Mathias</surname><given-names>RA</given-names></name><name><surname>Hennis</surname><given-names>A</given-names></name><name><surname>Watson</surname><given-names>H</given-names></name><name><surname>McKenzie</surname><given-names>C</given-names></name><collab>Bengali in Bangladesh (BEB)</collab><name><surname>Qadri</surname><given-names>F</given-names></name><name><surname>LaRocque</surname><given-names>R</given-names></name><name><surname>Sabeti</surname><given-names>PC</given-names></name><collab>Chinese Dai in Xishuangbanna, China (CDX)</collab><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>X</given-names></name><collab>Esan in Nigeria (ESN)</collab><name><surname>Sabeti</surname><given-names>PC</given-names></name><name><surname>Asogun</surname><given-names>D</given-names></name><name><surname>Folarin</surname><given-names>O</given-names></name><name><surname>Happi</surname><given-names>C</given-names></name><name><surname>Omoniwa</surname><given-names>O</given-names></name><name><surname>Stremlau</surname><given-names>M</given-names></name><name><surname>Tariyal</surname><given-names>R</given-names></name><collab>Gambian in Western Division – Mandinka (GWD)</collab><name><surname>Jallow</surname><given-names>M</given-names></name><name><surname>Sisay Joof</surname><given-names>F</given-names></name><name><surname>Corrah</surname><given-names>T</given-names></name><name><surname>Rockett</surname><given-names>K</given-names></name><name><surname>Kwiatkowski</surname><given-names>D</given-names></name><collab>Indian Telugu in the UK (ITU) and Sri Lankan Tamil in the UK (STU)</collab><name><surname>Kooner</surname><given-names>J</given-names></name><collab>Kinh in Ho Chi Minh City, Vietnam (KHV)</collab><name><surname>Tịnh Hiê`n</surname><given-names>T</given-names></name><name><surname>Dunstan</surname><given-names>SJ</given-names></name><name><surname>Thuy Hang</surname><given-names>N</given-names></name><collab>Mende in Sierra Leone (MSL)</collab><name><surname>Fonnie</surname><given-names>R</given-names></name><name><surname>Garry</surname><given-names>R</given-names></name><name><surname>Kanneh</surname><given-names>L</given-names></name><name><surname>Moses</surname><given-names>L</given-names></name><name><surname>Sabeti</surname><given-names>PC</given-names></name><name><surname>Schieffelin</surname><given-names>J</given-names></name><name><surname>Grant</surname><given-names>DS</given-names></name><collab>Peruvian in Lima, Peru (PEL)</collab><name><surname>Gallo</surname><given-names>C</given-names></name><name><surname>Poletti</surname><given-names>G</given-names></name><collab>Punjabi in Lahore, Pakistan (PJL)</collab><name><surname>Saleheen</surname><given-names>D</given-names></name><name><surname>Rasheed</surname><given-names>A</given-names></name><collab>Scientific management</collab><name><surname>Brooks</surname><given-names>LD</given-names></name><name><surname>Felsenfeld</surname><given-names>AL</given-names></name><name><surname>McEwen</surname><given-names>JE</given-names></name><name><surname>Vaydylevich</surname><given-names>Y</given-names></name><name><surname>Green</surname><given-names>ED</given-names></name><name><surname>Duncanson</surname><given-names>A</given-names></name><name><surname>Dunn</surname><given-names>M</given-names></name><name><surname>Schloss</surname><given-names>JA</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><collab>Writing group</collab><name><surname>Auton</surname><given-names>A</given-names></name><name><surname>Brooks</surname><given-names>LD</given-names></name><name><surname>Durbin</surname><given-names>RM</given-names></name><name><surname>Garrison</surname><given-names>EP</given-names></name><name><surname>Min Kang</surname><given-names>H</given-names></name><name><surname>Korbel</surname><given-names>JO</given-names></name><name><surname>Marchini</surname><given-names>JL</given-names></name><name><surname>McCarthy</surname><given-names>S</given-names></name><name><surname>McVean</surname><given-names>GA</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A global reference for human genetic variation</article-title><source>Nature</source><volume>526</volume><fpage>68</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1038/nature15393</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbeira</surname><given-names>AN</given-names></name><name><surname>Dickinson</surname><given-names>SP</given-names></name><name><surname>Bonazzola</surname><given-names>R</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Wheeler</surname><given-names>HE</given-names></name><name><surname>Torres</surname><given-names>JM</given-names></name><name><surname>Torstenson</surname><given-names>ES</given-names></name><name><surname>Shah</surname><given-names>KP</given-names></name><name><surname>Garcia</surname><given-names>T</given-names></name><name><surname>Edwards</surname><given-names>TL</given-names></name><name><surname>Stahl</surname><given-names>EA</given-names></name><name><surname>Huckins</surname><given-names>LM</given-names></name><collab>GTEx Consortium</collab><name><surname>Nicolae</surname><given-names>DL</given-names></name><name><surname>Cox</surname><given-names>NJ</given-names></name><name><surname>Im</surname><given-names>HK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>1825</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-03621-1</pub-id><pub-id pub-id-type="pmid">29739930</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbeira</surname><given-names>AN</given-names></name><name><surname>Bonazzola</surname><given-names>R</given-names></name><name><surname>Gamazon</surname><given-names>ER</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Park</surname><given-names>Y</given-names></name><name><surname>Kim-Hellmuth</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Hormozdiari</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Rao</surname><given-names>A</given-names></name><name><surname>Hamel</surname><given-names>AR</given-names></name><name><surname>Pividori</surname><given-names>MD</given-names></name><name><surname>Aguet</surname><given-names>F</given-names></name><collab>GTEx GWAS Working Group</collab><name><surname>Bastarache</surname><given-names>L</given-names></name><name><surname>Jordan</surname><given-names>DM</given-names></name><name><surname>Verbanck</surname><given-names>M</given-names></name><name><surname>Do</surname><given-names>R</given-names></name><collab>GTEx Consortium</collab><name><surname>Stephens</surname><given-names>M</given-names></name><name><surname>Ardlie</surname><given-names>K</given-names></name><name><surname>McCarthy</surname><given-names>M</given-names></name><name><surname>Montgomery</surname><given-names>SB</given-names></name><name><surname>Segrè</surname><given-names>AV</given-names></name><name><surname>Brown</surname><given-names>CD</given-names></name><name><surname>Lappalainen</surname><given-names>T</given-names></name><name><surname>Wen</surname><given-names>X</given-names></name><name><surname>Im</surname><given-names>HK</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Exploiting the GTEx resources to decipher the mechanisms at GWAS loci</article-title><source>Genome Biology</source><volume>22</volume><fpage>1</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1186/s13059-020-02252-4</pub-id><pub-id pub-id-type="pmid">33499903</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulik-Sullivan</surname><given-names>BK</given-names></name><name><surname>Loh</surname><given-names>P-R</given-names></name><name><surname>Finucane</surname><given-names>HK</given-names></name><name><surname>Ripke</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><collab>Schizophrenia Working Group of the Psychiatric Genomics Consortium</collab><name><surname>Patterson</surname><given-names>N</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Price</surname><given-names>AL</given-names></name><name><surname>Neale</surname><given-names>BM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>LD Score regression distinguishes confounding from polygenicity in genome-wide association studies</article-title><source>Nature Genetics</source><volume>47</volume><fpage>291</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1038/ng.3211</pub-id><pub-id pub-id-type="pmid">25642630</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Consortium</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The GTEx Consortium atlas of genetic regulatory effects across human tissues</article-title><source>Science</source><volume>369</volume><fpage>1318</fpage><lpage>1330</lpage><pub-id pub-id-type="doi">10.1126/science.aaz1776</pub-id><pub-id pub-id-type="pmid">32913098</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Leeuw</surname><given-names>CA</given-names></name><name><surname>Mooij</surname><given-names>JM</given-names></name><name><surname>Heskes</surname><given-names>T</given-names></name><name><surname>Posthuma</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>MAGMA: generalized gene-set analysis of GWAS data</article-title><source>PLOS Computational Biology</source><volume>11</volume><elocation-id>e1004219</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1004219</pub-id><pub-id pub-id-type="pmid">25885710</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Wong</surname><given-names>P-P</given-names></name><name><surname>He</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Ling</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Systematic analysis to identify transcriptome-wide dysregulation of Alzheimer’s disease in genes and isoforms</article-title><source>Human Genetics</source><volume>140</volume><fpage>609</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.1007/s00439-020-02230-7</pub-id><pub-id pub-id-type="pmid">33140241</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Franc</surname><given-names>V</given-names></name><name><surname>Hlaváč</surname><given-names>V</given-names></name><name><surname>Navara</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><source>Sequential Coordinate-Wise Algorithm for the Non-Negative Least Squares Problem</source><publisher-name>Springer</publisher-name><pub-id pub-id-type="doi">10.1007/11556121_50</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freshour</surname><given-names>SL</given-names></name><name><surname>Kiwala</surname><given-names>S</given-names></name><name><surname>Cotto</surname><given-names>KC</given-names></name><name><surname>Coffman</surname><given-names>AC</given-names></name><name><surname>McMichael</surname><given-names>JF</given-names></name><name><surname>Song</surname><given-names>JJ</given-names></name><name><surname>Griffith</surname><given-names>M</given-names></name><name><surname>Griffith</surname><given-names>OL</given-names></name><name><surname>Wagner</surname><given-names>AH</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts</article-title><source>Nucleic Acids Research</source><volume>49</volume><fpage>D1144</fpage><lpage>D1151</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa1084</pub-id><pub-id pub-id-type="pmid">33237278</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallagher</surname><given-names>MD</given-names></name><name><surname>Chen-Plotkin</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The Post-GWAS Era: From Association to Function</article-title><source>American Journal of Human Genetics</source><volume>102</volume><fpage>717</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2018.04.002</pub-id><pub-id pub-id-type="pmid">29727686</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gamazon</surname><given-names>ER</given-names></name><name><surname>Wheeler</surname><given-names>HE</given-names></name><name><surname>Shah</surname><given-names>KP</given-names></name><name><surname>Mozaffari</surname><given-names>SV</given-names></name><name><surname>Aquino-Michaels</surname><given-names>K</given-names></name><name><surname>Carroll</surname><given-names>RJ</given-names></name><name><surname>Eyler</surname><given-names>AE</given-names></name><name><surname>Denny</surname><given-names>JC</given-names></name><collab>GTEx Consortium</collab><name><surname>Nicolae</surname><given-names>DL</given-names></name><name><surname>Cox</surname><given-names>NJ</given-names></name><name><surname>Im</surname><given-names>HK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A gene-based association method for mapping traits using reference transcriptome data</article-title><source>Nature Genetics</source><volume>47</volume><fpage>1091</fpage><lpage>1098</lpage><pub-id pub-id-type="doi">10.1038/ng.3367</pub-id><pub-id pub-id-type="pmid">26258848</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gamazon</surname><given-names>ER</given-names></name><name><surname>Segrè</surname><given-names>AV</given-names></name><name><surname>van de Bunt</surname><given-names>M</given-names></name><name><surname>Wen</surname><given-names>X</given-names></name><name><surname>Xi</surname><given-names>HS</given-names></name><name><surname>Hormozdiari</surname><given-names>F</given-names></name><name><surname>Ongen</surname><given-names>H</given-names></name><name><surname>Konkashbaev</surname><given-names>A</given-names></name><name><surname>Derks</surname><given-names>EM</given-names></name><name><surname>Aguet</surname><given-names>F</given-names></name><name><surname>Quan</surname><given-names>J</given-names></name><collab>GTEx Consortium</collab><name><surname>Nicolae</surname><given-names>DL</given-names></name><name><surname>Eskin</surname><given-names>E</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>Dermitzakis</surname><given-names>ET</given-names></name><name><surname>Cox</surname><given-names>NJ</given-names></name><name><surname>Ardlie</surname><given-names>KG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variation</article-title><source>Nature Genetics</source><volume>50</volume><fpage>956</fpage><lpage>967</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0154-4</pub-id><pub-id pub-id-type="pmid">29955180</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gamazon</surname><given-names>E.R</given-names></name><name><surname>Zwinderman</surname><given-names>AH</given-names></name><name><surname>Cox</surname><given-names>NJ</given-names></name><name><surname>Denys</surname><given-names>D</given-names></name><name><surname>Derks</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Multi-tissue transcriptome analyses identify genetic mechanisms underlying neuropsychiatric traits</article-title><source>Nature Genetics</source><volume>51</volume><fpage>933</fpage><lpage>940</lpage><pub-id pub-id-type="doi">10.1038/s41588-019-0409-8</pub-id><pub-id pub-id-type="pmid">31086352</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandal</surname><given-names>MJ</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Hadjimichael</surname><given-names>E</given-names></name><name><surname>Walker</surname><given-names>RL</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Won</surname><given-names>H</given-names></name><name><surname>van Bakel</surname><given-names>H</given-names></name><name><surname>Varghese</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Shieh</surname><given-names>AW</given-names></name><name><surname>Haney</surname><given-names>J</given-names></name><name><surname>Parhami</surname><given-names>S</given-names></name><name><surname>Belmont</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Moran Losada</surname><given-names>P</given-names></name><name><surname>Khan</surname><given-names>Z</given-names></name><name><surname>Mleczko</surname><given-names>J</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Dai</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>YT</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Fish</surname><given-names>K</given-names></name><name><surname>Hof</surname><given-names>PR</given-names></name><name><surname>Warrell</surname><given-names>J</given-names></name><name><surname>Fitzgerald</surname><given-names>D</given-names></name><name><surname>White</surname><given-names>K</given-names></name><name><surname>Jaffe</surname><given-names>AE</given-names></name><collab>PsychENCODE Consortium</collab><name><surname>Peters</surname><given-names>MA</given-names></name><name><surname>Gerstein</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Iakoucheva</surname><given-names>LM</given-names></name><name><surname>Pinto</surname><given-names>D</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder</article-title><source>Science</source><volume>362</volume><elocation-id>eaat8127</elocation-id><pub-id pub-id-type="doi">10.1126/science.aat8127</pub-id><pub-id pub-id-type="pmid">30545856</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerring</surname><given-names>ZF</given-names></name><name><surname>Gamazon</surname><given-names>ER</given-names></name><name><surname>Derks</surname><given-names>EM</given-names></name><collab>Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium</collab></person-group><year iso-8601-date="2019">2019</year><article-title>A gene co-expression network-based analysis of multiple brain tissues reveals novel genes and molecular pathways underlying major depression</article-title><source>PLOS Genetics</source><volume>15</volume><elocation-id>e1008245</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1008245</pub-id><pub-id pub-id-type="pmid">31306407</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerring</surname><given-names>ZF</given-names></name><name><surname>Mina-Vargas</surname><given-names>A</given-names></name><name><surname>Gamazon</surname><given-names>ER</given-names></name><name><surname>Derks</surname><given-names>EM</given-names></name><name><surname>Valencia</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>E-MAGMA: an eQTL-informed method to identify risk genes using genome-wide association study summary statistics</article-title><source>Bioinformatics</source><volume>37</volume><fpage>2245</fpage><lpage>2249</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btab115</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillett</surname><given-names>AC</given-names></name><name><surname>Vassos</surname><given-names>E</given-names></name><name><surname>Lewis</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Transforming Summary Statistics from Logistic Regression to the Liability Scale: Application to Genetic and Environmental Risk Scores</article-title><source>Human Heredity</source><volume>83</volume><fpage>210</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1159/000495697</pub-id><pub-id pub-id-type="pmid">30865946</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="software"><person-group person-group-type="author"><collab>hakyimlab</collab></person-group><year iso-8601-date="2021">2021</year><data-title>MetaXcan</data-title><version designator="swh:1:rev:cfc9e369bbf5630e0c9488993cd877f231c5d02e">swh:1:rev:cfc9e369bbf5630e0c9488993cd877f231c5d02e</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:d751af806aed116450da5ddb3d3f3a7fe7674f2b;origin=https://github.com/hakyimlab/MetaXcan;visit=swh:1:snp:799a434225d880a1e06acde3cba4e6fda167496f;anchor=swh:1:rev:cfc9e369bbf5630e0c9488993cd877f231c5d02e">https://archive.softwareheritage.org/swh:1:dir:d751af806aed116450da5ddb3d3f3a7fe7674f2b;origin=https://github.com/hakyimlab/MetaXcan;visit=swh:1:snp:799a434225d880a1e06acde3cba4e6fda167496f;anchor=swh:1:rev:cfc9e369bbf5630e0c9488993cd877f231c5d02e</ext-link></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hekselman</surname><given-names>I</given-names></name><name><surname>Yeger-Lotem</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mechanisms of tissue and cell-type specificity in heritable traits and diseases</article-title><source>Nature Reviews. Genetics</source><volume>21</volume><fpage>137</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1038/s41576-019-0200-9</pub-id><pub-id pub-id-type="pmid">31913361</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="web"><person-group person-group-type="author"><collab>HGNC Database, H.G.N.C.H</collab></person-group><year iso-8601-date="2021">2021</year><article-title>European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI)</article-title><source>Wellcome Genome Campus</source><ext-link ext-link-type="uri" xlink:href="https://www.genenames.org/">https://www.genenames.org/</ext-link><date-in-citation iso-8601-date="2019-09-16">September 16, 2019</date-in-citation></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Himmelstein</surname><given-names>DS</given-names></name><name><surname>Lizee</surname><given-names>A</given-names></name><name><surname>Hessler</surname><given-names>C</given-names></name><name><surname>Brueggeman</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>SL</given-names></name><name><surname>Hadley</surname><given-names>D</given-names></name><name><surname>Green</surname><given-names>A</given-names></name><name><surname>Khankhanian</surname><given-names>P</given-names></name><name><surname>Baranzini</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Systematic integration of biomedical knowledge prioritizes drugs for repurposing</article-title><source>eLife</source><volume>6</volume><elocation-id>e26726</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.26726</pub-id><pub-id pub-id-type="pmid">28936969</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinrichs</surname><given-names>AS</given-names></name><name><surname>Karolchik</surname><given-names>D</given-names></name><name><surname>Baertsch</surname><given-names>R</given-names></name><name><surname>Barber</surname><given-names>GP</given-names></name><name><surname>Bejerano</surname><given-names>G</given-names></name><name><surname>Clawson</surname><given-names>H</given-names></name><name><surname>Diekhans</surname><given-names>M</given-names></name><name><surname>Furey</surname><given-names>TS</given-names></name><name><surname>Harte</surname><given-names>RA</given-names></name><name><surname>Hsu</surname><given-names>F</given-names></name><name><surname>Hillman-Jackson</surname><given-names>J</given-names></name><name><surname>Kuhn</surname><given-names>RM</given-names></name><name><surname>Pedersen</surname><given-names>JS</given-names></name><name><surname>Pohl</surname><given-names>A</given-names></name><name><surname>Raney</surname><given-names>BJ</given-names></name><name><surname>Rosenbloom</surname><given-names>KR</given-names></name><name><surname>Siepel</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>KE</given-names></name><name><surname>Sugnet</surname><given-names>CW</given-names></name><name><surname>Sultan-Qurraie</surname><given-names>A</given-names></name><name><surname>Thomas</surname><given-names>DJ</given-names></name><name><surname>Trumbower</surname><given-names>H</given-names></name><name><surname>Weber</surname><given-names>RJ</given-names></name><name><surname>Weirauch</surname><given-names>M</given-names></name><name><surname>Zweig</surname><given-names>AS</given-names></name><name><surname>Haussler</surname><given-names>D</given-names></name><name><surname>Kent</surname><given-names>WJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The UCSC Genome Browser Database: update 2006</article-title><source>Nucleic Acids Research</source><volume>34</volume><fpage>D590</fpage><lpage>D598</lpage><pub-id pub-id-type="doi">10.1093/nar/gkj144</pub-id><pub-id pub-id-type="pmid">16381938</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huckins</surname><given-names>LM</given-names></name><name><surname>Dobbyn</surname><given-names>A</given-names></name><name><surname>Ruderfer</surname><given-names>DM</given-names></name><name><surname>Hoffman</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Pardiñas</surname><given-names>AF</given-names></name><name><surname>Rajagopal</surname><given-names>VM</given-names></name><name><surname>Als</surname><given-names>TD</given-names></name><name><surname>T Nguyen</surname><given-names>H</given-names></name><name><surname>Girdhar</surname><given-names>K</given-names></name><name><surname>Boocock</surname><given-names>J</given-names></name><name><surname>Roussos</surname><given-names>P</given-names></name><name><surname>Fromer</surname><given-names>M</given-names></name><name><surname>Kramer</surname><given-names>R</given-names></name><name><surname>Domenici</surname><given-names>E</given-names></name><name><surname>Gamazon</surname><given-names>ER</given-names></name><name><surname>Purcell</surname><given-names>S</given-names></name><collab>CommonMind Consortium</collab><collab>Schizophrenia Working Group of the Psychiatric Genomics Consortium</collab><collab>iPSYCH-GEMS Schizophrenia Working Group</collab><name><surname>Demontis</surname><given-names>D</given-names></name><name><surname>Børglum</surname><given-names>AD</given-names></name><name><surname>Walters</surname><given-names>JTR</given-names></name><name><surname>O’Donovan</surname><given-names>MC</given-names></name><name><surname>Sullivan</surname><given-names>P</given-names></name><name><surname>Owen</surname><given-names>MJ</given-names></name><name><surname>Devlin</surname><given-names>B</given-names></name><name><surname>Sieberts</surname><given-names>SK</given-names></name><name><surname>Cox</surname><given-names>NJ</given-names></name><name><surname>Im</surname><given-names>HK</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name><name><surname>Stahl</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Gene expression imputation across multiple brain regions provides insights into schizophrenia risk</article-title><source>Nature Genetics</source><volume>51</volume><fpage>659</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1038/s41588-019-0364-4</pub-id><pub-id pub-id-type="pmid">30911161</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Xue</surname><given-names>C</given-names></name><name><surname>Dai</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>DESE: estimating driver tissues by selective expression of genes associated with complex diseases or traits</article-title><source>Genome Biology</source><volume>20</volume><elocation-id>233</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-019-1801-5</pub-id><pub-id pub-id-type="pmid">31694669</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>EA</given-names></name><name><surname>Davis</surname><given-names>JW</given-names></name><name><surname>Degner</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval</article-title><source>PLOS Genetics</source><volume>15</volume><elocation-id>e1008489</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1008489</pub-id><pub-id pub-id-type="pmid">31830040</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kung</surname><given-names>AWC</given-names></name><name><surname>Xiao</surname><given-names>S-M</given-names></name><name><surname>Cherny</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>GHY</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Tso</surname><given-names>G</given-names></name><name><surname>Lau</surname><given-names>KS</given-names></name><name><surname>Luk</surname><given-names>KDK</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Cui</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>M-J</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Yue</surname><given-names>H</given-names></name><name><surname>Xia</surname><given-names>W</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>Kiel</surname><given-names>DP</given-names></name><name><surname>Karasik</surname><given-names>D</given-names></name><name><surname>Hsu</surname><given-names>Y-H</given-names></name><name><surname>Cupples</surname><given-names>LA</given-names></name><name><surname>Demissie</surname><given-names>S</given-names></name><name><surname>Styrkarsdottir</surname><given-names>U</given-names></name><name><surname>Halldorsson</surname><given-names>BV</given-names></name><name><surname>Sigurdsson</surname><given-names>G</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name><name><surname>Richards</surname><given-names>JB</given-names></name><name><surname>Zhai</surname><given-names>G</given-names></name><name><surname>Soranzo</surname><given-names>N</given-names></name><name><surname>Valdes</surname><given-names>A</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Association of JAG1 with bone mineral density and osteoporotic fractures: a genome-wide association study and follow-up replication studies</article-title><source>American Journal of Human Genetics</source><volume>86</volume><fpage>229</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2009.12.014</pub-id><pub-id pub-id-type="pmid">20096396</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langfelder</surname><given-names>P</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>WGCNA: an R package for weighted correlation network analysis</article-title><source>BMC Bioinformatics</source><volume>9</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1186/1471-2105-9-559</pub-id><pub-id pub-id-type="pmid">19114008</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langfelder</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R</article-title><source>Bioinformatics</source><volume>24</volume><fpage>719</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btm563</pub-id><pub-id pub-id-type="pmid">18024473</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Legge</surname><given-names>SE</given-names></name><name><surname>Santoro</surname><given-names>ML</given-names></name><name><surname>Periyasamy</surname><given-names>S</given-names></name><name><surname>Okewole</surname><given-names>A</given-names></name><name><surname>Arsalan</surname><given-names>A</given-names></name><name><surname>Kowalec</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Genetic architecture of schizophrenia: a review of major advancements</article-title><source>Psychological Medicine</source><volume>51</volume><fpage>2168</fpage><lpage>2177</lpage><pub-id pub-id-type="doi">10.1017/S0033291720005334</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>MX</given-names></name><name><surname>Gui</surname><given-names>HS</given-names></name><name><surname>Kwan</surname><given-names>JSH</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>GATES: a rapid and powerful gene-based association test using extended Simes procedure</article-title><source>American Journal of Human Genetics</source><volume>88</volume><fpage>283</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2011.01.019</pub-id><pub-id pub-id-type="pmid">21397060</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Mak</surname><given-names>TSH</given-names></name><name><surname>Kwan</surname><given-names>JSH</given-names></name><name><surname>Xue</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Leung</surname><given-names>HCM</given-names></name><name><surname>Cui</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name><name><surname>Valencia</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A powerful conditional gene-based association approach implicated functionally important genes for schizophrenia</article-title><source>Bioinformatics</source><volume>35</volume><fpage>628</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty682</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>eDESE</data-title><version designator="207415a97">207415a97</version><source>Github</source><ext-link ext-link-type="uri" xlink:href="https://github.com/pmglab/eDESE">https://github.com/pmglab/eDESE</ext-link></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>JZ</given-names></name><name><surname>McRae</surname><given-names>AF</given-names></name><name><surname>Nyholt</surname><given-names>DR</given-names></name><name><surname>Medland</surname><given-names>SE</given-names></name><name><surname>Wray</surname><given-names>NR</given-names></name><name><surname>Brown</surname><given-names>KM</given-names></name><name><surname>Investigators</surname><given-names>A</given-names></name><name><surname>Hayward</surname><given-names>NK</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name><name><surname>Visscher</surname><given-names>PM</given-names></name><name><surname>Martin</surname><given-names>NG</given-names></name><name><surname>Macgregor</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A versatile gene-based test for genome-wide association studies</article-title><source>American Journal of Human Genetics</source><volume>87</volume><fpage>139</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2010.06.009</pub-id><pub-id pub-id-type="pmid">20598278</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maurano</surname><given-names>MT</given-names></name><name><surname>Humbert</surname><given-names>R</given-names></name><name><surname>Rynes</surname><given-names>E</given-names></name><name><surname>Thurman</surname><given-names>RE</given-names></name><name><surname>Haugen</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Reynolds</surname><given-names>AP</given-names></name><name><surname>Sandstrom</surname><given-names>R</given-names></name><name><surname>Qu</surname><given-names>H</given-names></name><name><surname>Brody</surname><given-names>J</given-names></name><name><surname>Shafer</surname><given-names>A</given-names></name><name><surname>Neri</surname><given-names>F</given-names></name><name><surname>Lee</surname><given-names>K</given-names></name><name><surname>Kutyavin</surname><given-names>T</given-names></name><name><surname>Stehling-Sun</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>AK</given-names></name><name><surname>Canfield</surname><given-names>TK</given-names></name><name><surname>Giste</surname><given-names>E</given-names></name><name><surname>Diegel</surname><given-names>M</given-names></name><name><surname>Bates</surname><given-names>D</given-names></name><name><surname>Hansen</surname><given-names>RS</given-names></name><name><surname>Neph</surname><given-names>S</given-names></name><name><surname>Sabo</surname><given-names>PJ</given-names></name><name><surname>Heimfeld</surname><given-names>S</given-names></name><name><surname>Raubitschek</surname><given-names>A</given-names></name><name><surname>Ziegler</surname><given-names>S</given-names></name><name><surname>Cotsapas</surname><given-names>C</given-names></name><name><surname>Sotoodehnia</surname><given-names>N</given-names></name><name><surname>Glass</surname><given-names>I</given-names></name><name><surname>Sunyaev</surname><given-names>SR</given-names></name><name><surname>Kaul</surname><given-names>R</given-names></name><name><surname>Stamatoyannopoulos</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Systematic localization of common disease-associated variation in regulatory DNA</article-title><source>Science</source><volume>337</volume><fpage>1190</fpage><lpage>1195</lpage><pub-id pub-id-type="doi">10.1126/science.1222794</pub-id><pub-id pub-id-type="pmid">22955828</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montana</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>HapSim: a simulation tool for generating haplotype data with pre-specified allele frequencies and LD coefficients</article-title><source>Bioinformatics</source><volume>21</volume><fpage>4309</fpage><lpage>4311</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bti689</pub-id><pub-id pub-id-type="pmid">16188927</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neale</surname><given-names>BM</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The future of association studies: gene-based analysis and replication</article-title><source>American Journal of Human Genetics</source><volume>75</volume><fpage>353</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1086/423901</pub-id><pub-id pub-id-type="pmid">15272419</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>MR</given-names></name><name><surname>Tipney</surname><given-names>H</given-names></name><name><surname>Painter</surname><given-names>JL</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Nicoletti</surname><given-names>P</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Floratos</surname><given-names>A</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name><name><surname>Li</surname><given-names>MJ</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Cardon</surname><given-names>LR</given-names></name><name><surname>Whittaker</surname><given-names>JC</given-names></name><name><surname>Sanseau</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The support of human genetic evidence for approved drug indications</article-title><source>Nature Genetics</source><volume>47</volume><fpage>856</fpage><lpage>860</lpage><pub-id pub-id-type="doi">10.1038/ng.3314</pub-id><pub-id pub-id-type="pmid">26121088</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Leary</surname><given-names>NA</given-names></name><name><surname>Wright</surname><given-names>MW</given-names></name><name><surname>Brister</surname><given-names>JR</given-names></name><name><surname>Ciufo</surname><given-names>S</given-names></name><name><surname>Haddad</surname><given-names>D</given-names></name><name><surname>McVeigh</surname><given-names>R</given-names></name><name><surname>Rajput</surname><given-names>B</given-names></name><name><surname>Robbertse</surname><given-names>B</given-names></name><name><surname>Smith-White</surname><given-names>B</given-names></name><name><surname>Ako-Adjei</surname><given-names>D</given-names></name><name><surname>Astashyn</surname><given-names>A</given-names></name><name><surname>Badretdin</surname><given-names>A</given-names></name><name><surname>Bao</surname><given-names>Y</given-names></name><name><surname>Blinkova</surname><given-names>O</given-names></name><name><surname>Brover</surname><given-names>V</given-names></name><name><surname>Chetvernin</surname><given-names>V</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Cox</surname><given-names>E</given-names></name><name><surname>Ermolaeva</surname><given-names>O</given-names></name><name><surname>Farrell</surname><given-names>CM</given-names></name><name><surname>Goldfarb</surname><given-names>T</given-names></name><name><surname>Gupta</surname><given-names>T</given-names></name><name><surname>Haft</surname><given-names>D</given-names></name><name><surname>Hatcher</surname><given-names>E</given-names></name><name><surname>Hlavina</surname><given-names>W</given-names></name><name><surname>Joardar</surname><given-names>VS</given-names></name><name><surname>Kodali</surname><given-names>VK</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Maglott</surname><given-names>D</given-names></name><name><surname>Masterson</surname><given-names>P</given-names></name><name><surname>McGarvey</surname><given-names>KM</given-names></name><name><surname>Murphy</surname><given-names>MR</given-names></name><name><surname>O’Neill</surname><given-names>K</given-names></name><name><surname>Pujar</surname><given-names>S</given-names></name><name><surname>Rangwala</surname><given-names>SH</given-names></name><name><surname>Rausch</surname><given-names>D</given-names></name><name><surname>Riddick</surname><given-names>LD</given-names></name><name><surname>Schoch</surname><given-names>C</given-names></name><name><surname>Shkeda</surname><given-names>A</given-names></name><name><surname>Storz</surname><given-names>SS</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Thibaud-Nissen</surname><given-names>F</given-names></name><name><surname>Tolstoy</surname><given-names>I</given-names></name><name><surname>Tully</surname><given-names>RE</given-names></name><name><surname>Vatsan</surname><given-names>AR</given-names></name><name><surname>Wallin</surname><given-names>C</given-names></name><name><surname>Webb</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Landrum</surname><given-names>MJ</given-names></name><name><surname>Kimchi</surname><given-names>A</given-names></name><name><surname>Tatusova</surname><given-names>T</given-names></name><name><surname>DiCuccio</surname><given-names>M</given-names></name><name><surname>Kitts</surname><given-names>P</given-names></name><name><surname>Murphy</surname><given-names>TD</given-names></name><name><surname>Pruitt</surname><given-names>KD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>D733</fpage><lpage>D745</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv1189</pub-id><pub-id pub-id-type="pmid">26553804</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="software"><person-group person-group-type="author"><collab>pmglab</collab></person-group><year iso-8601-date="2021">2021</year><data-title>eDESE</data-title><version designator="swh:1:rev:68fbbe429f23011f544cdd34ce09c98a2540f68b">swh:1:rev:68fbbe429f23011f544cdd34ce09c98a2540f68b</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:e05743e5b3d0bf28d873512a6a86398881e1baf2;origin=https://github.com/pmglab/eDESE;visit=swh:1:snp:0458f672b46af7d6b96a332263eea3531578a963;anchor=swh:1:rev:68fbbe429f23011f544cdd34ce09c98a2540f68b">https://archive.softwareheritage.org/swh:1:dir:e05743e5b3d0bf28d873512a6a86398881e1baf2;origin=https://github.com/pmglab/eDESE;visit=swh:1:snp:0458f672b46af7d6b96a332263eea3531578a963;anchor=swh:1:rev:68fbbe429f23011f544cdd34ce09c98a2540f68b</ext-link></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raudvere</surname><given-names>U</given-names></name><name><surname>Kolberg</surname><given-names>L</given-names></name><name><surname>Kuzmin</surname><given-names>I</given-names></name><name><surname>Arak</surname><given-names>T</given-names></name><name><surname>Adler</surname><given-names>P</given-names></name><name><surname>Peterson</surname><given-names>H</given-names></name><name><surname>Vilo</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>W191</fpage><lpage>W198</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz369</pub-id><pub-id pub-id-type="pmid">31066453</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaub</surname><given-names>MA</given-names></name><name><surname>Boyle</surname><given-names>AP</given-names></name><name><surname>Kundaje</surname><given-names>A</given-names></name><name><surname>Batzoglou</surname><given-names>S</given-names></name><name><surname>Snyder</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Linking disease associations with regulatory information in the human genome</article-title><source>Genome Research</source><volume>22</volume><fpage>1748</fpage><lpage>1759</lpage><pub-id pub-id-type="doi">10.1101/gr.136127.111</pub-id><pub-id pub-id-type="pmid">22955986</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sham</surname><given-names>PC</given-names></name><name><surname>Purcell</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Statistical power and significance testing in large-scale genetic studies</article-title><source>Nature Reviews. Genetics</source><volume>15</volume><fpage>335</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1038/nrg3706</pub-id><pub-id pub-id-type="pmid">24739678</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tam</surname><given-names>V</given-names></name><name><surname>Patel</surname><given-names>N</given-names></name><name><surname>Turcotte</surname><given-names>M</given-names></name><name><surname>Bossé</surname><given-names>Y</given-names></name><name><surname>Paré</surname><given-names>G</given-names></name><name><surname>Meyre</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Benefits and limitations of genome-wide association studies</article-title><source>Nature Reviews. Genetics</source><volume>20</volume><fpage>467</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1038/s41576-019-0127-1</pub-id><pub-id pub-id-type="pmid">31068683</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tokheim</surname><given-names>CJ</given-names></name><name><surname>Papadopoulos</surname><given-names>N</given-names></name><name><surname>Kinzler</surname><given-names>KW</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Karchin</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Evaluating the evaluation of cancer driver genes</article-title><source>PNAS</source><volume>113</volume><fpage>14330</fpage><lpage>14335</lpage><pub-id pub-id-type="doi">10.1073/pnas.1616440113</pub-id><pub-id pub-id-type="pmid">27911828</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trubetskoy</surname><given-names>V</given-names></name><name><surname>Pardiñas</surname><given-names>AF</given-names></name><name><surname>Qi</surname><given-names>T</given-names></name><name><surname>Panagiotaropoulou</surname><given-names>G</given-names></name><name><surname>Awasthi</surname><given-names>S</given-names></name><name><surname>Bigdeli</surname><given-names>TB</given-names></name><name><surname>Bryois</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>C-Y</given-names></name><name><surname>Dennison</surname><given-names>CA</given-names></name><name><surname>Hall</surname><given-names>LS</given-names></name><name><surname>Lam</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Frei</surname><given-names>O</given-names></name><name><surname>Ge</surname><given-names>T</given-names></name><name><surname>Harwood</surname><given-names>JC</given-names></name><name><surname>Koopmans</surname><given-names>F</given-names></name><name><surname>Magnusson</surname><given-names>S</given-names></name><name><surname>Richards</surname><given-names>AL</given-names></name><name><surname>Sidorenko</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Zeng</surname><given-names>J</given-names></name><name><surname>Grove</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Voloudakis</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Adams</surname><given-names>M</given-names></name><name><surname>Agartz</surname><given-names>I</given-names></name><name><surname>Atkinson</surname><given-names>EG</given-names></name><name><surname>Agerbo</surname><given-names>E</given-names></name><name><surname>Al Eissa</surname><given-names>M</given-names></name><name><surname>Albus</surname><given-names>M</given-names></name><name><surname>Alexander</surname><given-names>M</given-names></name><name><surname>Alizadeh</surname><given-names>BZ</given-names></name><name><surname>Alptekin</surname><given-names>K</given-names></name><name><surname>Als</surname><given-names>TD</given-names></name><name><surname>Amin</surname><given-names>F</given-names></name><name><surname>Arolt</surname><given-names>V</given-names></name><name><surname>Arrojo</surname><given-names>M</given-names></name><name><surname>Athanasiu</surname><given-names>L</given-names></name><name><surname>Azevedo</surname><given-names>MH</given-names></name><name><surname>Bacanu</surname><given-names>SA</given-names></name><name><surname>Bass</surname><given-names>NJ</given-names></name><name><surname>Begemann</surname><given-names>M</given-names></name><name><surname>Belliveau</surname><given-names>RA</given-names></name><name><surname>Bene</surname><given-names>J</given-names></name><name><surname>Benyamin</surname><given-names>B</given-names></name><name><surname>Bergen</surname><given-names>SE</given-names></name><name><surname>Blasi</surname><given-names>G</given-names></name><name><surname>Bobes</surname><given-names>J</given-names></name><name><surname>Bonassi</surname><given-names>S</given-names></name><name><surname>Braun</surname><given-names>A</given-names></name><name><surname>Bressan</surname><given-names>RA</given-names></name><name><surname>Bromet</surname><given-names>EJ</given-names></name><name><surname>Bruggeman</surname><given-names>R</given-names></name><name><surname>Buckley</surname><given-names>PF</given-names></name><name><surname>Buckner</surname><given-names>RL</given-names></name><name><surname>Bybjerg-Grauholm</surname><given-names>J</given-names></name><name><surname>Cahn</surname><given-names>W</given-names></name><name><surname>Cairns</surname><given-names>MJ</given-names></name><name><surname>Calkins</surname><given-names>ME</given-names></name><name><surname>Carr</surname><given-names>VJ</given-names></name><name><surname>Castle</surname><given-names>D</given-names></name><name><surname>Catts</surname><given-names>SV</given-names></name><name><surname>Chambert</surname><given-names>KD</given-names></name><name><surname>Chan</surname><given-names>RCK</given-names></name><name><surname>Chaumette</surname><given-names>B</given-names></name><name><surname>Cheng</surname><given-names>W</given-names></name><name><surname>Cheung</surname><given-names>EFC</given-names></name><name><surname>Chong</surname><given-names>SA</given-names></name><name><surname>Cohen</surname><given-names>D</given-names></name><name><surname>Consoli</surname><given-names>A</given-names></name><name><surname>Cordeiro</surname><given-names>Q</given-names></name><name><surname>Costas</surname><given-names>J</given-names></name><name><surname>Curtis</surname><given-names>C</given-names></name><name><surname>Davidson</surname><given-names>M</given-names></name><name><surname>Davis</surname><given-names>KL</given-names></name><name><surname>de Haan</surname><given-names>L</given-names></name><name><surname>Degenhardt</surname><given-names>F</given-names></name><name><surname>DeLisi</surname><given-names>LE</given-names></name><name><surname>Demontis</surname><given-names>D</given-names></name><name><surname>Dickerson</surname><given-names>F</given-names></name><name><surname>Dikeos</surname><given-names>D</given-names></name><name><surname>Dinan</surname><given-names>T</given-names></name><name><surname>Djurovic</surname><given-names>S</given-names></name><name><surname>Duan</surname><given-names>J</given-names></name><name><surname>Ducci</surname><given-names>G</given-names></name><name><surname>Dudbridge</surname><given-names>F</given-names></name><name><surname>Eriksson</surname><given-names>JG</given-names></name><name><surname>Fañanás</surname><given-names>L</given-names></name><name><surname>Faraone</surname><given-names>SV</given-names></name><name><surname>Fiorentino</surname><given-names>A</given-names></name><name><surname>Forstner</surname><given-names>A</given-names></name><name><surname>Frank</surname><given-names>J</given-names></name><name><surname>Freimer</surname><given-names>NB</given-names></name><name><surname>Fromer</surname><given-names>M</given-names></name><name><surname>Frustaci</surname><given-names>A</given-names></name><name><surname>Gadelha</surname><given-names>A</given-names></name><name><surname>Genovese</surname><given-names>G</given-names></name><name><surname>Gershon</surname><given-names>ES</given-names></name><name><surname>Giannitelli</surname><given-names>M</given-names></name><name><surname>Giegling</surname><given-names>I</given-names></name><name><surname>Giusti-Rodríguez</surname><given-names>P</given-names></name><name><surname>Godard</surname><given-names>S</given-names></name><name><surname>Goldstein</surname><given-names>JI</given-names></name><name><surname>González Peñas</surname><given-names>J</given-names></name><name><surname>González-Pinto</surname><given-names>A</given-names></name><name><surname>Gopal</surname><given-names>S</given-names></name><name><surname>Gratten</surname><given-names>J</given-names></name><name><surname>Green</surname><given-names>MF</given-names></name><name><surname>Greenwood</surname><given-names>TA</given-names></name><name><surname>Guillin</surname><given-names>O</given-names></name><name><surname>Gülöksüz</surname><given-names>S</given-names></name><name><surname>Gur</surname><given-names>RE</given-names></name><name><surname>Gur</surname><given-names>RC</given-names></name><name><surname>Gutiérrez</surname><given-names>B</given-names></name><name><surname>Hahn</surname><given-names>E</given-names></name><name><surname>Hakonarson</surname><given-names>H</given-names></name><name><surname>Haroutunian</surname><given-names>V</given-names></name><name><surname>Hartmann</surname><given-names>AM</given-names></name><name><surname>Harvey</surname><given-names>C</given-names></name><name><surname>Hayward</surname><given-names>C</given-names></name><name><surname>Henskens</surname><given-names>FA</given-names></name><name><surname>Herms</surname><given-names>S</given-names></name><name><surname>Hoffmann</surname><given-names>P</given-names></name><name><surname>Howrigan</surname><given-names>DP</given-names></name><name><surname>Ikeda</surname><given-names>M</given-names></name><name><surname>Iyegbe</surname><given-names>C</given-names></name><name><surname>Joa</surname><given-names>I</given-names></name><name><surname>Julià</surname><given-names>A</given-names></name><name><surname>Kähler</surname><given-names>AK</given-names></name><name><surname>Kam-Thong</surname><given-names>T</given-names></name><name><surname>Kamatani</surname><given-names>Y</given-names></name><name><surname>Karachanak-Yankova</surname><given-names>S</given-names></name><name><surname>Kebir</surname><given-names>O</given-names></name><name><surname>Keller</surname><given-names>MC</given-names></name><name><surname>Kelly</surname><given-names>BJ</given-names></name><name><surname>Khrunin</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>S-W</given-names></name><name><surname>Klovins</surname><given-names>J</given-names></name><name><surname>Kondratiev</surname><given-names>N</given-names></name><name><surname>Konte</surname><given-names>B</given-names></name><name><surname>Kraft</surname><given-names>J</given-names></name><name><surname>Kubo</surname><given-names>M</given-names></name><name><surname>Kučinskas</surname><given-names>V</given-names></name><name><surname>Kučinskiene</surname><given-names>ZA</given-names></name><name><surname>Kusumawardhani</surname><given-names>A</given-names></name><name><surname>Kuzelova-Ptackova</surname><given-names>H</given-names></name><name><surname>Landi</surname><given-names>S</given-names></name><name><surname>Lazzeroni</surname><given-names>LC</given-names></name><name><surname>Lee</surname><given-names>PH</given-names></name><name><surname>Legge</surname><given-names>SE</given-names></name><name><surname>Lehrer</surname><given-names>DS</given-names></name><name><surname>Lencer</surname><given-names>R</given-names></name><name><surname>Lerer</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Lieberman</surname><given-names>J</given-names></name><name><surname>Light</surname><given-names>GA</given-names></name><name><surname>Limborska</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>C-M</given-names></name><name><surname>Lönnqvist</surname><given-names>J</given-names></name><name><surname>Loughland</surname><given-names>CM</given-names></name><name><surname>Lubinski</surname><given-names>J</given-names></name><name><surname>Luykx</surname><given-names>JJ</given-names></name><name><surname>Lynham</surname><given-names>A</given-names></name><name><surname>Macek</surname><given-names>M</given-names></name><name><surname>Mackinnon</surname><given-names>A</given-names></name><name><surname>Magnusson</surname><given-names>PKE</given-names></name><name><surname>Maher</surname><given-names>BS</given-names></name><name><surname>Maier</surname><given-names>W</given-names></name><name><surname>Malaspina</surname><given-names>D</given-names></name><name><surname>Mallet</surname><given-names>J</given-names></name><name><surname>Marder</surname><given-names>SR</given-names></name><name><surname>Marsal</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>AR</given-names></name><name><surname>Martorell</surname><given-names>L</given-names></name><name><surname>Mattheisen</surname><given-names>M</given-names></name><name><surname>McCarley</surname><given-names>RW</given-names></name><name><surname>McDonald</surname><given-names>C</given-names></name><name><surname>McGrath</surname><given-names>JJ</given-names></name><name><surname>Medeiros</surname><given-names>H</given-names></name><name><surname>Meier</surname><given-names>S</given-names></name><name><surname>Melegh</surname><given-names>B</given-names></name><name><surname>Melle</surname><given-names>I</given-names></name><name><surname>Mesholam-Gately</surname><given-names>RI</given-names></name><name><surname>Metspalu</surname><given-names>A</given-names></name><name><surname>Michie</surname><given-names>PT</given-names></name><name><surname>Milani</surname><given-names>L</given-names></name><name><surname>Milanova</surname><given-names>V</given-names></name><name><surname>Mitjans</surname><given-names>M</given-names></name><name><surname>Molden</surname><given-names>E</given-names></name><name><surname>Molina</surname><given-names>E</given-names></name><name><surname>Molto</surname><given-names>MD</given-names></name><name><surname>Mondelli</surname><given-names>V</given-names></name><name><surname>Moreno</surname><given-names>C</given-names></name><name><surname>Morley</surname><given-names>CP</given-names></name><name><surname>Muntané</surname><given-names>G</given-names></name><name><surname>Murphy</surname><given-names>KC</given-names></name><name><surname>Myin-Germeys</surname><given-names>I</given-names></name><name><surname>Nenadić</surname><given-names>I</given-names></name><name><surname>Nestadt</surname><given-names>G</given-names></name><name><surname>Nikitina-Zake</surname><given-names>L</given-names></name><name><surname>Noto</surname><given-names>C</given-names></name><name><surname>Nuechterlein</surname><given-names>KH</given-names></name><name><surname>O’Brien</surname><given-names>NL</given-names></name><name><surname>O’Neill</surname><given-names>FA</given-names></name><name><surname>Oh</surname><given-names>S-Y</given-names></name><name><surname>Olincy</surname><given-names>A</given-names></name><name><surname>Ota</surname><given-names>VK</given-names></name><name><surname>Pantelis</surname><given-names>C</given-names></name><name><surname>Papadimitriou</surname><given-names>GN</given-names></name><name><surname>Parellada</surname><given-names>M</given-names></name><name><surname>Paunio</surname><given-names>T</given-names></name><name><surname>Pellegrino</surname><given-names>R</given-names></name><name><surname>Periyasamy</surname><given-names>S</given-names></name><name><surname>Perkins</surname><given-names>DO</given-names></name><name><surname>Pfuhlmann</surname><given-names>B</given-names></name><name><surname>Pietiläinen</surname><given-names>O</given-names></name><name><surname>Pimm</surname><given-names>J</given-names></name><name><surname>Porteous</surname><given-names>D</given-names></name><name><surname>Powell</surname><given-names>J</given-names></name><name><surname>Quattrone</surname><given-names>D</given-names></name><name><surname>Quested</surname><given-names>D</given-names></name><name><surname>Radant</surname><given-names>AD</given-names></name><name><surname>Rampino</surname><given-names>A</given-names></name><name><surname>Rapaport</surname><given-names>MH</given-names></name><name><surname>Rautanen</surname><given-names>A</given-names></name><name><surname>Reichenberg</surname><given-names>A</given-names></name><name><surname>Roe</surname><given-names>C</given-names></name><name><surname>Roffman</surname><given-names>JL</given-names></name><name><surname>Roth</surname><given-names>J</given-names></name><name><surname>Rothermundt</surname><given-names>M</given-names></name><name><surname>Rutten</surname><given-names>BPF</given-names></name><name><surname>Saker-Delye</surname><given-names>S</given-names></name><name><surname>Salomaa</surname><given-names>V</given-names></name><name><surname>Sanjuan</surname><given-names>J</given-names></name><name><surname>Santoro</surname><given-names>ML</given-names></name><name><surname>Savitz</surname><given-names>A</given-names></name><name><surname>Schall</surname><given-names>U</given-names></name><name><surname>Scott</surname><given-names>RJ</given-names></name><name><surname>Seidman</surname><given-names>LJ</given-names></name><name><surname>Sharp</surname><given-names>SI</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Siever</surname><given-names>LJ</given-names></name><name><surname>Sigurdsson</surname><given-names>E</given-names></name><name><surname>Sim</surname><given-names>K</given-names></name><name><surname>Skarabis</surname><given-names>N</given-names></name><name><surname>Slominsky</surname><given-names>P</given-names></name><name><surname>So</surname><given-names>H-C</given-names></name><name><surname>Sobell</surname><given-names>JL</given-names></name><name><surname>Söderman</surname><given-names>E</given-names></name><name><surname>Stain</surname><given-names>HJ</given-names></name><name><surname>Steen</surname><given-names>NE</given-names></name><name><surname>Steixner-Kumar</surname><given-names>AA</given-names></name><name><surname>Stögmann</surname><given-names>E</given-names></name><name><surname>Stone</surname><given-names>WS</given-names></name><name><surname>Straub</surname><given-names>RE</given-names></name><name><surname>Streit</surname><given-names>F</given-names></name><name><surname>Strengman</surname><given-names>E</given-names></name><name><surname>Stroup</surname><given-names>TS</given-names></name><name><surname>Subramaniam</surname><given-names>M</given-names></name><name><surname>Sugar</surname><given-names>CA</given-names></name><name><surname>Suvisaari</surname><given-names>J</given-names></name><name><surname>Svrakic</surname><given-names>DM</given-names></name><name><surname>Swerdlow</surname><given-names>NR</given-names></name><name><surname>Szatkiewicz</surname><given-names>JP</given-names></name><name><surname>Ta</surname><given-names>TMT</given-names></name><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Terao</surname><given-names>C</given-names></name><name><surname>Thibaut</surname><given-names>F</given-names></name><name><surname>Toncheva</surname><given-names>D</given-names></name><name><surname>Tooney</surname><given-names>PA</given-names></name><name><surname>Torretta</surname><given-names>S</given-names></name><name><surname>Tosato</surname><given-names>S</given-names></name><name><surname>Tura</surname><given-names>GB</given-names></name><name><surname>Turetsky</surname><given-names>BI</given-names></name><name><surname>Üçok</surname><given-names>A</given-names></name><name><surname>Vaaler</surname><given-names>A</given-names></name><name><surname>van Amelsvoort</surname><given-names>T</given-names></name><name><surname>van Winkel</surname><given-names>R</given-names></name><name><surname>Veijola</surname><given-names>J</given-names></name><name><surname>Waddington</surname><given-names>J</given-names></name><name><surname>Walter</surname><given-names>H</given-names></name><name><surname>Waterreus</surname><given-names>A</given-names></name><name><surname>Webb</surname><given-names>BT</given-names></name><name><surname>Weiser</surname><given-names>M</given-names></name><name><surname>Williams</surname><given-names>NM</given-names></name><name><surname>Witt</surname><given-names>SH</given-names></name><name><surname>Wormley</surname><given-names>BK</given-names></name><name><surname>Wu</surname><given-names>JQ</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Yolken</surname><given-names>R</given-names></name><name><surname>Zai</surname><given-names>CC</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Zhu</surname><given-names>F</given-names></name><name><surname>Zimprich</surname><given-names>F</given-names></name><name><surname>Atbaşoğlu</surname><given-names>EC</given-names></name><name><surname>Ayub</surname><given-names>M</given-names></name><name><surname>Benner</surname><given-names>C</given-names></name><name><surname>Bertolino</surname><given-names>A</given-names></name><name><surname>Black</surname><given-names>DW</given-names></name><name><surname>Bray</surname><given-names>NJ</given-names></name><name><surname>Breen</surname><given-names>G</given-names></name><name><surname>Buccola</surname><given-names>NG</given-names></name><name><surname>Byerley</surname><given-names>WF</given-names></name><name><surname>Chen</surname><given-names>WJ</given-names></name><name><surname>Cloninger</surname><given-names>CR</given-names></name><name><surname>Crespo-Facorro</surname><given-names>B</given-names></name><name><surname>Donohoe</surname><given-names>G</given-names></name><name><surname>Freedman</surname><given-names>R</given-names></name><name><surname>Galletly</surname><given-names>C</given-names></name><name><surname>Gandal</surname><given-names>MJ</given-names></name><name><surname>Gennarelli</surname><given-names>M</given-names></name><name><surname>Hougaard</surname><given-names>DM</given-names></name><name><surname>Hwu</surname><given-names>H-G</given-names></name><name><surname>Jablensky</surname><given-names>AV</given-names></name><name><surname>McCarroll</surname><given-names>SA</given-names></name><name><surname>Moran</surname><given-names>JL</given-names></name><name><surname>Mors</surname><given-names>O</given-names></name><name><surname>Mortensen</surname><given-names>PB</given-names></name><name><surname>Müller-Myhsok</surname><given-names>B</given-names></name><name><surname>Neil</surname><given-names>AL</given-names></name><name><surname>Nordentoft</surname><given-names>M</given-names></name><name><surname>Pato</surname><given-names>MT</given-names></name><name><surname>Petryshen</surname><given-names>TL</given-names></name><name><surname>Pirinen</surname><given-names>M</given-names></name><name><surname>Pulver</surname><given-names>AE</given-names></name><name><surname>Schulze</surname><given-names>TG</given-names></name><name><surname>Silverman</surname><given-names>JM</given-names></name><name><surname>Smoller</surname><given-names>JW</given-names></name><name><surname>Stahl</surname><given-names>EA</given-names></name><name><surname>Tsuang</surname><given-names>DW</given-names></name><name><surname>Vilella</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>S-H</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><collab>Indonesia Schizophrenia Consortium</collab><collab>PsychENCODE</collab><collab>Psychosis Endophenotypes International Consortium</collab><collab>SynGO Consortium</collab><name><surname>Adolfsson</surname><given-names>R</given-names></name><name><surname>Arango</surname><given-names>C</given-names></name><name><surname>Baune</surname><given-names>BT</given-names></name><name><surname>Belangero</surname><given-names>SI</given-names></name><name><surname>Børglum</surname><given-names>AD</given-names></name><name><surname>Braff</surname><given-names>D</given-names></name><name><surname>Bramon</surname><given-names>E</given-names></name><name><surname>Buxbaum</surname><given-names>JD</given-names></name><name><surname>Campion</surname><given-names>D</given-names></name><name><surname>Cervilla</surname><given-names>JA</given-names></name><name><surname>Cichon</surname><given-names>S</given-names></name><name><surname>Collier</surname><given-names>DA</given-names></name><name><surname>Corvin</surname><given-names>A</given-names></name><name><surname>Curtis</surname><given-names>D</given-names></name><name><surname>Forti</surname><given-names>MD</given-names></name><name><surname>Domenici</surname><given-names>E</given-names></name><name><surname>Ehrenreich</surname><given-names>H</given-names></name><name><surname>Escott-Price</surname><given-names>V</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Fanous</surname><given-names>AH</given-names></name><name><surname>Gareeva</surname><given-names>A</given-names></name><name><surname>Gawlik</surname><given-names>M</given-names></name><name><surname>Gejman</surname><given-names>PV</given-names></name><name><surname>Gill</surname><given-names>M</given-names></name><name><surname>Glatt</surname><given-names>SJ</given-names></name><name><surname>Golimbet</surname><given-names>V</given-names></name><name><surname>Hong</surname><given-names>KS</given-names></name><name><surname>Hultman</surname><given-names>CM</given-names></name><name><surname>Hyman</surname><given-names>SE</given-names></name><name><surname>Iwata</surname><given-names>N</given-names></name><name><surname>Jönsson</surname><given-names>EG</given-names></name><name><surname>Kahn</surname><given-names>RS</given-names></name><name><surname>Kennedy</surname><given-names>JL</given-names></name><name><surname>Khusnutdinova</surname><given-names>E</given-names></name><name><surname>Kirov</surname><given-names>G</given-names></name><name><surname>Knowles</surname><given-names>JA</given-names></name><name><surname>Krebs</surname><given-names>M-O</given-names></name><name><surname>Laurent-Levinson</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Lencz</surname><given-names>T</given-names></name><name><surname>Levinson</surname><given-names>DF</given-names></name><name><surname>Li</surname><given-names>QS</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Malhotra</surname><given-names>AK</given-names></name><name><surname>Malhotra</surname><given-names>D</given-names></name><name><surname>McIntosh</surname><given-names>A</given-names></name><name><surname>McQuillin</surname><given-names>A</given-names></name><name><surname>Menezes</surname><given-names>PR</given-names></name><name><surname>Morgan</surname><given-names>VA</given-names></name><name><surname>Morris</surname><given-names>DW</given-names></name><name><surname>Mowry</surname><given-names>BJ</given-names></name><name><surname>Murray</surname><given-names>RM</given-names></name><name><surname>Nimgaonkar</surname><given-names>V</given-names></name><name><surname>Nöthen</surname><given-names>MM</given-names></name><name><surname>Ophoff</surname><given-names>RA</given-names></name><name><surname>Paciga</surname><given-names>SA</given-names></name><name><surname>Palotie</surname><given-names>A</given-names></name><name><surname>Pato</surname><given-names>CN</given-names></name><name><surname>Qin</surname><given-names>S</given-names></name><name><surname>Rietschel</surname><given-names>M</given-names></name><name><surname>Riley</surname><given-names>BP</given-names></name><name><surname>Rivera</surname><given-names>M</given-names></name><name><surname>Rujescu</surname><given-names>D</given-names></name><name><surname>Saka</surname><given-names>MC</given-names></name><name><surname>Sanders</surname><given-names>AR</given-names></name><name><surname>Schwab</surname><given-names>SG</given-names></name><name><surname>Serretti</surname><given-names>A</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>St Clair</surname><given-names>D</given-names></name><name><surname>Stefánsson</surname><given-names>H</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name><name><surname>Tsuang</surname><given-names>MT</given-names></name><name><surname>van Os</surname><given-names>J</given-names></name><name><surname>Vawter</surname><given-names>MP</given-names></name><name><surname>Weinberger</surname><given-names>DR</given-names></name><name><surname>Werge</surname><given-names>T</given-names></name><name><surname>Wildenauer</surname><given-names>DB</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Yue</surname><given-names>W</given-names></name><name><surname>Holmans</surname><given-names>PA</given-names></name><name><surname>Pocklington</surname><given-names>AJ</given-names></name><name><surname>Roussos</surname><given-names>P</given-names></name><name><surname>Vassos</surname><given-names>E</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name><name><surname>Visscher</surname><given-names>PM</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Posthuma</surname><given-names>D</given-names></name><name><surname>Andreassen</surname><given-names>OA</given-names></name><name><surname>Kendler</surname><given-names>KS</given-names></name><name><surname>Owen</surname><given-names>MJ</given-names></name><name><surname>Wray</surname><given-names>NR</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Neale</surname><given-names>BM</given-names></name><name><surname>Sullivan</surname><given-names>PF</given-names></name><name><surname>Ripke</surname><given-names>S</given-names></name><name><surname>Walters</surname><given-names>JTR</given-names></name><name><surname>O’Donovan</surname><given-names>MC</given-names></name><collab>Schizophrenia Working Group of the Psychiatric Genomics Consortium</collab></person-group><year iso-8601-date="2022">2022</year><article-title>Mapping genomic loci implicates genes and synaptic biology in schizophrenia</article-title><source>Nature</source><pub-id pub-id-type="doi">10.1038/s41586-022-04434-5</pub-id><pub-id pub-id-type="pmid">35396580</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visscher</surname><given-names>PM</given-names></name><name><surname>Wray</surname><given-names>NR</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>Brown</surname><given-names>MA</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>10 Years of GWAS Discovery: Biology, Function, and Translation</article-title><source>American Journal of Human Genetics</source><volume>101</volume><fpage>5</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2017.06.005</pub-id><pub-id pub-id-type="pmid">28686856</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Sarkar</surname><given-names>A</given-names></name><name><surname>Carbonetto</surname><given-names>P</given-names></name><name><surname>Stephens</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A simple new approach to variable selection in regression, with application to genetic fine mapping</article-title><source>Journal of the Royal Statistical Society</source><volume>82</volume><fpage>1273</fpage><lpage>1300</lpage><pub-id pub-id-type="doi">10.1111/rssb.12388</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wishart</surname><given-names>DS</given-names></name><name><surname>Feunang</surname><given-names>YD</given-names></name><name><surname>Guo</surname><given-names>AC</given-names></name><name><surname>Lo</surname><given-names>EJ</given-names></name><name><surname>Marcu</surname><given-names>A</given-names></name><name><surname>Grant</surname><given-names>JR</given-names></name><name><surname>Sajed</surname><given-names>T</given-names></name><name><surname>Johnson</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Sayeeda</surname><given-names>Z</given-names></name><name><surname>Assempour</surname><given-names>N</given-names></name><name><surname>Iynkkaran</surname><given-names>I</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Maciejewski</surname><given-names>A</given-names></name><name><surname>Gale</surname><given-names>N</given-names></name><name><surname>Wilson</surname><given-names>A</given-names></name><name><surname>Chin</surname><given-names>L</given-names></name><name><surname>Cummings</surname><given-names>R</given-names></name><name><surname>Le</surname><given-names>D</given-names></name><name><surname>Pon</surname><given-names>A</given-names></name><name><surname>Knox</surname><given-names>C</given-names></name><name><surname>Wilson</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>DrugBank 5.0: a major update to the DrugBank database for 2018</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>D1074</fpage><lpage>D1082</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx1037</pub-id><pub-id pub-id-type="pmid">29126136</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Ferreira</surname><given-names>T</given-names></name><name><surname>Morris</surname><given-names>AP</given-names></name><name><surname>Medland</surname><given-names>SE</given-names></name><collab>Genetic Investigation of ANthropometric Traits (GIANT) Consortium</collab><collab>DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium</collab><name><surname>Madden</surname><given-names>PAF</given-names></name><name><surname>Heath</surname><given-names>AC</given-names></name><name><surname>Martin</surname><given-names>NG</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name><name><surname>Weedon</surname><given-names>MN</given-names></name><name><surname>Loos</surname><given-names>RJ</given-names></name><name><surname>Frayling</surname><given-names>TM</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>Hirschhorn</surname><given-names>JN</given-names></name><name><surname>Goddard</surname><given-names>ME</given-names></name><name><surname>Visscher</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits</article-title><source>Nature Genetics</source><volume>44</volume><fpage>369</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1038/ng.2213</pub-id><pub-id pub-id-type="pmid">22426310</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.70779.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Konopka</surname><given-names>Genevieve</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t9vx427</institution-id><institution>University of Texas Southwestern Medical Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" link-type="continued-by" object-id="10.1101/2021.06.08.447608" object-id-type="id" xlink:href="https://sciety.org/articles/activity/10.1101/2021.06.08.447608"/></front-stub><body><p>This manuscript describes a new method of identifying disease-relevant risk genes from genome wide association studies by using a conditional gene-based method (named eDESE). The authors apply this new approach in an analysis of schizophrenia datasets, and identify meaningful biological processes and potential drug repurposing candidates. Thus, this new method could provide improved gene prioritization for fine-mapping and functional studies of specific diseases.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.70779.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Konopka</surname><given-names>Genevieve</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t9vx427</institution-id><institution>University of Texas Southwestern Medical Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.06.08.447608">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.06.08.447608v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;MCGA: a multi-strategy conditional gene-based association framework integrating with isoform-level expression profiles reveals new susceptible and druggable candidate genes of schizophrenia&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Molly Przeworski as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) Systematic comparisons with existing methods are needed to demonstrate the potential gain in biological insight from this method. How do the results from MGCA_Dist, MGCA_eQTL, and MGCA_isoQTL compare with MAGMA? Can you include a direct comparison of MGCA with MAGMA, including the gene-based results, biological pathway enrichments, and drug repositioning analyses? Can the authors compare MGCA_eQTL to other eQTL-based approaches such as S-PrediXcan?</p><p>2) When comparing MCGA-eQTL and MCGA-sQTL, only power is considered. The authors should include analyses to demonstrate the performance in control for false positives.</p><p>3) When choosing a favorable exponent value c (1.432 chosen in the study), the authors found that the c value is robust to trait type, sample size or variant size, but the authors didn't explain what factors affect the choosing of c. Considering the potential application of MCGA method in other studies, the authors should explain what factor affects c value, and provide the guidance how to choose an optimal c. Can the authors show via simulations the relationship between the coefficient used to adjust the chi square statistic correlations, $c$, and the strength of association signals?</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>– How do the results from MGCA_Dist, MGCA_eQTL, and MGCA_isoQTL compare with MAGMA? Can you include a direct comparison of MGCA with MAGMA, including the gene-based results, biological pathway enrichments, and drug repositioning analyses?</p><p>– Similarly, can you compare MGCA_eQTL to other eQTL-based approaches such as S-PrediXcan? I would like to see a systematic comparison with existing methods to see if novel biological insights can be derived from your results.</p><p>– Does MCGA provide information on tissue-specific eQTLs/isoQTLs? This information is available in GTEx but is not reported for association results in supplementary tables. Tissue-specific effects for each tissue might improve the interpretation of results.</p><p>– Can you provide more information on WGCNA results? Are MCGA susceptibility genes enriched in a particular co-expression module? Are synaptic signalling related biological pathways enriched in a particular module? How did the network modules compare across brain tissues? Is it possible to build a consensus network for the top five brain regions (or indeed all brain regions in GTEx) to simplify the results?</p><p>– The drug repositioning analysis could be improved by drawing on comprehensive drug-gene information from hetionet (https://doi.org/10.7554/<italic>eLife</italic>.26726.001). This resource might further refine some of your top associations by accounting for anatomies, biological processes, side-effects, and symptoms.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>GTEx v8 data contains samples from multiple tissues, and the significant gene-trait association in some tissue may be non-causal driven by gene expression correlation with causal tissues. It should be interesting to come up a new method to remove those false positive.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>My major concern is a lack of innovation as a new method. MCGA is based on DES, which integrates expression data with GWAS; and DESE relies on ECS to compute gene-level association evidence. Both DESE and ECS were developed by the authors in the past and published elsewhere. The only innovation in the MCGA methodology seems the improved control of type I error by formally assessing the null distribution of the conditional test statistic for ECS and adjust the test statistic. This improvement is definitely crucial to ECS. But in my view, this is a fix to a long standing issue of ECS rather than a new method in itself. Even with this improvement, the ECS is still not a completely statistically solid method because it still involves heuristic procedures to determine how much the ECS statistics should be adjusted. There is still no methodological guarantee of controlled type I error.</p><p>[Editors’ note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for resubmitting your work entitled &quot;A conditional gene-based association framework integrating isoform-level eQTL data reveals new susceptibility genes for schizophrenia&quot; for further consideration by <italic>eLife</italic>. Your revised article has been evaluated by Molly Przeworski (Senior Editor) and a Reviewing Editor.</p><p>The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined below:</p><p>Reviewer #3 has 2 remaining issues that we would like you to more fully address before we would consider accepting the manuscript. Please read these comments carefully and revise accordingly. Thank you.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>I would like to thank the authors for their detailed response to my questions and concerns. I have no further comments on the manuscript.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The authors have resolved all my concerns. Nice job.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>The revised manuscript was submitted in PDF format with track changes. Although it clearly shows what's been changed since the original submission, it is therefore very difficult to read the complete article for a second overall assessment. I will therefore focus on comments I raised in my first review.</p><p>Two major issues remain.</p><p>1. The authors failed to respond properly to my comment on the overall concern that conditional analysis may not be the best approach for this type of problem. Figure 1 of SuSiE paper illustrates the exact scenarios why this could be a bad idea, which motivated my A-B-C genes example. Also incidentally, it is not true that SuSiE cannot work with summary statistics.</p><p>2. The response to the question of the choice of c (from another reviewer and myself) is still not satisfactory. It seems the favorable c still was computed in very specific scenarios. In fact, the new Figure 9 exactly demonstrates my concern: optimal choice of c depends greatly on LD and effect size, and for variants with small effects (OR &lt; 1.4 which would be the case for most GWAS signals) the range of optimal c is wide. Given this result, I remain unconvinced that the tests are calibrated under current choice of c. From Figure 9 I would conclude that a conservative c = 1.8 should be used in general, which is different from the recommended choice from the authors.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.70779.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Systematic comparisons with existing methods are needed to demonstrate the potential gain in biological insight from this method. How do the results from MGCA_Dist, MGCA_eQTL, and MGCA_isoQTL compare with MAGMA? Can you include a direct comparison of MGCA with MAGMA, including the gene-based results, biological pathway enrichments, and drug repositioning analyses? Can the authors compare MGCA_eQTL to other eQTL-based approaches such as S-PrediXcan?</p></disp-quote><p>We thank the reviewers for their suggestions, and we agree that systematic comparisons with existing methods can help demonstrate the potential gain of our framework. Before the comparison with other methods, we recapped the inheritance and the extensions of our framework (eDESE) with our previous methods (i.e., ECS and DESE) in &quot;Overview of the present study&quot; of the revised manuscript, as suggested by Reviewer #3. We emphasized the two important advantages of the eDESE over ECS and DESE. We renamed MCGA_Dist as eDESE:dist and renamed MCGA_eQTL and MCGA_isoQTL as eDESE:gene and eDESE:isoform, respectively (see lines 110-139 in the revised manuscript). To clearly address all the reviewer's questions in point 1, we have organized these questions as follows and will address them in order:</p><disp-quote content-type="editor-comment"><p>Question A: How do the results from MGCA_Dist, MGCA_eQTL, and MGCA_isoQTL compare with MAGMA?</p></disp-quote><p>To discuss the limitations of MCGA in our last manuscript, we mentioned the number of significant genes identified by MAGMA to suggest that though the number of significant genes identified by MCGA (especially MCGA_isoform) was a little big, so was MAGMA. Considering that MCGA is a conditional gene-based association approach, we had no intention of directly comparing MCGA with MAGMA in our last manuscript.</p><disp-quote content-type="editor-comment"><p>Question B: Can you include a direct comparison of MGCA with MAGMA, including the gene-based results, biological pathway enrichments, and drug repositioning analyses?</p></disp-quote><p>Yes. Because conventional MAGMA and eDESE:dist both can perform gene-based association analysis by mapping variants to genes based on the variant-gene physical distance (+/-5kb around the gene boundary), we compared the susceptibility genes identified by eDESE:dist with that identified by MAGMA from the aspect of the significant gene counts, GO enrichment terms, text-mining results and the druggability of the susceptibility genes (see lines 208-245 and 434-478 in the revised manuscript).</p><disp-quote content-type="editor-comment"><p>Question C: Can the authors compare MGCA_eQTL to other eQTL-based approaches such as S-PrediXcan?</p></disp-quote><p>Yes. Since S-PrediXcan and eDESE (eDESE:gene and eDESE:isoform) both can perform the gene-based association analysis by considering the genetic regulatory effects on transcriptome (i.e., eQTLs), we compared the susceptibility genes identified by eDESE with S-PrediXcan.</p><p>The precalculated data in the PredictDB repository (http://predictdb.org) is important to S-PrediXcan. However, PredictDB provides gene-level expression and splicing predictors, but no isoform-level expression predictors, based on the MASHR models. Besides, there is no tutorial for the MASHR models in the PredictDB for now (see details in https://groups.google.com/g/predixcanmetaxcan/c/tTYlg8HIBeA/m/QNVskMCUCAAJ). So, we performed S-PrediXcan analysis only based on the gene-level expression predictors based on the MASHR models.</p><p>Before comparing S-PrediXcan and eDESE, we firstly optimized five brain regions based on eDESE:dist, eDESE:gene and eDESE:isoform (see lines 281-313 in the revised manuscript). Then, based on the five optimized brain regions, we compared the significant gene counts, GO enrichment terms, enriched consensus modules, text-mining results of the susceptibility genes (see lines 315-432 in the revised manuscript). We also compared the enrichment of drug-gene interactions and druggability of the susceptibility genes identified by MAGMA, S-PrediXcan and eDESE (see lines 434-478 in the revised manuscript).</p><p>The comparisons of eDESE with the two benchmark methods (i.e., MAGMA and S-PrediXcan) showed our framework's utility and potential gains.</p><disp-quote content-type="editor-comment"><p>2) When comparing MCGA-eQTL and MCGA-sQTL, only power is considered. The authors should include analyses to demonstrate the performance in control for false positives.</p></disp-quote><p>Thanks for pointing out this important question! In our last manuscript, we reported the power of isoform-level eQTLs over that of gene-level eQTLs in association analysis but neglected the performance in control for the false positives. In the revised manuscript, we reported the powers and false positives of gene/isoform-level eQTLs in association analysis. Our results showed that the false positives were controlled within a reasonable level (on average &lt; 0.1% by a <italic>p</italic>-value cutoff of 0.001). Besides, the power of isoform-level eQTLs was higher than that of gene-level eQTLs in all scenarios in which gene expression can affect the phenotype (see lines 247-279 in the revised manuscript).</p><disp-quote content-type="editor-comment"><p>3) When choosing a favorable exponent value c (1.432 chosen in the study), the authors found that the c value is robust to trait type, sample size or variant size, but the authors didn't explain what factors affect the choosing of c. Considering the potential application of MCGA method in other studies, the authors should explain what factor affects c value, and provide the guidance how to choose an optimal c. Can the authors show via simulations the relationship between the coefficient used to adjust the chi square statistic correlations, $c$, and the strength of association signals?</p></disp-quote><p>Thanks for pointing out these important questions! To clearly address all the reviewer's questions, we have organized the questions as follows and will address them in order:</p><disp-quote content-type="editor-comment"><p>Question A: what factors affect the choosing of c?</p></disp-quote><p>Motived from the boundary of chi-square correlation, we adopted simulation studies to empirically choose <italic>c</italic> for controlling the type I error of the effective chi-square test. Besides the correlation of chi-square statistics, the choosing of <italic>c</italic> for the effective chi-square test may also be affected by the approximated non-negative solutions. However, the correlation of chi-square statistics is the major factor. Our simulation showed that the derived boundary and influence trend of LD on chi-square statistics were also applicable to the effective chi-square test. In the revised manuscript, we showed that the correlation of chi-square statistics is affected by the non-centrality parameter of chi-square statistics (see lines 640-655 in the revised manuscript).</p><disp-quote content-type="editor-comment"><p>Question B: how to choose an optimal c?</p></disp-quote><p>As the optimal <italic>c</italic> for controlling the type I error of the effective chi-square test would be affected by the non-centrality parameter of chi-square statistics which are generally unknown in practice, we have to resort to a grid search algorithm to explore an empirically optimal <italic>c</italic>. In our last manuscript, we mixed the methods of choosing optimal <italic>c</italic> with the introduction of new effective chi-squared statistics. We wrote a new subsection in Materials and methods to describe the procedure of choosing the optimal <italic>c</italic> in the revised manuscript (see lines 610-628 in the revised manuscript).</p><disp-quote content-type="editor-comment"><p>Question C: Can the authors show via simulations the relationship between the coefficient used to adjust the chi square statistic correlations, $c$, and the strength of association signals?</p></disp-quote><p>Yes. In the revised manuscript, we further investigated how the strength of association signals influenced the chi-square statistic correlations. Consistent with the theoretical derivation, the correlation of chi-square statistics quickly approached the maximal value |<italic>r</italic>| as the effect size increased. A stronger association signal led to a smaller <italic>c,</italic> and the <italic>c</italic> can quickly approach 1 as the association signals increased even in a moderate sample size (1000 cases and 1000 controls) (see Figure 9).</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>– How do the results from MGCA_Dist, MGCA_eQTL, and MGCA_isoQTL compare with MAGMA? Can you include a direct comparison of MGCA with MAGMA, including the gene-based results, biological pathway enrichments, and drug repositioning analyses?</p></disp-quote><p>We thank Reviewer #1 overall for the numerous insightful and helpful suggestions and comments. Please refer to Question A and B of Essential Revisions point 1.</p><disp-quote content-type="editor-comment"><p>– Similarly, can you compare MGCA_eQTL to other eQTL-based approaches such as S-PrediXcan? I would like to see a systematic comparison with existing methods to see if novel biological insights can be derived from your results.</p></disp-quote><p>We thank the reviewer for this suggestion and comment. Please refer to Question C of Essential Revisions point 1.</p><disp-quote content-type="editor-comment"><p>– Does MCGA provide information on tissue-specific eQTLs/isoQTLs? This information is available in GTEx but is not reported for association results in supplementary tables. Tissue-specific effects for each tissue might improve the interpretation of results.</p></disp-quote><p>We thank the reviewer for this suggestion. In our last manuscript, we provided the gene-level and isoform-level eQTLs for each tissue but did not provide tissue-specific eQTLs/isoQTLs. Indeed, GTEx v8 provided the tissue-specific gene-level eQTLs and splicing QTLs for each tissue. However, we cannot directly access the original tissue-specific eQTLs because the download is not free.</p><p>Fortunately, we found a processed gene-level tissue-specific eQTLs set of GTEx v8 from the E-MAGMA tutorial document (https://github.com/eskederks/eMAGMA-tutorial), in which the tissue-specific SNP-gene associations were provided. We downloaded the E-MAGMA annotation files for Brain-Front Cortex (BA9) and Brain-Cerebellum, i.e., Brain_Frontal_Cortex_BA9.genes.annot and Brain_Cerebellum.genes.annot, from https://github.com/eskederks/eMAGMA-tutorial/blob/gtex_v8/emagma_annot_1.tar.gz.</p><p>We then extracted the tissue-specific SNP-gene associations from the above two annotation files and converted the tissue-specific SNP-gene associations to the eQTLs file format required by the eDESE:gene. We then perform the eDESE:gene analysis based on the tissue-specific eQTLs of Brain-Front Cortex (BA9) and Brain-Cerebellum, respectively. Our results showed that no tissue was significantly associated with schizophrenia by using the tissue-specific eQTLs of Brain-Front Cortex (BA9) (cutoff <italic>p</italic>-value &lt; 0.05/50=1e-3, <xref ref-type="fig" rid="sa2fig1">Author response image 1a</xref>), while eight brain regions were predicted to be significantly associated with schizophrenia by using the tissue-specific eQTLs of Brain-Cerebellum (<xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>) .</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><title>The tissue importance generated by eDESE:gene based on the tissue-specific eQTLs.</title><p>(a) Brain-Front Cortex (BA9); (b) Brain-Cerebellum. The red dotted lines denote the significant threshold.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70779-sa2-fig1-v1.tif"/></fig><p>Interestingly, though the tissue estimation based on the tissue-specific eQTLs of Brain-Front Cortex (BA9) was not satisfying, we found several brain regions ranked high among all the fifty tissues, and Brain-Front Cortex (BA9) ranked the second in the full tissue list (<italic>p</italic>-value = 2.4E-2). Brain-Cerebellum itself ranked second and was significantly associated with schizophrenia by using the tissue-specific eQTLs of Brain-Cerebellum. Further, we also investigated the potential susceptibility genes identified by eDESE:gene based on the tissue-specific eQTLs of Brain-Front Cortex (BA9) and Brain-Cerebellum, respectively. We found that these potential susceptibility genes were enriched with few GO terms, in which there was no biologically sensible GO term.</p><p>As suggested by the reviewer, our result showed that eDESE could benefit from the tissue-specific eQTLs, though the results of phenotype-associated tissue estimation based on the tissue-specific eQTLs were not as good as that based on the single tissue eQTLs in the current condition. This might result from the small sample size and strict threshold in eQTLs identification in GTEx v8. We believe that future genetic studies based on the increased sample sizes might alleviate this problem and increase the power of tissue-specific eQTLs. Integrating the tissue-specific eQTLs with eDESE will also be a topic for our further exploration. We also cited the paper and acknowledged the data in our Acknowledgments.</p><disp-quote content-type="editor-comment"><p>– Can you provide more information on WGCNA results? Are MCGA susceptibility genes enriched in a particular co-expression module? Are synaptic signalling related biological pathways enriched in a particular module? How did the network modules compare across brain tissues? Is it possible to build a consensus network for the top five brain regions (or indeed all brain regions in GTEx) to simplify the results?</p></disp-quote><p>We thank the reviewer for these suggestions and comments and for the opportunity to clarify.</p><p>In our last manuscript, we investigated the normalized intra-module connectivity score of the potential susceptibility genes identified by MCGA_eQTL and MCGA_isoQTL in each potential susceptibility brain region. The measurements were the statistics and statistical significance of the Wilcoxon rank-sum test based on the normalized intra-module connectivity score of the susceptibility and non-susceptibility genes in each tissue. In our last manuscript, we used Table 2 to present the tissues in which the intra-module connectivity score of the susceptibility was significantly higher than that of the non-susceptibility genes. We had no intention of comparing the network modules across brain regions.</p><p>We appreciate the reviewer's recommendation to build a consensus network to simplify the results, which we were previously unaware of. Following the reviewer's suggestion, we built a consensus network based on all thirteen brain regions' gene-level expression profiles (GTEx v8). We found that the potential susceptibility genes in the Brain-Cerebellum and Brain-Front Cortex (BA9) identified by eDESE:gene, and the potential susceptibility genes in the Brain-Cerebellum identified by eDESE:isoform were all significantly enriched with the same consensus module, which was significantly enriched with plenty of neuronal and synaptic signaling-related GO terms. However, no enriched consensus module was found for the susceptibility genes identified by S-PrediXcan (see lines 384-402 in the revised manuscript). The consensus analysis results supported the utility of our framework.</p><disp-quote content-type="editor-comment"><p>– The drug repositioning analysis could be improved by drawing on comprehensive drug-gene information from hetionet (https://doi.org/10.7554/eLife.26726.001). This resource might further refine some of your top associations by accounting for anatomies, biological processes, side-effects, and symptoms.</p></disp-quote><p>We thank the reviewer for this suggestion and appreciate the reviewer's recommendation to use Hetionet v1.0 to refine our top associations. We were mainly concerned about the potential susceptibility of the identified genes to schizophrenia and considered the drug repositioning evidence as a supplement. One reason is that some of our top associations contain many non-coding genes and pseudogenes that are not druggable. Another reason is that drug repositioning is complex and usually needs the support of multi-omics data. Thus we only investigated the drug-gene interaction terms and potential druggability of the susceptibility genes in our analysis.</p><p>We also studied Hetionet v1.0 and found that its function &quot;Connectivity search&quot; is interesting and useful in investigating the potential associations in genes, anatomies, biological processes, side-effects, symptoms and so on. We then used Hetionet v1.0 to support the top phenotype-gene associations for the susceptibility genes exclusively predicted by eDESE:isoform (see lines 349-354 in the revised manuscript).</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>GTEx v8 data contains samples from multiple tissues, and the significant gene-trait association in some tissue may be non-causal driven by gene expression correlation with causal tissues. It should be interesting to come up a new method to remove those false positive.</p></disp-quote><p>This is a very good recommendation! We thank the reviewer for this comment, which has allowed us to improve the estimation results of phenotype-associated tissues. The issue about how to remove the false positive in the gene-trait association analysis is complex. We attempted to alleviate the issue by removing those false positives in the phenotype-associated tissues. The gene-trait association in more reliable phenotype-associated tissues might be more likely the truly susceptibility genes.</p><p>The significant tissues identified based on eDESE:dist may not all be phenotype-associated due to the high correlations between brain expression profiles. Based on the eDESE:dist, all thirteen brain regions were ranked top by statistical significance and predicted as the significant phenotype-associated tissues for schizophrenia, no matter based on gene-level or isoform-level (transcript-level) expression profiles (see lines 281-286 in the revised manuscript and supplementary file 1d). For schizophrenia, the Brain-Frontal Cortex is the most known potential susceptibility region, while what roles of other twelve brain regions play in the development of schizophrenia remains obscure.</p><p>Our framework, eDESE, inherits the framework of DESE and can also predict potential phenotype-associated tissues and susceptibility genes with the guide of <italic>cis</italic>-eQTLs. What eDESE over DESE is: First, eDESE is built based on a new ECS, with which the type I error could be controlled within a proper level. Second, eDESE expands the conditional gene-based association analysis of DESE by using different SNPs sets, i.e., physically nearby SNPs (DESE did), gene-level and isoform-level variant-gene eQTLs associations.</p><p>We then assumed that if a tissue (say <italic>T<sub>1</sub></italic>) is a phenotype-associated tissue, potential susceptibility genes identified by eDESE with the eQTLs of <italic>T<sub>1</sub></italic> will be more likely to be phenotype-associated genes and be selectively expressed in <italic>T<sub>1</sub></italic> or similar tissues. Using the isoform-level eQTLs, based on a more precise resolution, we found that the analysis results may be more powerful, as demonstrated in the simulations in the revised manuscript (see lines 247-279 in the revised manuscript). Thus, we integrated the outputs of eDESE:dist, eDESE:gene and eDESE:isoform. Based on the principle of &quot;the wisdom of the crowd&quot;, we finally optimized five brain regions, which were all predicted as the potential susceptibility tissues by eDESE:dist, eDESE:gene and eDESE:isoform, respectively.</p><p>This is also our first trial to remove those non-direct phenotype-associated tissues. The method might be rough but can be a reference for further explorations.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>My major concern is a lack of innovation as a new method. MCGA is based on DES, which integrates expression data with GWAS; and DESE relies on ECS to compute gene-level association evidence. Both DESE and ECS were developed by the authors in the past and published elsewhere. The only innovation in the MCGA methodology seems the improved control of type I error by formally assessing the null distribution of the conditional test statistic for ECS and adjust the test statistic. This improvement is definitely crucial to ECS. But in my view, this is a fix to a long standing issue of ECS rather than a new method in itself. Even with this improvement, the ECS is still not a completely statistically solid method because it still involves heuristic procedures to determine how much the ECS statistics should be adjusted. There is still no methodological guarantee of controlled type I error.</p></disp-quote><p>We understand the concern of Reviewer #3 about the novelty of our study. Indeed, MCGA (called eDESE in the revised manuscript) is based on the ECS and DESE, which were our previously published work. eDESE had at least two advantages over ECS and DESE. First, as the reviewer pointed out, we made a crucial improvement for the ECS to control the type I error by formally assessing the null distribution of the conditional gene-based association analysis based on the ECS and adjust the test statistic. Second, different from DESE, eDESE can perform conditional gene-based association analysis not only by mapping variants to genes according to their physical distance (like DESE), more importantly, but also based on gene-level and isoform-level gene-variant eQTLs associations. These improvements can help eDESE to use the distal variants to predict more significant susceptibility genes and tissues. We also found that isoform-level eQTLs could help eDESE identify more susceptibility genes than gene-level eQTLs in association analysis and produce the potentially significant phenotype-associated isoforms (or transcripts). Though mainly limited by sample size, the eQTL-guided models can be an important supplement for the gene-based approach. The methodology improvement of eDESE, the simulation studies and the comparisons with other methods demonstrated, at least partly, the potential gains of our framework.</p><p>[Editors’ note: further revisions were suggested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>The revised manuscript was submitted in PDF format with track changes. Although it clearly shows what's been changed since the original submission, it is therefore very difficult to read the complete article for a second overall assessment. I will therefore focus on comments I raised in my first review.</p></disp-quote><p>We apologize for the inconvenience in assessing our revised manuscript in PDF format. To address this issue, we have provided the clean version of the revised manuscript through the &quot;Related Manuscript File&quot; option in the <italic>eLife</italic> submission system to facilitate the review process. We thank Reviewer #3 overall for the insightful and helpful comments and for the opportunity to clarify the confusion.</p><disp-quote content-type="editor-comment"><p>However two major issues remain.</p><p>1. The authors failed to respond properly to my public comment on the overall concern that conditional analysis may not be the best approach for this type of problem. Figure 1 of SuSiE paper illustrates the exact scenarios why this could be a bad idea, which motivated my A-B-C genes example. Also incidentally, it is not true that SuSiE cannot work with summary statistics.</p></disp-quote><p>We thank the reviewer for these comments and for the opportunity to correct and clarify. Yes, SuSiE can work with summary statistics. We apologize for not adequately addressing the difference between SuSiE and our approach in our last response.</p><p>The role of our conditional association analysis is to remove redundant association signals per se. We agree with the reviewer that the conditional association analysis may not be the best approach for the fine-mapping analysis because the gene order of entering the conditional association analysis will influence the performance. Gene enters the conditional association analysis in a pre-defined order. In conventional conditional association analysis, the gene order can be determined according to the <italic>p</italic>-value of the gene's overall association with the phenotype. The conditional <italic>p</italic>-value of the second gene was obtained by conditioning on the first gene, and that of the third gene was obtained by conditioning on the first two genes. The conditional <italic>p</italic>-values of subsequent genes were calculated according to the same procedure. Thus, genes with priority to enter the conditional iteration tend to be significant, while genes entering the conditional iteration later tend to be insignificant. In the A-B-C gene example, as the reviewer pointed out, if the non-causal gene C has a stronger marginal signal than either true susceptibility gene A or B, then gene C will enter the conditional association analysis procedure first, which might lead to the true susceptibility genes (A and B) to be insignificant in the conventional conditional association analysis. Also similar to Figure 1b of SuSiE, conventional conditional association analysis may incorrectly identify non-causal gene C as the significant phenotype-associated gene, and gene A and B's association signal will become weaker by conditioning on gene C.</p><p>To address this issue, in this study, we proposed to use the gene selective expression (not the conventional association <italic>p</italic>-value) to guide the gene order of entering the conditional association analysis, which worked well in the real data analysis. The main assumption of gene selective expression is that the true susceptibility genes tend to selectively express in phenotype-associated tissues (e.g., Nat Genet. 2018;50:621–9. Genome Biol. 2019;20(1):233), which might result in a relatively high gene selective expression score for the true susceptibility genes and prioritize the true susceptibility genes to enter the conditional association analysis. For the A-B-C gene example, though gene C has a stronger marginal signal than either gene A or B, according to our assumption, the true susceptibility gene A or B might selectively express in phenotype-associated tissues and tend to have a higher gene selective expression score than gene C, thus can enter the conditional association analysis before gene C. Finally, by conditioning on the true susceptibility gene A or B, the non-causal gene C will be insignificant, which might help alleviate the problems in the A-B-C gene example.</p><p>In addition, as the reviewer pointed out, SuSiE is also a solid and efficient fine-mapping approach. Incorporating the advantages of SuSiE with our method will be interesting and helpful, which we will carefully consider in our future research. As SuSiE is an important fine-mapping tool, we also cited the original paper of SuSiE and discussed the relevant issue in the revised manuscript. We have added the following introduction about SuSiE in our revised manuscript (or see lines 62-65 of the clean version manuscript):</p><p>&quot;SuSiE (sum of single effects), a novel and popular approach to variable selection in linear regression, can use summary statistics and LD to produce gene-level evidence of association in terms of Bayes Factor<sup>10</sup>.&quot;</p><p>We have also added the following discussion in our revised manuscript (see lines 562-566 of the clean version manuscript):</p><p>&quot;Third, the performance of conditional association analysis for fine-mapping can be greatly influenced by the gene orders of entering the analysis. Though the improved effective chi-squared test with eDESE can work well in the real data of schizophrenia, integrating some non-conditional fine-mapping methods, such as SuSiE, with eDESE is worth trying.&quot;</p><disp-quote content-type="editor-comment"><p>2. The response to the question of the choice of c (from another reviewer and myself) is still not satisfactory. It seems the favorable c still was computed in very specific scenarios. In fact, the new Figure 9 exactly demonstrates my concern: optimal choice of c depends greatly on LD and effect size, and for variants with small effects (OR &lt; 1.4 which would be the case for most GWAS signals) the range of optimal c is wide. Given this result, I remain unconvinced that the tests are calibrated under current choice of c. From Figure 9 I would conclude that a conservative c = 1.8 should be used in general, which is different from the recommended choice from the authors.</p></disp-quote><p>We thank the reviewer for these comments and for the opportunity to clarify. The <italic>c</italic> in Figure 9 was merely the correlation of chi-square statistics, which increased with OR up to the upper bound (|r|). We initially performed relevant analysis and drew Figure 9 to respond to the comment 3 of Reviewer #3 in our last response. The meaning of <italic>c</italic> value in Figure 9 is different from the <italic>c</italic> value used for the association test.</p><p>The factors that affect the choosing of favorable <italic>c</italic> for the association test are complex, including such as the correlation of chi-square statistics, the redundancy of degree of freedom and the approximated non-negative solutions. We generated the favorable <italic>c</italic> for the association test by extensive simulations. Specifically speaking, we simulated many relatively common scenarios, which included various sample sizes and variant numbers for both binary and continuous traits, respectively. The description of the common scenarios is as follows (or see lines 627-631 in the clean version manuscript).</p><p>&quot;We considered in total 84 parameter settings, i.e., a combination of three different sample sizes (10,000, 20,000 and 40,000) and 14 different variant number (10, 30, 50, 80, 100, 125, 150, 200, 250, 300, 400, 500, 800, and 1000) for both binary and continuous traits, respectively. For a parameter setting, 40,000 datasets were simulated and used to produce <italic>p</italic>-values to determine the favorable <italic>c</italic> value.&quot;</p><p>We apologize for the confusion about the <italic>c</italic> in Figure 9. We have replaced the expression of <italic>c</italic> in Figure 9 with <italic>c'</italic> to distinguish it from the <italic>c</italic> for the association test (or see lines 640-665 in the clean version manuscript).</p><p>To further address the reviewer's concern, we also performed simulation analyses (similar to the analyses in Figure 4 in the revised manuscript) with <italic>c</italic>=1.8. The Q-Q plots in <xref ref-type="fig" rid="sa2fig2">Author response image 2</xref> simply that the <italic>c</italic>=1.8 led to a higher false-positive rate in the conditional association analysis. It seems that a larger <italic>c</italic> will make the test more liberal. Therefore, we chose a more conservative <italic>c</italic> (i.e., 1.432) in this study. We also added the following discussion in our revised manuscript:</p><p>&quot;Fourth, the optimal <italic>c</italic> value of the effective chi-squared test is still empirical although we derived its range and relevant factors. The optimal <italic>c</italic> value can be improved to be better suited for other specific application scenarios.&quot;</p><fig id="sa2fig2" position="float"><label>Author response image 2.</label><caption><title>Q-Q plots of the conditional, unconditional gene-based association test and likelihood-ratio test under the null hypothesis (<italic>c</italic>=1.8).</title><p>(<bold>a</bold>) and (<bold>d</bold>), two gene-variant pairs with the similar variant number (SIPA1L2 with 29 variants and LOC729336 with 30 variants). (<bold>b</bold>) and (<bold>e</bold>): two gene-variant pairs with different variant numbers, and the first is larger than the second (CACHD1 with 41 variants and RAVER2 with eight variants). (<bold>c</bold>) and (<bold>f</bold>): two gene-variant pairs with different variant numbers, and the second is larger than the first (LOC647132 with five variants and FAM5C with 48 variants). (<bold>a</bold>), (<bold>b</bold>) and (<bold>c</bold>): the former gene has no QTL, and QTL explained 0.5% of heritability in the latter gene. (<bold>d</bold>), (<bold>e</bold>) and (<bold>f</bold>): the former gene has no QTL, and QTL explained 1% of heritability in the latter gene. Ten thousand phenotype datasets were simulated for each scenario. Unconditional Eff. Chi. (the red) represents unconditional association analysis at the former gene by the improved ECS. Conditional Eff. Chi (the blue) represents conditional association analysis at the former gene conditioning on the latter gene by the improved ECS. The likelihood ratio test (the yellow) was conducted based on the nested linear regression models.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70779-sa2-fig2-v1.tif"/></fig></body></sub-article></article>